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Abstract 
Little is known about the usefulness of Case Formulation (CF) to Cognitive 
Behavioural Therapy (CBT) practice and outcome despite its highly held esteem 
within Clinical Psychology.  The aim of this study was to explore the use of a new 
approach to formulating, Hallam’s (2013) Individual Case Formulation (ICF), as a 
potential mechanism for contributing to change in PTSD treatment using a single case 
experimental design (SCED). The study had two components: firstly, training on ICF 
to shed light on how skills in formulation are developed and secondly, use of ICFs 
during PTSD treatment of eight individuals. It was hypothesised that ICF workshop 
training could increase therapist formulation skill. It was also tentatively hypothesised 
that quality and complexity of ICFs might relate to outcome for people with PTSD 
and that other specific elements captured within the ICF might link to outcome and 
rate of improvement for people with PTSD. A secondary hypothesis that sharing a 
formulation during treatment could be associated with reducing symptoms was also 
investigated. Formulation diagrams were coded using a newly devised rating scale in 
order to identify potential elements within ICFs. Coding results from diagrams and 
patterns of outcome measures from the eight participants were explored at group and 
individual levels. Due to the small sample size and the observational nature of many 
of the analyses, results were interpreted with caution. Findings from the training 
indicated increased formulation quality, suggesting that formulation skill can be 
enhanced in therapists. Group and individual analysis offered initial, preliminary 
support for the idea that higher quality CFs might be associated with reduction in 
symptoms. Other specific items within CFs appeared to show some association with 
change in symptoms. It was difficult to adequately address the hypothesis regarding 
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complexity, as very little complexity was shown across the sample of diagrams. Initial 
support was found for the secondary hypothesis, with visual analysis suggesting that 
some participants demonstrated symptom change following the shared formulation, 
suggesting that change in symptoms was linked to this process. Potential implications 
of the findings and suggestions for future research are discussed. 
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Introduction 
 
Case Formulation (CF) is a core clinical component widely advocated for use within 
Clinical Psychology as a way of synthesising theory, research and individual 
experience to assist in the collaborative understanding of a person’s presenting 
difficulties. CF has been described as the heart of evidence-based practice (Hartley, 
Jovanoska, Roberts, Burden & Berry, 2015; Kuyken, Fothergill, Musa, & Chadwick, 
2005) viewed as an essential skill taught to mental health professionals as a way of 
expressing, understanding and communicating a variety of psychological problems.  
Despite its high regard, little systematic research exists on evaluation of the 
components or processes of CF. There is a particular lack of research investigating the 
link between formulation and treatment outcome. Therefore, although CF is viewed as 
a highly important element of Cognitive Behavioural Therapy (CBT), it is poorly 
understood at an empirical level (Zivor, Salkovskis, & Oldfield, 2013).  
With the national roll-out of CBT across mental health services, there is a 
danger that formulation-based CBT may not survive in the current climate of the 
“mass-production of trained therapists” (Zivor et al., 2013, p.2). With psychology 
services increasingly treating more complex individuals with co-morbidities 
(Goddard, Wingrove, & Moran, 2015), it is more important than ever to scientifically 
evaluate components of CBT such as CF, to determine the worth it can provide for 
effective psychological therapy and maintain and enhance recovery rates.  
There is a move towards theory-driven idiosyncratic models for evidence-
based individualised treatment that focus on commonalities between disorders rather 
than viewing difficulties as single entities to be treated separately (Batten & Hayes, 
2005). Due to increased interest in individualised approaches, CF is gaining more 
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attention. Hallam (2013) promotes training and use of an Individual Case Formulation 
(ICF) to assist in the full understanding and targeting of symptoms. However, there 
remains little research investigating the use, process and components of ICF (Macneil, 
Hasty, Conus, & Berk, 2012; Tarrier, 2006), including Hallam’s (2013) approach. 
Hallam (2013) proposes that an ICF system is a useful way to identify 
components that predict symptom trajectory and could be useful for difficult to treat 
disorders. Outcomes for Post-Traumatic Stress Disorder (PTSD) are poorer than for 
other disorders (Kar, 2011). This may be due to complexity of the presentation (Foa, 
Keane & Friedman, 2000) and a number of factors that potentially require formulation 
for fuller understanding. The ICF approach is intended to promote better formulations 
that enable therapists to better formulate complexity, which could help to enhance 
recovery rates of PTSD to the extent that they are able to better direct treatment. 
There also continues to be uncertainty around the process of completing formulations 
including whether sharing a formulation with a client could act as a mechanism of 
change in CBT (Gladwin & Evangeli, 2013). Again, there is a lack of systematic 
research investigating sharing CFs within services where CBT is rolled out on a large 
scale (Kuyken, 2006). Investigation into this process could highlight an important 
contribution to facilitating change within therapy (Hallam, 2013).  
This preliminary and exploratory study of formulation for PTSD tested a 
newly proposed approach to operationalising formulation and a new scale for 
evaluating expertise in formulation. Using a small case series, the aim of the study 
was to (1) determine how therapist formulation skill develops following ICF training, 
(2) determine whether overall quality or complexity of case formulations are related 
to outcome and rate of improvement in PTSD symptoms, (3) evaluate whether 
specific components within an ICF appear to be associated with outcome and rate of 
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improvement for people with PTSD and (4) examine whether the process of sharing a 
CF with a client during PTSD treatment can produce change. By focusing on these 
aims, it was hoped that a clearer picture of what makes a “good” formulation that can 
improve treatment would emerge. 
Case Formulation 
Case Formulation (CF) represents idiographic theory of an individual and their 
current functioning detailing descriptions of the main difficulties being experienced, 
information on the development of the problem, current situational triggers and 
maintaining factors that describe how components relate to each other (Hallam, 
2013). CFs often detail cognitions, beliefs and behaviours (Hartley et al., 2015), 
connecting assessment and treatment phases of psychological therapy, identifying 
variables that can be targeted within interventions (Jose & Goldfried, 2008). CFs have 
been created from multiple theoretical perspectives including cognitive, behavioural, 
systemic, psychodynamic and humanistic approaches (Sturmey, 2010) and used for 
understanding a multitude of psychological problems for children, adults and older 
adults across individuals, couples and within families. Use of CF enables effective 
selection and guiding of treatment using evidence-based interventions that aim to 
reduce psychological distress and improve well-being (Hartley et al., 2015; Kuyken, 
Padesky & Dudley, 2008). Flinn, Braham, and Nair (2015) suggest that CF 
corresponds with a scientist-practitioner view using “psychological science to help 
solve human problems” (DCP, 2010, p.3).  
Case conceptualisation is a skill held in high regard within psychological 
treatment and reflects the contribution that a good formulation can make to the 
success of therapy (Hallam, 2013).   
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Formulation vs diagnosis 
Psychiatric diagnosis has traditionally been emphasised within Psychiatry with 
the implied benefits that it reliably guides intervention (Kendell & Jablensky, 2003; 
Macneil et al., 2012). Within research, diagnosis enables categorisation of people by 
disorders for clinical and randomised controlled trials (RCTs) enabling empirically 
supported disorder-specific treatments to be developed (Shafran et al., 2009). 
However, Hallam (2013) claims that used alone, psychiatric diagnosis is not 
sufficient for explaining the causes of a difficulty or for capturing the personal 
experience of that difficulty. Within current psychiatric diagnostic systems that use 
lists of possible criteria, the same diagnosis could be given to two people who have no 
symptoms in common (Tarrier & Calam, 2002) suggesting diagnosis could poorly 
inform clinicians about the intervention to use (Kuyken, 2006).  
 Although diagnostic categories suggest intervention based on clinical trials, 
they do not help clinicians to predict suitability to treatment, likelihood of outcome or 
offer explanation for non-responsiveness to interventions. Sim, Gwee, and Bateman 
(2005) argue that clinicians must determine suitability for psychological intervention 
and suggest that understanding of a person gained through CF facilitates this, 
connecting “aetiology, description, theory, practice and science” (Sim et al., 2005, p. 
289).  
Despite acknowledging that diagnoses may be useful working concepts, 
Kendell and Jablensky (2003) argue that many are not valid since they are not 
discretely separate from other disorders. Recognition of the limitations of psychiatric 
diagnosis has contributed to the increased interest that CF has started to receive 
(Macneil et al., 2012). 
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CF can be used as a Clinical Psychologist’s alternative to diagnosis (Bucci, 
French & Berry, 2016), deemed a viable substitute by the Division of Clinical 
Psychology (DCP, 2013). CFs offer shared understanding of individual presentations 
linking current and past experiences within a person’s context (DCP, 2011), help 
determine factors that have influenced experiences and assume that, “at some level it 
all makes sense” (Butler, 1998, p.2). Furthermore, they have the potential to help 
determine the problems to prioritise, anticipate challenges that might arise and 
identify criteria necessary for successful outcome (Butler, 1998; Johnstone & Dallos, 
2006). Importantly, CF can promote collaborative therapy, providing a shared 
rationale and agenda for intervention (Macneil et al., 2012) and if completed 
thoughtfully involving clients, has the potential to “provide considerably better 
outcomes than diagnosis alone” (Macneil et al., 2012, p. 3). 
Conversely, describing difficulties within an illness model can reduce agency 
and service user (SU) self-efficacy to work towards recovery (Boyle, 2013) leading to 
discrimination (Lasalvia et al., 2013), reducing self-esteem and collaborative 
decision-making (Pasman, 2011). Diagnosis might ignore contextual links between 
mental health and experiences, beliefs and behaviours including cultural and social 
contexts (DCP, 2013) whereas a CF can include these factors, detailing formation and 
maintenance of difficulties (Hallam, 2013). The DCP (2013) argues that approaches 
that contextualise distress and behaviour and recognise complexity of interactions 
between psychological, social, historical and biological factors are preferable and are 
in accordance with core principles of formulation in Clinical Psychology. Developing 
a CF enables negotiation of a shared psychological perspective between SUs and 
clinicians, normalising problems and enhancing containment for clients and 
therapists, aspects that can be lost in psychiatric diagnosis (DCP, 2011).  
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Summary. Various etiological factors may predispose people to psychological 
morbidity and will differ in how each factor affects an individual (Macneil et al. 
2012). Integrating this information into a CF that enables individual treatment 
planning could enhance effective care. Macneil et al. (2012) warn that failure to do so 
may not only result in reduced outcomes but might exacerbate a person’s symptoms. 
Advocates of CF claim that case conceptualisation allows synthesis of research and 
individual experience, combining rich information and enabling thorough 
understanding in ways that diagnosis alone does not (Hallam, 2013; Sim et al., 2005).   
 
The reality of CF in clinical practice: concerns 
Despite strong proponents for use of formulation, the reality is that little is 
known about how CF is implemented within clinical practice. This is in contrast to the 
scrutiny of investigation that CBT has undergone and suggests a need for detailed 
investigation into the use of CF (Zivor et al., 2013). 
Poor agreement often exists between cognitive therapists when theory driven 
inferences are made about a person’s difficulties (Dudley, Park, James, & Dodgson, 
2010; Mumma & Smith, 2001; Persons, Mooney & Padesky, 1995). Some of the 
concerning inconsistencies associated with CF might be in relation to therapist skill 
and expertise as well as the lack of systematic research linking formulation to 
treatment outcome, the nomothetic components of current formulation systems and 
the unknown validity of CFs.  
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Skill and expertise. Level of skill and knowledge in CF have long been 
considered to be essential components that contribute to therapist competence in CBT 
highlighting formulation skills as fundamental for effective therapy (Dobson & Shaw, 
1993). CBT is broadly disseminated as part of the Improving Access to Psychological 
Therapies (IAPT) programme (Zivor et al., 2013), a national government initiative 
aiming to improve access to psychological therapy within the NHS. A report detailing 
the necessary activities for high quality and effective CBT within IAPT found that 
developing a CF is a key competency in enabling development of a treatment plan 
(Roth & Pilling, 2007). The importance of CF is further recognised within the 
Cognitive Therapy Scale – Revised (CTS-R; Blackburn et al., 2001) that measures 
clinician CBT skills and promotes the use of individual conceptualisation.  
However, there is concern about whether formulation based CBT will survive 
with the high volume of therapists trained with varying levels of formulation skill and 
expertise, with particular concern regarding the level of CF skill in novice therapists 
(Kendjelic & Eells, 2007; Misch, 2000). One study compared CFs between novice, 
experienced and expert clinicians (Eells, Lombart, Kendjelic, Carolyn, & Lucas, 
2005) and found that CFs created by expert clinicians were more comprehensive, 
elaborate, explanatory and complex compared to the other two groups. The authors 
found that expert knowledge, that novices lacked, predicted best CFs rather than 
experience. Indeed, other research has suggested that experience alone is not 
sufficient to develop expertise and instead teaching and repetition of formulation 
skills, reflection on formulations and feedback from other therapists appears essential 
(Feltovich, Prietula, & Ericsson, 2006). Within Eells et al. (2005) “expertise” was 
defined as those who had published formulation systems or led formulation 
workshops. There is unlikely to be this level of expertise across all clinicians treating 
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psychological disorders. However, perhaps if these expert skills can be identified, 
they could be taught to novice therapists to increase formulation ability. Without this, 
the therapists “on the ground” are likely to be left in an unsatisfactory position 
whereby formulation based CBT is encouraged and shown to be effective in clinical 
trials involving practitioners trained very differently from themselves (Zivor et al., 
2013).  
Dudley et al. (2010) investigated level of agreement across mental health 
clinicians with varying levels of skill, qualification and training. Formulations were 
collected from 82 clinicians following a video of a person displaying delusional 
psychotic beliefs. Formulations were compared to a “benchmark” formulation of the 
same case that was created by three expert therapists. Increased clinical experience 
improved agreement with the benchmark formulation and theory-driven components 
of formulations were increased in those with more CBT experience. Interestingly, 
increased experience of working with psychosis reduced the rate of agreement with 
the benchmark formulation. This study suggested that experience in CBT predicts 
formulation skills rather than knowledge of a specific area and is therefore 
contradictory to the findings of Eels et al. (2005). Experience of trainees has also been 
shown to predict ability to integrate information in complex case conceptualisation 
(Ladany, Marotta, & Muse-Burke, 2001).  
Kuyken et al. (2005) rated formulations on reliability and quality across 
mental health practitioners with different experience. Clinicians provided a CF based 
on a case description, and reliability (inter-rater agreement) and agreement with an 
expert formulation were measured. Results indicated that for quality of CFs, 22.1% of 
formulations were deemed “very poor”, 33.6% as “poor”, 34.5% as “good enough”, 
9.7% as “good”. Therefore overall 44.2% were rated as “good enough”. Levels of 
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agreement between clinicians and with the expert formulation were reduced when 
greater levels of theory driven inferences were made. The differences in reliability 
and quality of formulations were associated with prior experience and training. 
Increased number of years post-qualification experience and professional qualification 
were positively associated with levels of theory driven inferences and higher quality 
formulations. This study suggests that increased qualification increases CF quality 
and highlights that CF is a complex skill that requires teaching to enhance CF 
reliability and quality within clinical practice. 
Synthesis of this research suggests that there are differences between 
therapists in CF skill and indicates that CF is a skill requiring practice, time, resource 
and commitment to develop with experience and training appearing to be necessary in 
predicting quality of CF. Brosan, Reynolds, and Moore (2008) found that many 
clinicians rate their CF skills unrealistically highly, further suggesting that it is 
essential that these skills continue to be measured, developed, tested and fostered 
within practitioners, to promote good quality care. 
 
Case Formulation and treatment outcome. CFs are linked to reducing 
emotional distress (Hartley et al., 2015), increasing meaning, agency and hope (DCP, 
201) and ensuring that SU voices are heard, promoting a collaborative therapeutic 
style (Johnstone, 2011). However, as Kuyken (2006) asserts, the “primary criterion 
whereby CF stands or falls is whether it directly or indirectly improves the process or 
outcome of CBT” (Kuyken, 2006, p. 24).  Interestingly, despite being defined as “the 
lynch pin that holds theory and practice together” (Butler 1998, p. 2) and an 
underpinning principle of cognitive therapy (Beck 1995), research on the impact of 
CF on outcome is scarce (Macneil et al., 2012). Tarrier (2006) suggests that it is 
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possible that CF has found a place in practice ahead of any evidence for its proposed 
advantages. Despite this, it is a widely used tool in CBT often viewed as the “first 
principle” when planning treatment (Freeston et al., 2001; Morrison, 2002). It is 
therefore concerning that the role of CF has not been linked to outcome.  
Some preliminary research suggests that intervention guided by CF can 
improve outcome. Silberschatz, Fretter, and Curtis (1986) conducted one of the only 
studies investigating the effect of CF on outcome. They hypothesised that use of a 
“patient plan” (dynamic CF) that enhances therapist understanding and guides 
intervention would increase progress in therapy. Using brief psychotherapy, they 
found that “plan-compatible interpretations” utilised in treatment were related to 
better outcomes than those with lower proportions of interpretations. In other words, 
when therapists used CFs to guide interpretations, this led to better treatment 
outcomes. Crits-Christoph, Cooper, and Luborsky (1988) also investigated if accuracy 
of therapist interpretations within psychodynamic psychotherapy would predict 
treatment outcome. They measured the use of CF that included therapist interpretation 
and found that increased accuracy of clinician interpretation was strongly related to 
treatment outcome, suggesting a link between quality of CF and outcome. Although 
promising, these studies have mostly been conducted in psychodynamic 
psychotherapy and the research by Silberschatz et al. (1986) was conducted with only 
three individuals. The studies are also out-dated and are less likely to be applicable to 
services that routinely implement CBT. Kuyken et al. (2005) emphasise the need for 
CF studies to extend to investigation of the link to therapy outcome within CBT.  
Worryingly, other interventions guided by formulation have not shown to 
enhance treatment (Macneil et al. 2012). Emmelkamp, Bouman, and Blaauw (1994) 
found that individualised behavioural treatment was no more effective than 
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standardised treatment for people with OCD, with both approaches leading to 
significant reductions in symptoms. Schulte, Kunzel, Pepping, and Shulte-Bahrenberg 
(1992) compared individual treatment planning, standardised exposure therapy and a 
control group in people with phobias. Contrary to expectations, the standardised 
group was found to produce the most successful outcomes in both experienced and 
inexperienced therapists. This suggests superiority of manualised approaches over 
formulation driven approaches in improving outcome regardless of therapist skill. 
However, these studies mainly focused on specific disorders with existing protocols 
as opposed to complex and comorbid cases, which CF could be most helpful for. 
Despite this limitation, the usefulness of CF to treatment outcome remains unclear, 
with a lack of empirical evidence from the literature for its proposed advantages. 
Indeed, Kuyken (2006) describes that the ‘idea’ of CF as a useful tool within CBT is 
not sufficient enough to advocate its use. A fuller understanding of its application and 
suitability to clinical practice and its explanatory and predictive power is fundamental 
as well as empirical research into how CF relates to treatment outcome. Measuring 
specific components and processes that occur within CFs whilst tracking outcomes 
will shed light onto the efficacy of CF. Without this, questions regarding usefulness of 
CF remain unanswered (Kuyken et al., 2005).  
 
Existing representation schemes. Another problematic aspect of 
formulations may include the current representation schemes available to therapists. 
Many treatment protocols incorporate diagrammatic or written formulations that 
detail relationships and demonstrate how difficulties are maintained through cycles. A 
number of diagrammatic conceptualisations have been developed for specific 
disorders (Clark & Wells, 1995, Social Anxiety Disorder; Ehlers & Clark, 2000, Post-
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Traumatic Stress Disorder; Salkovskis, 1985, Obsessive Compulsive Disorder). More 
general representations also exist including Padesky and Mooney’s (1990) Hot Cross 
Bun that demonstrates how a trigger can lead to specific presenting problems, 
detailing the interaction between thoughts, emotions, physical sensations and 
behaviour. The Five Ps is another common formulation method used for describing 
presenting problems, predisposing factors, precipitating factors, perpetuating factors 
and protective factors (Johnstone & Dallos, 2006).  These frameworks are often easy 
to measure within research, useful as supervision aids (Johnstone, 2011) and go 
beyond diagnosis to provide descriptions of individual experience and suggest targets 
for treatment (Macneil et al., 2012). However, they are often presented as one off 
“formulations-as-events” (Cole & Johnstone, in press) and suggest a clear start and 
end point to a difficulty (Johnstone, 2011). Moorey (2010) describes that these types 
of case conceptualisations are simple, quick and easy to use but generic and lack 
specificity and suggests that developing therapist and SU understanding through 
formulation takes time to effectively complete. 
Regan (2013) interviewed CBT therapists within IAPT services on attitudes 
towards formulation and found that with increasing targets and time pressure, coupled 
with less space for reflection there is less opportunity for detailed, comprehensive and 
complex formulating. Therefore, disorder specific models and “formulations-as-
events” might be the only option for therapists but may not fully reflect an 
individual’s experience, especially in the current climate whereby services such as 
IAPT are having to meet the needs of more complex clients (Goddard et al., 2015).  
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Looming nomothetic principles. The presence of nomothetic elements within 
current representation systems might also hinder therapist choice to use CFs. 
Qualitative feedback from CBT therapists reported that “people don’t fit into boxes”, 
concerned that disorder specific CFs are like diagnostic and medical models, that can 
be detrimental to clients when symptoms are matched to a model (Regan, 2013). 
Disorder specific models, based on diagnosis, serve a different function to CF 
(Kuyken, Padesky, & Dudley, 2008) and Hallam (2013) suggests that despite specific 
CBT techniques such as Socratic questioning and identifying core beliefs to promote 
idiographic formulations, the “nomothetic element can loom very large when 
problems are matched to a psychiatric diagnosis” (Hallam, 2013, p.29). For example, 
although Persons (2008) suggests that her proposed formulation model is based on 
ICF, she includes a symptom and disorder level. Hallam (2013) asserts that 
formulation should not involve matching clients to models and that the therapist’s role 
is to tailor formulation and treatment according to a person’s presentation. In support, 
Moorey (2010) suggests that there is no “off-the-shelf” diagram to explain complex 
interactions that maintain difficulties. 
Diagnosis appears to loom in other transtheoretical approaches to CF also. 
Nezu, Nezu, and Lombardo (2004) suggested a functional approach to CF using a 
problem-solving model focusing on working towards goals, rather than symptom 
reduction. However, this approach uses diagnostic categories and nomothetic 
principles to describe presenting problems. Hallam (2013) suggests that this is a “top 
down” approach to functional analysis and argues that the diagrams produced by 
Nezu et al. (2004) are not precise or succinct enough to use effectively. Macneil et al. 
(2012) argue that a key challenge is creating a formulation approach that integrates 
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clinical and theory-driven understanding from the evidence-base with a person’s 
unique experience to move towards evidence-based individualised therapy.  
 
Validity of CFs. Despite increased CF manuals being developed, there 
continues to be uncertainty around the validity of CFs (Kuyken et al., 2005). Validity 
should be evaluated to enhance CF accuracy and determine its usefulness in assisting 
with treatment (Mumma, 2011). However, CF validity has barely been addressed 
(Johnstone, 2011). This is surprising for a number of reasons: (i) validity has 
historically been a major factor considered when psychological constructs are being 
developed, (ii) CBT has been rigorously tested whereas consideration of CF validity 
has generally been ignored (Mumma, 2011) and, (iii) other therapies, including 
psychodynamic approaches, have developed methods to evaluate CF validity 
(Horowitz & Eells, 2007). Within CBT, theories and approaches are usually 
empirically tested to enhance validity (Shadish, Cook, & Campbell, 2002) and 
therefore it is concerning that little attention has been paid to CF validity on 
conceptual, methodological and empirical levels (Bieling & Kuyken, 2003; Mumma, 
2011).  
Validity of CFs also appears to be overlooked within formulation research. 
Within Emmelkamp et al. (1994) and Schulte et al. (1992), that concluded that 
manualised treatments were superior to formulation approaches, CF validity was not 
evaluated. Without measuring the quality of the CFs, it is difficult to accurately infer 
that formulation approaches lacked efficacy in these studies (Mumma, 2011). 
Secondly, these studies used standardised materials to measure symptom change, 
which does not reflect an idiographic approach to measuring subjective experience, 
suggesting that possible significant changes could have been missed.  
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Bucci et al. (2016) conducted a systemic review of available measures for 
assessing the quality of CFs, measuring ease of administration, generalisability, 
reliability, validity and psychometric properties. They found no single measure that 
has been validated for use across a range of settings. Although the researchers 
outlined measures that could be reliable and valid in particular settings, such as the 
Collaborative Case Conceptualisation Rating Scale (CCC-RS; Padesky, Kuyken, & 
Dudley, 2011) for evaluating CFs in live therapy, the review is limited by a number of 
issues. Firstly, only a small number of studies were included with different methods 
for validating the measures and were thus not easily comparable. Furthermore, many 
scales identified were not published and lacked items such as scoring manuals, 
suggesting a lack of rigorous and systematic methods used for evaluating CF scales. 
Additionally, the authors found that scales had been developed for different purposes, 
such as training or research, potentially accounting for the lack of clarity amongst 
clinicians with regards to measuring CFs. In agreement, Völlm (2014) found that 
within a Delphi survey of professionals, there was no consensus regarding the best 
way to evaluate a CF. Bucci et al. (2016) concluded that more robust and rigorous 
research is needed to develop and validate case conceptualisation scales by either 
modifying existing scales or creating new scales that assess all aspects of reliability 
and validity. Ridley, Jeffrey, and Roberson (2017) argue that it is unethical to have a 
lack of validity for such an integral part of treatment. Therefore, it is paramount to 
have a measure of the quality of CFs (Eels, 2010) for increased ethical and good 
practice of CF and enable more valid comparisons between formulation and 
manualised approaches in future research (Mumma, 2011). 
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Summary. CF is promoted for use within treatment for mental health problems. 
However, the reality in clinical practice suggests that for therapists using 
formulations, “on the ground”, there are worrying factors regarding use of CFs. Some 
of these include differing skills and expertise amongst therapists, concern from 
therapists around using disorder specific models that may include unhelpful 
nomothetic elements as well as practical considerations such as lack of time needed to 
complete comprehensive formulations. This is worsened by the little knowledge about 
the link of formulations to treatment outcome and the unknown validity of CFs. 
Further understanding of how CF can be measured and related to clinical change is 
vital. The variability amongst the quality and use of formulations is of concern and 
suggests a need for proposed solutions and scientific evaluation to improve and 
investigate formulation. Without this, a potential clinical tool that might activate a 
mechanism for clinical change may be lost. 
 
Solutions for Case Formulation  
A number of potential solutions may increase use and efficacy of CFs. These 
include training on CF to enhance skill, a move towards idiographic approaches to 
improve validity, sharing CFs with SUs and research investigating how these 
processes predict treatment outcome.  
 
Training. For complex cases, training and expertise in creating formulations that 
better capture complexity are becomingly increasingly recognised as essential for 
developing a systematic approach to CF (Bieling & Kuyken, 2003) that enables more 
coherent conceptualisations that identify specific targets for treatment (Kuyken et al., 
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2005). Despite this, Kendjelic and Eells (2007) found no studies that evaluated a 
training manual specifically for CF. Holmes (2002) suggested that CBT is often 
viewed as a simple therapy and that practitioners could be underestimating the need 
for advanced CF training. However, training in CF seems to predict higher quality 
formulations. 
Zivor et al. (2013) investigated knowledge, attitudes and use of formulation 
for obsessive compulsive disorder (OCD) between clinicians and highly specialist 
practitioners (HS) who had previous extensive training in CBT formulation. Zivor et 
al. (2013) found differences between the groups on what was deemed most important 
to include within an initial CBT formulation. Furthermore, the HS group tended to 
share formulations earlier on in treatment, share updated re-formulations more 
frequently and were less likely to adhere to a prescriptive CBT model than the 
clinician group, producing more non-standardised models, suggesting more 
idiosyncratic approaches to formulation. Interestingly, less specialist clinicians rated 
themselves as lower on perceived competency in formulation skills, although higher 
on general CBT skill, suggesting that formulation is recognised as a stand-alone skill 
that potentially requires extra training. This study also indicates that more extensive 
training can enhance formulation skill and increase confidence to use non-
standardised approaches. This finding could be helpful to address clinicians concerns 
that (i) they lack training in formulation (Fleming & Patterson, 1993; Kelsey, 2014; 
Perry, Cooper, & Michels, 1987) and (ii) they do not wish to solely prescribe to 
disorder-specific models (Regan, 2013). It seems reasonable to assume that higher 
training through qualification leads to increased formulation skill, demonstrated by 
research showing that PhD level training predicts formulation ability (Persons, 
Mooney, & Padesky, 1995). However, this level of qualification is not always present 
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within all mental health workers and it is therefore necessary to determine if 
formulation skill can be taught without need for further qualification and determine if 
skills in increasing CF quality, especially the ability to adequately address the 
complexity of a case can be enhanced. Kendjelic and Eells (2007) compared 
psychotherapy CFs between 20 clinicians receiving 2-hour formulation training and 
23 controls who received no training. Trained clinicians produced higher quality, 
more complex, comprehensive, elaborate and precise formulations compared to the 
control group. More higher-level inferences were also made in the training group, 
compared to simpler descriptions found in control group formulations. However, this 
study has limitations, as the authors could not ensure that the groups did not differ on 
skill level prior to the training. Comparing pre and post training formulations could 
have been a useful way to measure how skill level changed and to determine whether 
higher quality and more complex formulations were found as a result of the training. 
The authors also suggest that a two-hour training session may not be enough to 
significantly propel clinicians to an “expert” status and more intensive training may 
be necessary for this. Despite limitations, the results are promising and suggest that 
even a two-hour training session can improve quality and ability to formulate case 
complexity. Further research is required to replicate these findings. Increasing 
availability of formulation workshops could be important in order to provide 
therapists that implement CBT with increased and more adequate training.  
Kendjelic and Eells (2007) outline a number of benefits that can be gained 
through training in CF, including increasing the number of inferences made, 
increasing communication and treatment planning, and enhancing SU and clinician 
confidence in the therapy. In addition, with comprehensive and integrative 
formulations, briefer, more targeted treatments might be facilitated that can also 
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predict when longer treatment may be required (Kendjelic & Eells, 2007). Hallam 
(2013) suggests one of the main contributions to outcome is CF skill. There is 
promising research showing that formulation skill can be taught. Shafran et al. (2009) 
suggests that outcomes can increase with clinician training and therefore training on 
CF could have implications for increasing recovery rates. 
 
A move towards idiographic approaches. Another potential solution to 
difficulties encountered with current CBT formulation is a move towards use of 
idiosyncratic models that are tailored to an individual’s experience (Kuyken, Padesky, 
& Dudley, 2009) and guide individualised treatment (Dudley, Kuyken, & Padesky, 
2011) more than disorder-specific models. Popularity for interventions targeting 
common processes between disorders, rather than focusing on one disorder is 
increasing. Accordingly, “formulations-as-processes” have no start or end point and 
no clear guidelines on what to include (Johnstone, 2011). Bieling and Kuyken (2003) 
suggest that in the transfer from nomothetic to idiographic CFs, formulations should 
be evolving processes that move away from diagnostic labels.  
Nezu, Nezu, and Cos (2007) suggest a bottom-up idiographic approach that 
excludes diagnosis. After identifying ultimate outcomes, instrumental outcomes and 
treatment targets, a clinical pathogenesis map is created, depicting idiographic 
variables hypothesised to be development and maintenance factors of an individual’s 
presentation. Nezu et al. (2007) suggest that depicting variables in visual format 
enables SUs to feedback more easily once the CF is shared with them.  Diagrams can 
be modified if an intervention suggested by the model does not produce an expected 
outcome.   
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Haynes and O’Brien (1990, 2000) focus on idiographic functional analytic 
clinical case models that encompass important causal variables associated with a 
person’s difficulties and behaviours and the strength of hypothesised relationships. 
Functional equations are used to express parts of the model, generate alternative 
hypotheses and describe complex functional relationships between variables (Haynes 
& O’Brien, 2000). However, equations are often applied for nomothetic causal 
models and assume more predictive accuracy than is achievable (Haynes & O’Brien, 
1990). Functional analytic causal models change over the course of assessment and 
intervention phases once new information arises or when treatment outcomes are not 
met post intervention. Haynes and O’Brien (2000) describe that the models increase 
understanding of difficulties and clinical decisions and enable communication of these 
processes between SUs and healthcare professionals.  
Jose and Goldfried (2008) proposed the use of a Causal Analysis and 
Synthesis of Events (CASE) system. The CF details intrapersonal and interpersonal 
elements and identifies repeating patterns that are functionally linked and could be 
contributing to a person’s difficulties. The authors suggest that CASE increases 
communication between clients and therapists during CF development, directly 
informs targets for intervention and can be implemented alongside validated treatment 
methods and other models.  
Hallam (2013) suggests that in the move towards idiographic approaches, his 
proposed system extends other methodologies, allowing information to be drawn from 
the evidence-base in conjunction with an individualised approach. 
 
Hallam’s (2013) ICF. Hallam’s (2013) ICF is a pragmatic synthesis of well-
recognised therapy principles, compatible with treatment protocols and existing 
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theories and models to assist in the choice of intervention. Similarly to other 
idiographic approaches, Hallam’s ICF is built around functional analysis principles, 
although he argues that he makes more explicit functional links than other authors. 
Hallam (2015) describes a preference for bottom-up processes, allowing for 
scepticism that individual problems fall into distinct categories explained by a specific 
theoretical model. Instead, an ICF allows for intervention grounded in theory applied 
to an individual case rather than driven by a diagnostic label or the interventions 
available. For ICF construction, a number of different theoretical perspectives should 
be drawn upon, meaning that a final CF “may not resemble anything that has been 
produced in any previous case analysis” (Hallam, 2015, p.54).  
 Hallam (2013) stipulates ways of arranging the information within the 
diagram. Figure 1 details a formulation diagram of an anxiety case depicted in an ICF. 
Observations (placed in circles) refer to the basic circumstances observed, including 
behaviour, thoughts, feelings, and emotions. The diagram shows the behavioural 
observations of avoiding eye contact and situating oneself at the periphery and 
speaking only when spoken to. Other observations are also detailed in circles. Some 
observations might also lead to, and affect, other observations. For example, a person 
anticipating humiliation might anticipate this more when they attend to body 
sensations or have the thought that they are turning red or that they are being judged 
by people. These reciprocal relationships are represented by a double-headed arrow. 
Explanations are provided in order to suggest ways to make sense of the 
information represented by the observations. Explanations can take any number of 
forms: hypotheses, theories, diagnoses, inferred aetiology, inferred historical 
processes or developmental events. They are placed in rectangles and connected to the 
element they explain by a dashed, un-headed line. Behavioural avoidance has been 
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inferred to be an explanation for the observations of socially withdrawing oneself. 
The figure also demonstrates that sensitivity to judgment might explain why some of 
the observations occur at specific events.  
Observations that serve the same function are said to be functionally 
equivalent. In the diagram, functionally equivalent observations are connected with 
non-headed double lines. In the case example, three functionally equivalent 
consequences of anxiety all permit a person to avoid social interaction. Other 
important elements included are contextual antecedents to make clear when the 
problem is more likely to occur. The antecedents include being at a charity event, a 
crowded shopping centre and at an exercise class. These are also functionally 
equivalent, demonstrated by the double lines, meaning that these triggering events all 
function to elicit a similar response in the person.  
The central purpose of a formulation is to help guide where and how to 
intervene to ameliorate the circumstances being addressed. Within the formulation, 
there should be adequate information conveyed regarding how the circumstances in 
question arise and how they are maintained to enhance the ability to anticipate how 
they might change under different conditions and in response to different therapeutic 
strategies.  Figure 1 demonstrates some of the situations and behaviours that could be 
potentially targeted in order to consider how to help with the thoughts and behaviours 
associated with this anxiety presentation. The process involves a SU and clinician 
collaboratively constructing an ICF, and unlike similar previous efforts (Haynes & 
O’Brien, 2000), avoids use of medical or technical behavioural analysis terminology 
that can be difficult for novices to understand and explain. It is considerably more 
flexible than the formulation templates typically employed in CBT such as the Hot 
Cross Bun and Five Ps. Resulting diagrams include client and therapist perspectives, 
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allowing for detailed behavioural descriptions, causal connections and higher levels of 
inferences from observations and interpretations, allowing complexity and 
comorbidity to be represented.  
Figure 1: Example of a constructed ICF as according to Hallam (2013). 
 
O’Connor (2014) argues that Hallam’s approach demonstrates flexibility of 
theoretical, scientific yet impartial and empathic approaches to suit individual 
experiences and highlights the benefits of the open-mindedness and vigilance to SU 
cues, promoting client-centred ICFs.  
 
Increasing validity. Use of idiographic approaches could also increase CF 
validity. CFs based on nomothetic theory contain a number of different validity issues 
  36 
at both individual and aggregate levels (Mumma, 2011). Conversely, idiographic 
assessment should increase relevance and specificity to individuals as “fine-grained, 
highly individualised” (Mumma 2011, p.34) CFs can be developed which sensitively 
detect relationships between variables within a person’s current situation, increasing 
content validity of CFs. Mumma (2011) suggests that developing more individualised 
CFs allow clinicians to make relevant and person-specific predictions that can 
increase CF validity.  
Testing hypotheses and processes to evaluate the predictive validity of a CF 
“is a critical step that has all but been ignored” (Mumma, 2011, p.46). Johnstone 
(2011) and Messer (1996) argue that formulations can only be assessed in terms of 
usefulness to the individual. By developing a CF based on idiographic principles 
whilst completing idiographic outcome measurement, clinicians can tailor treatment 
to specific issues and life circumstances, testing specific hypotheses detailed within 
the formulation, relevant to the SU (Mumma, 2011).  A more idiographic functionally 
based approach to formulation diagramming, such as use of Hallam’s (2013) ICF 
could address validity and reliability issues that are a central weakness of existing 
literature on CF (Kuyken et al., 2005). 
 
Sharing formulations. A final factor that could enhance use of CFs is sharing 
formulations, a process promoted by the DCP (2011). Sharing formulations within 
staff teams has been shown to reduce blame, increase optimism and increase 
understanding of SU difficulties, promoting positive feelings towards SUs (Berry, 
Barrowclough, & Wearden, 2009; Summers, 2006).  
Sharing CFs with SUs in diagrammatic, written or verbal format differs 
between therapists, therapeutic models and presenting problems. It is an active part of 
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treatment within some modalities including Cognitive Analytic Therapy (CAT), but 
not always deemed an essential part of CBT. CAT involves sharing written 
reformulation letters and diagrammatic formulations with SUs that describe 
presenting problems within the context of an individual’s developmental and social 
history (Ryle, 1990). SUs are given the opportunity to change and update 
formulations, aimed at increasing their understanding of difficulties and instilling 
hope (Ryle & Kerr, 2003). Research has indicated that developing and sharing 
formulations can reduce SU distress and increase coping (Horowitz, 1997) and might 
further therapist understanding (Kinderman & Lobban, 2000).  
Evans and Parry (1996) shared formulations within CAT, aiming to enhance 
therapeutic relationships, focus the intervention and increase SU understanding. 
Results showed no association between sharing written CFs and improving outcome 
for people with borderline personality disorder. Gladwin and Evangeli (2013) 
explored the association between sharing CFs and the quality of written CFs and 
weight in women receiving CAT for anorexia nervosa (AN). They found evidence 
supporting an association between sharing written CFs and weight change (weight 
gain and loss). Higher quality CF was not associated with weight change. Therefore, it 
was suggested that sharing CFs can significantly impact therapeutic change but higher 
quality CFs do not necessarily benefit therapy. The authors also suggested that 
clinicians should not assume that sharing formulations is therapeutic in itself.  
Chadwick, Williams, and Mackenzie (2003) and Pain, Chadwick, and Abba 
(2008) investigated the impact of sharing CFs on clients receiving CBT for psychosis. 
Chadwick et al. (2003) found that therapists reported enhanced optimism and 
understanding of presenting problems and theory-practice links. Some clients also 
reported increased hope, reassurance, encouragement and optimism, demonstrating 
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that there appears to be some therapeutic gains from shared formulations. However, 
with regards to outcome, there was no significant impact of the CF reducing 
conviction in core beliefs, easing distress or for improving therapeutic alliance. 
However, this study has a number of limitations and therefore needs replicating. 
Dependent variables were predetermined and were not idiographic measures, 
suggesting that individual benefits of sharing CFs may not have been captured. 
Furthermore, the effectiveness of CFs was only assessed once and thus there was no 
assessment of delayed benefits of the CF that may have occurred. Furthermore, data 
analysis lacked robust qualitative methodology and consequently, the results should 
be interpreted with caution. The authors also suggested that CF could provide other 
benefits not tested within this research, although they concluded that it appears that 
CF does not demonstrate short-term impact on clients.  Within Pain et al. (2008), 
clients were encouraged to review their CF diagram and accompanying formulation 
letter. The CF impacted some clients positively, increasing hopefulness and enhancing 
the therapeutic relationship. Others responded negatively although Pain et al. (2008) 
suggest that this is normal in response to difficulties being recognised. The authors 
found that sharing the CF was “emotionally and cognitively powerful” (Pain et al., 
2008, p.136) with some clients reporting that written formulations acted as a coping 
tool, allowing them to measure progress.  
Treasure and Schmidt (2013) reviewed their Cognitive-Interpersonal 
Maintenance Model (2006) for AN which uses three sub-diagrammatic formulations 
detailing complex interactions including cognitive, social and emotional traits as well 
as carer vulnerabilities that can affect coping and maintenance of AN. The authors 
concluded that the model enhanced individual and family understanding of 
mechanisms underpinning and maintaining AN. The Maudsley Model of Anorexia 
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Nervosa, (Schmidt, Wade, & Treasure, 2014) was developed based on this model 
involving a “formulation phase” of treatment (Schmidt et al., 2012) where a 
collaborative CF is developed with SUs (Schmidt et al., 2013) and presented to the 
SU in diagrammatic form and a letter.  
Overall, sharing CFs does not seem to be explicitly linked to improving 
treatment outcome. Kuyken (2006) argues that these studies raise questions about 
whether the idea that sharing CFs could be beneficial, holds any weight. However, 
small samples used within these studies and the limitations in methodology and 
analysis do not provide sufficient or robust evidence to rule out the efficacy of sharing 
CFs in assisting with therapy.  
Hallam (2013) suggests that the therapeutic alliance “cannot be viewed as 
independent of the skills of formulation” (Hallam, 2013, p.121) and is premised on 
the agreement of a shared formulation between the therapist and client (Mumma & 
Mooney, 2007). Therefore, it follows that the juncture at which the formulation is 
shared could itself mark a point of change. Further research appears necessary to 
determine if sharing CFs with SUs could contribute to facilitating change. Despite 
being methodologically challenging, investigating causality of the process of sharing 
CFs by isolating this specific procedure appears necessary to test the impact on 
outcome.  
Summary.  There may be a number of possible solutions to assist with the 
problems associated with current CF in clinical practice. Training could be an 
important component to increase therapist formulation skill and confidence. Secondly, 
a move towards ICFs for clients could assist in more specific targets for treatment, as 
well as increasing validity of CFs and helping to identify components that maintain 
difficult to treat mental health problems by going beyond current existing models. 
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Sharing formulations within CBT requires further research to determine its usefulness 
to clinical practice. Indeed, CF in CBT appears to be in need of urgent research to 
investigate these ideas and thus shed light onto its potential for assisting treatment. 
Implications for research  
Despite lack of sufficient and robust evidence for use of CF in CBT, 
researchers continue to advocate its use in treatment planning (Grey, 2007). A more 
detailed investigation into CF is essential to focus on what form CF routinely takes, 
how CF is developed, whether it can assist with treatment outcome and whether CFs 
should be shared with SUs (Kuyken, 2006). This can potentially provide insight into 
how best to carry out effective techniques in CBT. The first step of research is to 
explore the usefulness of CF to treatment outcome. Focusing on a disorder with 
poorer outcomes would be a useful starting point to determine whether CF can assist 
in enhancing treatment. 
Outcomes are particularly low for Post-Traumatic Stress Disorder (PTSD, 
Kar, 2011), commonly attributed to greater complexity that leads to challenges in 
treatment (Foa et al., 2000). Training has been shown to increase formulation quality 
and complexity (Kenjelic & Eells, 2007). The next step in formulation treatment is to 
link whether a better formulation might assist treatment. If an ICF can represent 
sufficient expertise in formulating increasingly complex cases (Hallam, 2013),  
difficult to treat disorders such as PTSD could potentially be better understood and 
potentially more effectively treated. This is a tentative idea but important to test with 
regards to the efficacy of a formulation in guiding treatment. If ICFs can provide 
additional individualised formulation alongside existing models this could enable 
increased relationships between variables and complexity to be captured to 
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demonstrate potential factors contributing to more chronic disorders. An ICF would 
also allow for an idiographic approach to CF and treatment detailing individual 
mediators and processes between factors. 
Using formulations to increase treatment effects is suggested within the 
literature. Tarrier (2006) proposes that a high quality CF is essential for effective 
therapy. Evaluation of ICFs during PTSD treatment would enable an idiographic 
approach to measuring treatment effects in more difficult to treat disorders, as 
recommended by Kaczkurkin et al. (2016). 
Post-traumatic Stress Disorder  
 Post-traumatic Stress Disorder (PTSD) arises from exposure to actual or 
threatened death, serious injury or sexual violence (The Diagnostic Statistical Manual 
of mental disorders 5th ed, DSM-V, 2013). Symptoms include re-experiencing 
intrusive memories, distressing dreams, flashbacks or dissociative reactions. Other 
symptoms include negative alterations in cognitions and mood as well as changes in 
arousal that can lead to difficulty sleeping, poor concentration and jumpiness. 
Avoidance of trauma related stimuli such as thoughts, memories, emotions and other 
reminders are common consequences. Re-experiencing symptoms are considered to 
be the hallmark of PTSD and involve fragmented, sensory representations of a past 
trauma (Ehlers & Clark, 2000). They can include images, sounds, smells, tastes and 
bodily sensations (Hackmann, Ehlers, Speckens, & Clark, 2004) and often involve the 
worst parts of the trauma known as hot spots (Holmes, Grey & Young, 2005). 
Sensory impressions are experienced as if they are happening in the present moment, 
often accompanied by original emotions and physiological reactions (Ehlers & Clark, 
2000). These are triggered by trauma related external or internal cues such as a pattern 
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of light, tone of voice or body shape (Ehlers & Clark, 2000). The distressing nature of 
intrusions that lead to strong physiological reactions and emotions mean that 
avoidance of trauma related stimuli is common and can severely impact functioning.  
 
Development and Maintenance of Intrusive Images. The main models that 
describe the development and maintenance of PTSD include the Cognitive model 
(Ehlers & Clark, 2000), Emotional Processing Theory (Foa & Rothbaum, 1998; Foa, 
Steketee, & Rothbaum, 1989) and Dual-Representation Theory (Brewin, Dalgleish, & 
Joseph, 1996; Brewin, Gregory, Lipton & Burgess, 2010). The Cognitive model is 
described below due to its application in CBT for PTSD (CBT-PTSD).  
Cognitive Model. The Cognitive model (Ehlers & Clark, 2000) describes 
formation and maintenance of PTSD using a formulation diagram to depict how 
symptoms arise and are maintained (see Figure 2). As the formulation indicates, the 
way a traumatic event and/or its sequelae is processed can lead to a sense of current 
threat via two processes: (1) negative appraisals of the trauma and/or its sequelae and 
(2) the nature of the trauma memory. Negative appraisals of the trauma and the 
aftermath might include external appraisals (“The world is dangerous”), internal 
appraisals (“I attract disaster”), appraisal of behaviour (“Arousal during rape means 
that I am disgusting”), responsibility (“It was my fault”), coping (“I am going mad”) 
the consequences of the trauma (“I am permanently damaged”) and regarding 
violation of personal rules. Appraisals often have catastrophic implications for people 
and can lead to overgeneralisation about the danger of normal activities or exaggerate 
the probability of further traumatic events, leading to a sense of current threat that is 
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likely to result in avoidance, dysfunctional coping strategies and maintain fear (Ehlers 
& Clark, 2000).  
 
      Figure 2. Ehlers & Clark (2000) Cognitive Model of PTSD (from Grey, 2007). 
 
The nature of the trauma memory is also involved in maintaining PTSD. 
Ehlers and Clark (2000) suggest that unlike normal autobiographical memories that 
are stored in an ordered, time-stamped way that allow for intentional retrieval, high 
levels of physiological arousal during a traumatic event means that trauma memories 
are poorly elaborated and inadequately integrated into current autobiographical 
memory in context or time with subsequent and previous information. Retrieval of 
triggered memories from environmental cues occurs via an involuntary route that does 
not allow for the integration of trauma memories with other information. This 
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explains the nature of intrusions as being uncontrollable, easily triggered and the 
sense of them happening in the here and now. Strategies intended to help with PTSD 
symptoms such as avoidance can maintain symptoms, as there is no opportunity to 
update negative appraisals or the trauma memory. 
 
Treatment implications. Exposure-based therapies are most effective for 
treating PTSD (Foa et al., 2000; NICE, 2005), involving reliving trauma details in the 
mind’s eye as if it is happening in the present, describing images, sounds, smells, 
body reactions, thoughts and emotions as vividly as possible (Ehlers & Clark, 2000). 
Exposure can also involve writing a detailed narrative of experiences (Resick & 
Schnikce, 1993) or listening back to audio recordings of re-living (Grey, 2007). Eye 
movement desensitisation and reprocessing (EMDR, Shapiro, 1996) also has high 
effect sizes (National Centre for PTSD, 2011) and involves clients making saccadic 
eye movements whilst holding trauma images and content in mind (Grey, 2007). 
Cognitive restructuring alongside exposure that restructures the meaning of hot spots 
and creates alternative perspectives that are incorporated into reliving is often an 
essential part of treatment (Bryant, Moulds, Guthrie, Dang, & Nixon 2003; Ehlers & 
Clark, 2000). 
 
Reducing symptoms. Ehlers and Clark (2000) suggest that trauma treatment 
should aim to: (i) reduce re-experiencing symptoms through elaborating on trauma 
memories to integrate them within autobiographical memory storage, (ii) address 
negative appraisals of the trauma and its sequelae and (iii) change avoidant strategies 
that prevent processing of memories and maintain appraisals. The main theories agree 
on the aims of treatment and all endorse reliving as essential in enabling elaboration 
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and contextualisation of memories. However, the mechanisms behind how reliving 
works are unclear, with theories offering different explanations (Brewin & Holmes, 
2003).  
Ehlers and Clark (2000) focus on the importance of reliving as a way of 
integrating memories into the context of the person’s existing autobiographical 
memory store to give the memory context and a time-stamp. As treatment progresses, 
the nature of the trauma memory changes with added verbal descriptions and the 
narrative becomes more coherent, losing its here and now quality (Ehlers & Clark, 
2000). This inhibits retrieval of sensory and physiological responses to trauma 
triggers. Reliving can also immediately update appraisals as new information is 
retrieved that was previously inaccessible and discriminates between the past and 
present (Ehlers & Clark, 2000).  
In the emotional processing theory, Foa and Rothbaum (1998) suggest that 
reliving activates a fear network alongside corrective information and enables the 
memory to reintegrate with the existing memory network with disconfirmatory 
information incorporated, reducing fear associated with the trauma memory. 
Brewin et al. (1996) describe that elaborating on trauma memories enables 
new and detailed verbal accessible memories to be created that reduce amygdala 
responses to trauma cues. In imagery rescripting, Brewin et al. (2010) suggested the 
retrieval competition hypothesis whereby new and less dangerous representations of 
the event are created that includes positive material. This memory competes with 
original representations to be retrieved following a trauma trigger and therefore the 
new competing representation is created to block the original memory (Brewin & 
Holmes, 2003). With retrieval practice, the new memory will be preferentially 
retrieved (Brewin, 2006).  
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As described, theories differ to whether PTSD treatment alters or elaborates 
original memories or whether new information is created and retrieved alternatively to 
original memories. Although mechanisms for symptom change may not be fully 
agreed upon, all theories have the same expectation of treatment: to reduce re-living 
symptoms and update key meanings of images. These changes should also reduce 
avoidance and help an individual learn that trauma memories and associated triggers 
are not threatening.  
Recovery rates for PTSD  
Ehlers and Clark (2000) treatment approach displays the largest treatment 
effect sizes (Ehlers et al., 2003, 2005) demonstrating significant symptom 
improvements (Gillespie et al., 2002), suggesting why it is widely carried out and 
recommended in IAPT services (Roth & Pilling, 2007). Despite efficacy of PTSD 
treatment in clinical trials that demonstrate large effect sizes  (Cloitre et al., 2012) and 
recovery rates of 73-77% (Ehlers et al., 2014) PTSD recovery rates in IAPT (from 
Psychological Therapies: Annual report on the use of IAPT services, 2014-2016), 
were 37.5% in 2014/2015 and 37.8% in 2015/2016, the second worst recovery rate 
out of nine specific disorders investigated. Kar (2011) conducted a literature review of 
CBT-PTSD and found that nonresponse was as high as 50%. This is a worrying 
finding since it is widely acknowledged that PTSD can have a devastating impact on a 
person’s level of functioning and well-being and is associated with greater risk of 
suicide, including increased risk of completed suicide (Kang et al., 2015). A number 
of reasons could account for observed recovery rates.  
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Co-morbidity. Grinage (2003) found that 80% of people with PTSD had at 
least one co-morbid psychiatric disorder, suggesting that PTSD treatment could be 
complicated by added complexity of co-morbidities. PTSD and substance use disorder 
(SUD) are highly co-morbid (Debbell et al., 2014), with occurrence of one of these 
disorders significantly increasing risk of the other (Breslau, Davis & Schultz, 2003). 
PTSD is also comorbid with anxiety and depression (D’Ardenne & Hecke, 2014), 
chronic pain (Roth, Geisser & Bates, 2008) and suicidality (Marshall et al., 2001).  
Multiple diagnoses may also result in ineffective directing of treatment, 
contributing to poor outcomes (Kar, 2011). According to NICE guidelines (CG26), a 
diagnosis of PTSD and SUD should result in initial treatment for SUD to prevent 
interference with PTSD treatment. However, PTSD and substance misuse are often 
viewed as functionally related (Brown, Stout, & Gannon-Rowley, 1998) with 
substances used to regulate negative emotions (‘self-medication hypothesis’, 
Khantzian, 1997) yet are treated using different models and treatment providers. 
Consequently, treatment does not always fully meet the needs of those with dual 
diagnoses and engagement in treatment may be poor if clients view co-morbidities as 
secondary to PTSD (Batten & Hayes, 2005). Outcomes for individuals with co-
morbidities plus PTSD are poorer than those without PTSD (Berenz & Coffey, 2012; 
Resko & Mendoza, 2012). Due to the high prevalence of co-morbidities, interventions 
are being developed combining treatments (Kaczkurkin, Asnaani, Alpert, & Foa, 
2016). 
Research suggests that if therapists use CBT interventions flexibly during 
PTSD treatment, the presence of co-morbidity does not predict poor outcome (Shafran 
et al., 2009) or reduce outcomes (Gillepsie, Duffy, Hackmann, & Clark, 2002). Duffy 
et al. (2007) found that presence of another psychiatric disorder or physical disability 
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did not impact PTSD treatment. Therapists within these studies used sessions flexibly 
to target co-morbidities allowing treatment for PTSD with and without co-morbidity 
to show similar, good outcomes. Transdiagnostic protocols to help with co-
morbidities are emerging (McHugh, Murray, & Barlow, 2009); however, existing 
protocols typically lack guidance in relation to co-morbidity and thus, treatment may 
be ineffectively directed or delayed and clinicians continue to be left with an 
unsatisfactory understanding of where to focus treatment. This needs to be addressed 
as research suggests that the majority of clients seeking treatment for mental health 
problems display co-morbidities (Kessler, Chiu, Demler, & Walters, 2005). However, 
PTSD studies mainly exclude individuals with co-morbidities (Zandberg, Rosenfield, 
Aplert, McLean, & Foa, 2016) and thus the current research on PTSD may not be 
fully representative.  
 
The nature of PTSD. The IAPT recovery workshop (2016) suggested that 
CBT-PTSD is a challenging treatment to deliver, possibly due to the nature of the 
disorder. Firstly, imagery can maintain PTSD, with images often characterised as 
distressing, consuming, full of sensory information, vivid and associated with extreme 
negative emotions (Brewin et al., 2009), impacting emotion more than thoughts 
(Holmes & Matthews, 2005). Wheatley and Hackmann (2011) found that presence of 
intrusive images predicts depression at follow-up, suggesting the role of imagery in 
maintaining difficult to treat psychological disorders (Brewin, Reynolds, & Tata, 
1999). The strong role of images in maintaining PTSD suggests why targeting and 
modifying images in imagery rescripting is powerful in reducing PTSD symptoms 
(Smucker, 1997).  
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Furthermore, clients displaying sadness, fear, anger or disgust have reduced 
outcomes using exposure than those reporting anxiety as the main emotion (Power & 
Fyvie, 2013) with shame and guilt also found to be more treatment resistant than other 
emotions (Lee, Scragg, & Turner, 2001). These emotions are highly prevalent in 
PTSD (Lee et al., 2001) which could influence recovery rates. Steil and Ehlers (2000) 
suggested that dysfunctional appraisals are important maintenance factors in PTSD 
that often require extensive verbal and imagery cognitive restructuring (Foa & 
Meadows, 1997) with mental defeat also requiring more intense treatment (Ehlers et 
al., 1998) before reliving can be beneficial.  
Lastly, people with PTSD often display a multitude of systemic difficulties 
including social and legal problems (d’Ardenne & Heke, 2014) following violence or 
trauma. A lack of awareness from clinicians of these contributing factors could lead to 
higher drop-out rates in assessment and treatment stages (D’Ardenne & Heke, 2014), 
found to be as high as 41.4% for CBT-PTSD (McDonagh et al., 2005). Therefore, it is 
essential that these factors are identified. 
 
Knowledge of PTSD. The IAPT review suggested that staff might require 
extra training in trauma focused CBT or EMDR and highlighted that there is a need 
for CPD in this area to increase PTSD recovery rates. Shafran et al. (2009) argued that 
an obstacle to effective CBT is gaps in knowledge about delivery of treatments and 
suggested that for complex interventions such as trauma-focused CBT, further 
training is required. By filling gaps with training, an increased understanding of how 
to apply research findings to routine clinical practice could be obtained.  
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Lack of evidence-based working. Lastly, the IAPT review found that around 
20% of sessions were not recommended by NICE guidelines. Indeed, research has 
indicated that despite clinicians reporting having used CBT, often sessions do not 
reflect evidence-based treatment (Carroll & Rounsaville 2007; Stobie et al., 2007). 
This means that therapists are deviating from current treatment protocols, suggesting 
protocols are not fully meeting the needs of clients. Research by Taylor and Chang 
(2008) suggested that clinicians select parts from various treatment protocols based on 
preference. Clinicians sometimes have concerns regarding the safety of exposure-
based treatment when clients report fear of re-traumatisation from exposure (Young, 
2009), acting as a barrier to treatment and reducing the likelihood of carrying out this 
technique (Becker, Zayfert, & Anderson, 2004). Waller (2009) argues that these 
preferences combined with clinician beliefs are likely to contribute to therapist drift 
and lead to ineffective treatment or even harm to the client. A way of expressing and 
capturing therapist assumptions could increase awareness of these. 
 
Summary. There appears to be a number of potential factors that could 
account for low recovery rates for people with PTSD. These include co-morbidity and 
complexity of PTSD, including potentially difficult to shift images, appraisals or 
emotions, reduced knowledge about treating PTSD and lack of evidence-based 
practice that suggests that therapist factors also play a role in the maintenance of 
PTSD. PTSD appears to be a complex disorder to treat and there is a need to identify 
and formulate factors that could be contributing to poorer outcome. This is especially 
important since recovery rates observed within clinical trials are not being met in 
routine clinical practice. Identifying factors to help determine predictors of outcome 
could help inform effective treatment and increase recovery rates of PTSD.  
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Enhancing recovery rates of PTSD using ICF 
  Overview of the research literature has indicated that a growing number of 
studies are highlighting the utility of developing treatment protocols that go beyond 
disorder-specific models, in light of low recovery rates and increased complexity of 
clients (Goddard et al., 2015). Further formulation appears necessary in PTSD as a 
way of identifying components maintaining difficulties that are currently not captured 
within standardised models. An ICF could be a helpful tool to capture factors that 
extend current disorder specific models and influence change in PTSD symptoms 
such as contextual information, current social stressors, difficult to shift emotions, co-
morbidities, observations and therapist interpretations that could be contributing to 
symptoms. Individualised formulation appears useful for understanding complex 
presentations (Bucci et al., 2016; Lee, 2006), for assisting with treatment of co-
morbid problems (Drake & Ward, 2003; Eells, Kendjelic, & Lucas, 1998) and 
particularly important for non-responders to traditional interventions (Davidson, 
2006). Grey and Young (2008) argue that individual factors are strong predictors of 
psychological problems and that individual variables and the links between them need 
to be identified within an ICF, drawing on systemic and identity theories alongside 
existing models. Use of an ICF might be helpful in demonstrating when to deviate 
from a routine protocol (Malatesta, 1995a, 1995b) and could potentially illustrate 
components that predict change in PTSD symptoms. 
To fully test the efficacy of ICFs and the contribution to outcome in PTSD, 
therapists would require ICF training. Training appears to enhance formulation skill 
and can improve SU outcome (Shafran et al., 2009). It is important to determine if 
increased quality and increased ability of CFs to capture complexity of cases could be 
gained following ICF training and then if quality or ability to capture complexity of 
  52 
ICFs can predict symptom trajectory. Training on completing an ICF is also necessary 
so that detailed idiographic analysis can be carried out on formulation diagrams that 
accurately indicate specific factors that could be predictors of change in PTSD and 
thus assist with increasing effective ways of carrying out CBT, an area in need of 
research (Shafran et al., 2009). Modifications to increase protocol flexibility to 
counter some of the difficulties associated with treating the PTSD population may be 
required to assist with poor recovery rates and therapist lack of evidence-based 
working. Research has highlighted a gap whereby inclusion of typical PTSD cases is 
required and use of a structured design to isolate and test specific treatment 
interventions idiographically and subsequently link these factors to treatment 
outcome. 
 
Single Case Experimental Designs (SCEDs)  
SCEDs allow for a rigorous evaluation of an intervention under different 
conditions within an individual, requiring a stable baseline that should reflect patient 
variables prior to implementation of an intervention. Following this, there is 
systematic introduction of an intervention allowing data to be compared between 
baseline and intervention phases. SCEDs use repeated measurement of a dependent 
variable before (baseline phase) and during an intervention (intervention phase) 
(Kratochwill et al., 2010). With an acquired stable baseline, SCEDs can attribute 
observed changes to the onset of an intervention. This enables causal inferences to be 
made that describe whether a functional relationship exists (Smith, 2012) between an 
intervention and change in participant variables. Therefore, within SCED, individuals 
act as their own controls to enable comparison of their data across different phases 
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(Krathochwil et al., 2010) increasing internal validity (Horner et al., 2005). 
Replication across a number of cases enables patterns to be identified across a series 
of individuals, enhancing external validity (Horner et al., 2005).  SCEDs are useful in 
testing conceptual theories and for isolating and detecting effective interventions in 
clinical practice (Horner et al., 2005) and therefore an appropriate design for a study 
investigating processes of CF. 
 
The current study  
This exploratory study used SCED to evaluate Hallam’s (2013) system for 
developing ICFs and aimed to investigate how components within ICFs might 
contribute to clinical change in PTSD symptoms. Two phases were conducted. Phase 
1 investigated changes between CFs before and after workshop training on creating 
ICFs. Four pre-/post- workshop formulations were analysed and rated to compare 
changes, thus also testing a rating scale of formulations for use in Phase 2. Phase 2 
prospectively examined treatment for PTSD across eight participants using SCED. 
The main aim of this phase was to explore whether a relationship could be established 
between the presence or absence of components within ICFs and change in outcome. 
Furthermore, this phase aimed to provide evidence for whether sharing formulations 
with participants during treatment could be associated with change. Measures of 
image intrusiveness were completed by participants that explored frequency, distress, 
interference, controllability and sense of nowness, key meanings of images and 
degree of belief in the meanings. Thus, the study explored change at an image 
symptom level and at a global level (meaning of the image), variables targeted in 
PTSD treatment. Participant data was examined at an individual level to inspect small 
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changes following shared formulations to investigate whether this impacted on image 
intrusiveness and the believability in the meaning of images. Participants were also 
divided into high and low treatment responders based on reductions in symptom 
severity (combined frequency and distress of image intrusiveness), enabling 
comparison of participants at a group level.  
A number of preliminary and exploratory hypotheses were made. Firstly, that 
ICF workshop training would increase therapist formulation skill, potentially 
demonstrated though increased quality of ICFs. Secondly, that increased quality and 
ability to capture complexity within formulations might relate to outcome and rate of 
improvement for people with PTSD at a group and individual level. Next, that 
specific elements captured within ICFs might relate to outcome and rate of 
improvement for people with PTSD at a group and individual level. The final 
hypothesis was that sharing a formulation diagram would be associated with change 
in PTSD symptoms.  
If specific aspects of the ICF are able to predict some contributors to change in 
PTSD, there are implications for use of ICFs across psychology services and for 
informing psychological treatment interventions. Furthermore, results will inform the 
evidence-base about the clinical usefulness of CFs, for training formulation skills and 
measuring CFs, aiming to enhance reliability and quality of CFs (Flinn et al., 2015). It 
will also add to existing understanding of theories for PTSD, potentially providing 
evidence for salient factors that could facilitate change in PTSD. 
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Method 
Two Phases were involved. Phase 1 was carried out with therapists to investigate the 
changes between formulations following workshop teaching on ICF. This phase 
explored elements that contribute to expertise in formulation and the effect of training 
on therapist skill and quality of formulations. Phase 2 prospectively examined 
treatment for PTSD to investigate if elements included within ICFs related to 
therapeutic change and if sharing formulations related to change in symptoms of 
PTSD. 
Phase 1 
Sample.  Four Therapists who attended ICF workshop training completed pre 
and post formulation diagrams. They were all high intensity therapists trained in 
treating a range of psychological difficulties, including CBT Therapists (n=3) and a 
Clinical Psychologist (n=1). The mean number of years of working in treating 
psychological problems was 5.4 years (SD=6, range=7 months-14 years). 
 
Recruitment and setting. Therapists were invited to attend a training 
workshop on ICF as part of continuing professional development. They were invited 
from three NHS Improving Access to Psychological Therapy (IAPT) out-patient 
services, where Phase 2 of the study would be carried out. At the first service, 
therapists were invited to attend two half-day training workshops and the other two 
services were invited to attend a one full day workshop on ICF run by Dr Gary Brown 
(GB), the project supervisor and Professor Richard Hallam (RH), the author of ICF 
diagramming. Preference for a half or full day training session was decided by the 
head of the respective services. Figure 3 demonstrates the flow of therapists into the 
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training and those who completed pre and post formulation diagrams.  
 
 
 
 
 
 
Figure 3. Flow of therapists into the workshop and Phase 1. 
 
Measures. 
Individual Case Formulation - Rating Scale (ICF-RS). The ICF-RS was 
used to analyse pre-/post- individual case formulations. The ICF-RS is a 9-item rating 
scale for measuring the elements that exist within an ICF diagram. The ICF-RS 
consists of two clusters: the definition of the problem (A) and validity and 
explanatory sufficiency (B). Raters record each of the 9 defined items indicating the 
extent to which a specific criterion is present within a diagram. Pre-workshop 
diagrams were rated dichotomously, indicating whether an item was absent or present 
(0=absent, 1=present). Post-workshop diagrams were rated using the full scale, 
whereby each item is rated on a four-point scale (0= not present, 1= partially present, 
2=moderately present, 3= definitely present). Total scores range from 0-27, with the 
Service 1 Service 2 + 3 
Full day workshop: n=16 
 
Half day workshop part 1: 
n= 23 
Half day workshop part 2: 
n= 12 
Pre- formulations received: n=5 
 
Post- formulations received: n=4 
 
No pre/post formulations 
collected 
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maximum score being 27. A higher score indicates that an increased number of 
criteria were met within the ICF, suggesting that the formulation is of higher quality 
and detailed, indicating a high level of ICF skill. This tool was created by GB and RH 
as no such measure currently exists for identifying elements contained within an ICF 
diagram. Therefore, this tool has not been validated for use. However, it has been 
used within a research study conducted by Pettman (2017) who found that the 
measure displayed good internal consistency (α=.91) and inter-item correlation 
(r=.71). Table 1 provides a brief summary of each of the 9 items. A full description of 
the items and criteria required for accurate scoring of the ICF-RS can be found in 
Appendix 1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  58 
Table 1. 
 
Summary of ICF-RS items. 
 
 
 
 
A. The problem 
is clearly defined. 
 
The nature and source of observations are clear and explicit. 
The nature and basis for how observations relate to each other 
is clear. 
 
Explanations are included that are distinct from observations, 
used to help synthesise and make sense of the information 
included in the diagram. 
 
Key contextual elements are included. 
 
Functional equivalence between elements (triggers or 
responses) is denoted where this has implications for 
understanding the problem. 
 
Significant mediators are identified and their roles are made 
clear. 
 
B. Validity and 
Explanatory 
sufficiency 
 
The formulation is a coherent and comprehensive account of 
the available information. 
The formulation delineates mechanisms of change and provides 
a basis for understanding where and how to intervene and what 
to prioritise.  
 
The formulation manages complexity successfully. 
 
Design. Phase 1 used a single group repeated measures design. Pre-
formulation diagrams were completed before the workshop and were rated and 
compared to post-formulation diagrams by the same therapist. This enabled the 
changes in formulation skill post ICF workshop to be identified. 
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Table 2. 
 
Summary of the content of the ICF workshop. 
 
Topic 1 Policy context: five year forward view for mental health.  
 
Topic 2 What is formulation? Working through 3 vignettes illustrating pitfalls 
 of incorrect formulations. 
 
Topic 3 The individual case formulation (ICF) approach as a means for 
depicting formulations and identifying problems. 
 
Topic 4 Review of single disorder models. 
 
Topic 5 Importance of Functional Analysis. 
 
Topic 6 Review of the concepts so far. 
 
Topic 7 Understanding formulation in Clinical Practice as a response to the 
challenges of improving efficacy in applied settings and the 
relationship to evidence based practice. 
 
Topic 8 Description of formulation models (theoretical, conceptual, didactic). 
 
Topic 9 ICF diagrams as a means of balancing fidelity and flexibility. 
Topic 10 Application to PTSD (review of Ehlers & Clark, 2000, group ICF of 
PTSD vignette and independent ICF of a second PTSD vignette). 
 
Procedure. The workshop took place over two half days (for service one) and 
one full day (for services two and three). The workshop slides were put together and 
facilitated by GB and RH. Table 2 briefly describes the content of the workshop. The 
half-day workshop covered topics 1-5 in Session one and topics 5-10 in Session two. 
Following the training at service one, feedback suggested it would have been useful to 
measure if therapist skill had increased following the workshop. Therefore, prior to 
the workshop with the second and third services, therapists were given a set of 
instructions asking them to complete a pre-workshop formulation based on a clinical 
vignette. Therapists were asked to draw a non-structured diagram that would be more 
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similar to an ICF rather than a structured one such as a single disorder model. An 
example of a non-structured diagram was provided for therapist guidance. Therapists 
were also asked to explain the symbols they used in their diagrams, for example: 
boxes= behaviours to ensure that the researchers could fully understand the 
components of the diagrams. Therapists were assigned an ID number so that their 
diagrams would remain anonymous to the researchers. Therapists gave in their 
formulation diagrams at the beginning of the workshop training. 
Following the workshop, therapists were asked to complete a post-workshop 
formulation diagram based on the training, using the same vignette as previously and 
provided with instructions on how to create an ICF based on Hallam (2013). 
Following completion, therapists gave their post-workshop formulations to an admin 
member of staff, with their ID number to ensure anonymity and to enable comparison 
of pre-/post- workshop formulations. Appendix 2 shows instructions given to 
therapists for completing pre-/post- workshop diagrams. 
The ICF-RS was used to measure pre-/post- workshop formulations. Pre-
workshop diagrams were rated dichotomously and post-diagrams were rated using the 
full scale. To increase accuracy of ratings and increase inter-rater reliability, two 
researchers (AG & DP for pre-diagrams and GB & RH for post-diagrams) used the 
tool to rate the diagrams. The researchers discussed the items on the scale to ensure a 
similar understanding. Diagrams were rated independently and then compared. 
Discrepancies were minimal but when identified, researchers discussed their decision 
process and a consensus was agreed and any alterations made to the ICF-RS. The 
rating scale was also used within Phase 2 and therefore Phase 1 provided practice and 
familiarly of using the tool for the prospective phase. 
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Phase 2 
Sample. Eight participants (6 female, 2 male) meeting criteria for PTSD took 
part in the study. The sample was highly heterogeneous, an important 
recommendation within SCED research to ensure intervention effects are tested across 
a diverse group of individuals (Kazdin, 1981). Participants had experienced a range of 
traumatic events including single instances of trauma and others with repeated or 
multiple traumas. The mean age was 33 years (SD= 10; range=19-48 years).  
Participants came from a range of ethnic backgrounds including White British (n=4), 
White other (n=1) Black African (n=1), Black Caribbean (n=1) and Portuguese (n=1). 
One person required an interpreter. Participants also had a range of co-morbidities 
including low self-esteem (n=1), depression (n=2), panic disorder (n=1), complicated 
grief (n=1), specific phobia (n=1) and health anxiety (n=1). See Table 3 for individual 
participant information. Some information has been altered to protect participant 
anonymity.  
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Table 3. 
Individual participant information. 
 
Inclusion criteria. Participants who were suitable for treatment for PTSD and 
experienced intrusive images as part of their PTSD were included in the study. PTSD 
diagnosis was determined by the treating clinician through use of PTSD measures 
such as the PTSD Checklist for DSM-5 (PCL-5, Weathers et al., 2013) and Impact of 
Events Scale-Revised (IES-R; Weiss, 2007) and/or clinical interview. A diagnostic 
tool was not used as part of the study for a number of reasons: (i) to enable an 
increased number of potential participants into the study, (ii) to capture a variety of 
individuals with ranging PTSD symptoms, which more accurately reflects those 
seeking treatment for PTSD and (iii) to reduce time pressure on 
P Gender Age Ethnicity Medication Co-morbidities 
Years 
since 
Trauma  
 
A  F 24 Portuguese None Low self-esteem 0.5 
B  F 28 White-British Sertraline None 5 
C  M 34 
 
White-Other None Depression 0.5 
D  F 39 White-British None Specific phobia 4 
E  F  41 
Black-
African 
Propranolol  
Fluoxetine  
Depression 
 
Health anxiety 
Panic disorder 15  
F M 48 
 
Black- 
Caribbean None 
 
 
Grief disorder 0.5 
G F 28 
 
White-British None None 1 
H F 19 
 
White-British None None 1-2.5  
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participants/clinicians. Completion of the IES-R (Weiss, 2007) as part of the study 
within Session 1 also indicated that all participants met criteria for PTSD according to 
this measure. The authors describe that a cut off point of 33 is a reasonable value to 
propose. All participants scored over the value of 33 at Session 1, indicating PTSD. 
Exclusion criteria included presence of a psychotic disorder, borderline 
personality disorder, high and dangerous levels of substance abuse or those at high 
risk of self-harm or suicide, or if presence of any Axis I or II disorder may have 
interfered with PTSD treatment. This is similar to normal exclusion criteria for 
treatment within IAPT services. 
There was not a standardised approach to inclusion/ exclusion criteria and the 
criteria is similar to normal exclusion criteria for treatment within IAPT services. The 
non-standardised approached meant that the sample gained was more likely to reflect 
people routinely seeking help for PTSD.  
 
Sample size. For single case designs, number of observations rather than 
number of participants is most clinically significant (Allison, Silverstein, & Gorman, 
1996). However, it is agreed that increased number of cases increases power (Shadish, 
Hedges, & Pustejovsky, 2014). What Works Clearinghouse (WWC) standards for 
single-case designs (Kratochwill et al., 2010) provide little guidance on the adequate 
number of cases to include for SCED. Therefore, sample size for this study was 
guided by suggestions from existing SCED literature (Shadish & Sullivan, 2011; 
Shadish et al., 2014). The median number of cases used within SCED is three 
(Shadish & Sullivan, 2011) and the WWC standards (Kratochwill et al., 2010) suggest 
a minimum of three data points per phase. However, according to Shadish et al. 
(2014), power of .80 will only be obtained with three cases when there is at least 6 
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observations in each phase and an anticipated effect size of d= 0.8. Shadish et al. 
(2014) suggest that when d=0.5, power is adequate with 7 cases with 3 observations 
per phase or 5 cases and 9 observations per phase. Arntz, Sofi, and van Breukelen 
(2013) suggest that 80% power will be obtained with ten cases and enable a change of 
d=.1 to be detected. 
With consideration of SCED literature, the study aimed to recruit ten 
participants. Ten participants were approached by treating clinicians with two 
declining to take part. The remaining eight participants took part. No participants 
dropped out of the study. The current study aimed to use phase lengths that enabled a 
minimum of 3 data points per phase. Phase lengths met this standard for almost all 
participants in Phase A and often consisted of more than 3 data points within Phase B 
meaning that observed effect sizes were likely to be moderate. 
 
Recruitment and setting. Participants were recruited from three NHS 
Improving Access to Psychological Therapy (IAPT) out-patient services. IAPT treats 
people for a range of mental health problems, including PTSD. Treatment was carried 
out by CBT therapists (n=3) and Clinical Psychologists (n= 2). The mean number of 
years of working in treating psychological problems was 4.8 years (SD=3, range=8 
months- 8.5years). All therapists had been trained in treatment for PTSD and received 
regular supervision. Eight services were contacted to take part. Three IAPT services 
and one specialist trauma service agreed to take part. The specialist trauma centre 
withdrew from participation, leaving three recruitment sites in total. Figure 4 depicts 
service involvement and final number of participants recruited from each site. 
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Figure 4. Final service and participant involvement. 
 
 
 
 
 
 
 
 
 
Services contacted to take part: n= 8 
6 x IAPT services 
2 x Specialist trauma settings 
Services agreed to take part: n=4 
3 x IAPT services 
1 x Specialist trauma setting (dropped out) 
 
Final services involved: n=3 
3 x IAPT services 
 
IAPT service 1: 
Participants 
screened: n= 68 
Suitable n= 11 
Consented n= 2 
IAPT service 2: 
Participants 
screened: n= 5 
Suitable n= 3 
Consented n= 2 
 
IAPT service 3: 
Participants 
screened: n= 5 
Suitable n= 5 
Consented n= 4 
 
Final sample: n=8 
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Ethical approval. Ethical approval for the study was granted through the 
South East Scotland Research Ethics Committee 02 on 11 April 2016. Approval from 
the Health Research Authority (HRA) was granted 25 May 2016. A substantial 
amendment was made to include other co-morbidities, amend measures and add a 
new recruitment site. Approval for this amendment was granted on 19 October 2016 
by the South East Scotland Research Ethics Committee (with added title change 27 
October 2016), with HRA approving these amendments on 26 October 2016. 
Subsequent approval was granted by Royal Holloway University Departmental Ethics 
Committee and local Research and Development (R&D) departments. Non-
substantial amendments to the study were made including adding a measure and 
adding new recruitment sites and approved by HRA and local sites for 
implementation. See Appendices 3-9 for ethical approval letters. 
 
Measures.  A fundamental part of SCED is the repeated measurement of 
participant variables across different phases over time (Hayes, 1981). The measures 
were used in order to test the research hypotheses and thus for pragmatic reasons as 
opposed to a priori theorising. Two types of measures were administered as part of the 
study including weekly measures and pre-/post- measures. Weekly measures 
consisted of Visual Analogue Scales (VASs) and were used because they are quick, 
easy to complete and easy to score (Briggs & Closs, 1999). Importantly, they are also 
sensitive to small changes across short periods of time. Pre-/Post- measures were used 
at the start of the baseline phase and during the intervention phase and were used as a 
way of measuring reliable and significant change following the intervention (Morley, 
2015b). 
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Weekly measures.  
Image Intrusiveness Visual Analogue Scales (IVAS). Image intrusiveness was 
measured using Brewin et al.’s (2009) self-report visual analogue scales (VASs). 
Participants rated intrusive images on a scale of 0-100 for frequency, distress, level of 
interference and uncontrollability. A fifth scale measuring sense of “nowness” was 
added as intrusive symptoms often have a here and now quality to them, with past 
traumatic events re-experienced as if they are happening in the present moment 
(Ehlers, Hackmann, & Michael, 2004).  
Encapsulated Belief Scale (EBVAS). This scale identified the key meaning of 
intrusive images and measured the extent to which participants believed this meaning 
to be true on a scale of 0-100. The scale was adapted from previous studies 
(Hackmann, Clark, & McManus, 2000; Wild & Clark, 2011).  
Although these VASs have not been validated, VASs are considered to be 
easy to administer (de Boer et al., 2004) and a simple way to measure subjective 
experience (McCormack, Horne, & Sheather, 1988). They are sensitive to measuring 
small changes within individuals (Maxwell, 1978) and for measuring therapy 
processes over time (Morley, 2015a). They are therefore extremely useful within 
SCEDs to enable multiple measures across a baseline phase and continuous measures 
across intervention phases. They are also suitable for use across different ethnic 
backgrounds (Gaston-Johansson, Albert, Fagan, & Zimmerman, 1990) and have been 
shown to have high reliability and validity (Ahearn, 1997). The IVAS and EBVAS 
were also used as part of a previous doctoral research project conducted by Looney 
(2016) and this study indicated that both of these VASs were sensitive to small 
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changes across therapeutic interventions. 
Pre-/post- measures.  
Impact of Events Scale-Revised (IES-R; Weiss, 2007). The IES-R is a 22 item 
self-report questionnaire measuring subjective distress in relation to a traumatic event. 
It is a widely used tool for assessing PTSD (Joseph, 2000), adapted from the original 
Impact of Events Scale (IES; Horowitz, Wilner, & Alvarez, 1979), which is a reliable, 
stable and valid measure of distress (Sundin & Horowitz, 2002). Beck et al. (2008) 
described that despite not being a diagnostic tool, the IES-R can discriminate between 
those with and without PTSD and enhances clinical and research assessment of 
PTSD. The IES-R consists of three subscales: intrusion, avoidance and hyperarousal. 
Respondents rate each of the 22 items on a 5-point scale (0=not at all, 1= a little bit, 
2=moderately, 3= quite a bit, 4= extremely) rating how distressing each item has been 
over the past week. The total score ranges from 0-88 with IAPT suggesting a clinical 
cut-off of 33 for PTSD. Creamer, Bell, and Failla (2003) found that the IES-R has 
good psychometric properties with high levels of internal consistency (α=.96) and 
subscales demonstrating adequate to good concurrent validity (r=.66-.84) with 
subscales of the PCL (Weathers et al., 1993) and good test-retest reliability (r=.89-.94, 
Weiss & Marmar, 1997). 
 
PTSD checklist for DSM- 5 (PCL-5, Weathers et al., 2013). The PCL-5 is a 20 
item self-report measure for assessing DSM-V symptoms of PTSD. It is used to 
screen for PTSD and monitor symptom change across treatment (Weathers et al., 
2013). The PCL-5 consists of four clusters: intrusion, avoidance, negative alterations 
in cognitions and mood and alteration in arousal. Respondents rate each of the 20 
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items on a 5-point scale (0=not at all, 1= a little bit, 2=moderately, 3= quite a bit, 4= 
extremely). Total scores range from 0-80 with a clinical cut off suggested as 38 
(Weathers et al., 2013). The PCL-5 has been found to have strong internal consistency 
(α=.94) as well as test-retest reliability (r=.82) and convergent (rs=.75-.85) and 
discriminant validity (rs=.31-.60, Blevins, Weathers, Davis, Witte, & Domino, 2015).  
Life Events Checklist (LEC, Blake et al., 1995). The LEC is a 17 item self-
report measure for assessing exposure to 16 events known to result in PTSD with one 
extra item to include a traumatic event not captured within the 16 items. It is a tool 
that can identify how many traumas an individual may have experienced or been 
exposed to over their lifetime, a factor that might be important to consider in therapy. 
Respondents tick each of the 16 events on a 5-item scale (Happened to me, Witnessed 
it, Learned about it, Not Sure, Doesn’t Apply). The LEC displays good test-rest 
reliability (r=.82) and good convergence (r=-.55) with an established measure of 
trauma history and measures of trauma specific psychopathology (Gray, Litz, Hsu, & 
Lombardo, 2004).  
Mood and functioning. The following measures are used routinely within 
IAPT services.  
The Patient Health Questionnaire (PHQ-9, Kroenke, Spitzer, & Williams, 
2001). The PHQ-9 is a brief 9 item self-report questionnaire measuring symptoms of 
low mood over the previous 2 weeks. It has been shown to discriminate between those 
with and without major depression (Kroneke et al., 2001). Respondents rate each of 
the items measuring symptoms of depression on a 4-point scale (0= not at all, 1= 
several days, 2= more than half the days, 3= nearly every day) to reflect symptoms 
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over the past week. There is a total score from 0-27 with scores of 5-9, 10-14, 15-19 
and 20-27 indicating mild, moderate, moderately severe and severe depression 
respectively. The PHQ-9 has good psychometric properties (Cameron et al., 2008) 
with excellent internal reliability (α=.89) and test-retest reliability (r=.84, Kroenke et 
al., 2001). It can be used to measure symptoms over time and has been shown to have 
superior criterion validity compared with other depression measures (Lowe et al., 
2004).  
The Generalised Anxiety Disorder Scale (GAD7; Spitzer, Kroenke, Williams, 
& Lowe, 2006). The GAD-7 is a brief, 7 item self-report questionnaire used to 
measure symptoms of anxiety over the previous 2 weeks. Respondents rate each of 
the items that measure symptoms of anxiety on a 4-point scale (0= not at all, 1= 
several days, 2= more than half the days, 3= nearly every day). A total score of 21 is 
obtained with scores of 5-9, 10-14 and 15+ indicating mild anxiety, moderate anxiety 
and severe anxiety respectively. The GAD-7 has excellent internal consistency 
(α=.92), good convergent validity (r=.74) (Mills et al., 2014; Spitzer et al., 2006), test-
retest reliability (r=.83), construct validity, criterion validity and good procedural 
validity (r=.83) (Spitzer et al., 2006). 
The Work and Social Adjustment Scale (W&SAS, Mundt, Marks, Shear, & 
Greist, 2002). The W&SAS is a measure of the extent to which a difficulty interferes 
with a person’s ability to carry out every day tasks. It measures how much a person is 
impaired in five areas: work, home management, social leisure activities, private 
leisure activities and family and relationships on a scale of 0-8 (0= not at all, 2= 
slightly, 4= definitely, 6= markedly, 8= very severely). A total score of 40 is obtained 
and a score of 1-10 11-20, 21+ suggests mild, moderate and severe functional 
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impairment respectively. The W&SAS has good internal consistency (α=.70-.94), 
test-retest reliability (r=.73) and is a useful tool within clinical research (Mundt et al., 
2002).  See Appendices 10-17 for measures. 
 
Reliable change: severity of symptoms. In order to form another pre-/post- 
measure to distinguish high from low responders, two of the IVAS subscales were 
combined: frequency and distress. This is because VASs are more sensitive to change 
than the other pre-/post- measures and thus were likely to provide increased 
information about the changes in symptoms across therapy that might be lost with use 
of other measures. The reason for choosing the subscales of frequency and distress is 
because of the recognised importance of these two items. The Clinician-Administered 
PTSD Scale (CAPS; Blake et al., 1995), a well-validated measure of PTSD (National 
Centre for PTSD, 2016) uses frequency and distress to measure severity of PTSD 
symptoms and the latest version, the CAPS for DSM-5 (CAPS-5; Weathers, Blake, 
Schnurr, Kaloupek, Marx, & Keane, 2013) combines these items to give a single 
rating that reflects severity of PTSD symptoms. Therefore, within this study, 
frequency and distress subscales were combined to provide a pre/post outcome 
measure named “severity of symptoms” to discriminate between high- and low-
responders.  This score was then divided by 2 to give a total score between 0-100. The 
IES-R will also be used to measure reliable and clinically significant change.  
 
Design.  Phase 2 used a SCED approach with an AB design and aimed to 
follow participants before (Phase A) and after (Phase B) implementation of a 
formulation. Replication across eight participants with varying cultural backgrounds, 
trauma histories and demographics was used to enhance generalisability of findings. 
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To associate changes with sharing a formulation it was necessary to 
demonstrate symptom stability before the introduction of a formulation. SCED 
requires a minimum of three data points under each phase and to avoid interrupting 
routine treatment, baseline data was collected at the start of the first 3 sessions of 
PTSD treatment. This was Phase A. 
Ideally, participants would not have commenced any type of treatment within 
the baseline period. This would increase the chance of obtaining a stable baseline, 
which becomes increasingly difficult when participants are already receiving 
treatment. Isolating treatment components and acquiring a stable baseline for 
participants already in therapy within naturalistic treatment and without disrupting SU 
care is a challenge for SCED. By collecting baseline data within the first 3 sessions, it 
ensured that participants were not having to wait unduly for treatment and still 
enabled repeated measures to be collected weekly, at 3 time points to investigate 
baseline stability. Despite treatment having commenced, it was still hoped that a 
stable baseline would be achieved to allow assessment of further changes brought 
about specifically through sharing a formulation.  
Due to the limited time to recruit and to increase the power of the study, 
criteria for inclusion was broadened to include participants who had already 
commenced treatment and therefore for one participant it was not possible to acquire 
3 baseline data points. 
Treatment for PTSD within IAPT services begins with assessment of 
difficulties, typically followed by creation of a formulation. This may or may not be 
shared with clients and is not a requirement of CBT-PTSD. For this study, therapists 
were required to create an ICF prior to Session 3 and then share any type of 
formulation with participants in Session 3. Therapists were explicitly asked not to 
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begin formulating with the client before Session 3. This ensured the start of Phase B 
to help associate any symptom change with sharing a formulation. SCED requires at 
least three data points within each Phase and therefore measures were collected from 
Session 4-6 as a minimum. Following the formulation, routine treatment for PTSD 
usually moves onto processing of the trauma memories, which might involve reliving 
traumatic events, imagery rescripting or EMDR.  Treatment for PTSD was treatment 
as usual that was required for the specific client. Participants completed extra 
measures more frequently than usual as this is an important component of SCED. 
Other than asking therapists to explicitly formulate in Session 3, treatment procedures 
themselves remained unaltered.  
 
Procedure.  The study was described to potential participants by treating 
clinicians and/or the principal investigator after they were assessed and deemed 
appropriate for PTSD treatment. If they were interested in taking part, they were 
given an information sheet (Appendix 18) and asked to sign a consent form 
(Appendix 19). Potential participants were told that if they did not wish to take part, it 
would have no impact on their treatment. Once a participant had consented, they 
completed Session 1 measures before their first treatment session.  
Specifications about the particular trauma treatment to use were not imposed 
on therapists to ensure participants received the most useful treatment for them. 
Treatment included CBT-PTSD involving reliving (n=8).  
Anonymity. To ensure clinician anonymity, all therapists that could potentially 
be involved in the study were assigned a unique ID number by an admin member of 
staff.  When clinicians had a potential participant, they emailed the admin member 
who contacted the principal investigator. Anonymity for clinicians was maintained as 
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it is acknowledged that it can be exposing for clinicians to have formulations 
examined, rated and linked to SU outcome. Therefore, the principal investigator was 
not able to link ID numbers to specific clinicians. Once a participant was identified, 
the principal investigator dropped off a study folder for therapists to use labeled with 
the therapist ID number. This ensured anonymity of therapists and also helped the 
study implementation to be as simple and easy for therapists as possible and 
maintained a standardised procedure across participants. The research pack included 
session-by-session measures, check boxes and reminders for clinicians about which 
measures to administer and when to complete formulation processes. Two example 
pages from the study folder are shown in Appendix 20.  
For participants, all data was anonymised and stored on an encrypted memory 
stick. As described, some demographic information and details of specific traumas 
has been altered or omitted to protect client identity.  
 
Session 1. Clinicians completed the demographic details sheet giving 
information on participant age, gender, ethnicity, trauma type, co-morbidities, current 
medication and previous treatment. Participants were asked to complete the PCL-5, 
IES-R, LEC, VAS’s and the IAPT minimum data set (PHQ-9, GAD-7, W&SAS) 
before the start of the session. 
Image intrusiveness was measured using the IVAS, measuring frequency, 
interference, distress, uncontrollability and sense of ‘nowness’ of intrusive images 
over the past week. To identify the key meaning of the intrusive images, therapists 
were encouraged to use Socratic questioning and downward arrow techniques to 
determine the key meaning of the images. Examples of questions that could be used to 
identify the encapsulated belief include, “What is the worst thing about this image?”, 
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“What does the image mean about you as a person?”, “What does the image mean 
about other people?”, “What does the image mean about the world?”, “What is it 
about this image that makes it so distressing for you?”. Once a key meaning was 
identified, it was recorded and then rated on the EBVAS to measure how much the 
participant believed the meaning to be true over the past week. Completion of these 
measures represents the first baseline point. One participant (C) completed Session 1 
baseline measures in his second treatment session.  
Session 2. Participants were asked to complete the VAS’s and the IAPT 
minimum data set before their session. This represents the second baseline point. 
Between Session 2 and 3. Prior to Session 3, therapists were asked to create 
an ICF diagram based on the workshop training that they had received. The principal 
investigator sent follow up information on how to conduct an ICF via admin to the 
therapist to remind them how to do this. They were asked to include all information 
relevant to the client’s presentation to ensure detailed formulations.  
Session 3. Participants were asked to complete the VAS’s and the IAPT 
minimum data set before their session. This represents the third and final baseline 
point. Once measures were completed, this marked the end of Phase A. Within 
Session 3, therapists were required to share any type of formulation with participants. 
Due to the naturalistic design, no specifications about the particular formulation to be 
shared with the participant were imposed. They were told that they could share a 
verbal, diagrammatic or written formulation depending on what the therapist felt to be 
most helpful for the client. Originally it was hoped that therapists would share the 
completed ICF diagram, however to ensure more naturalistic treatment and to reduce 
imposing any particular formulations on clients, it was decided that therapists could 
share a formulation that they deemed to be most useful for the participant. Therapists 
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were asked to record the type of formulation they shared with the participant. A range 
of formulations were shared including a vicious flower (n=1), Ehlers and Clark (2000) 
cognitive model of PTSD (n=4) and the individual case formulation (n=3).  Session 3 
represented the start of Phase B. 
Session 4 onwards. At the start of Session 4, following sharing of the 
formulation from the previous week, the IVAS and EBVAS were re-administered as 
well as the IAPT minimum data set (PHQ-9, GAD-7, W&SAS). These measures were 
also collected in the proceeding sessions as repeated measurements across Phase B. 
Within Session 6, participants also completed the IES-R and PCL-5 again, as this 
marks the sixth data point and also reflects approximate half way of PTSD treatment 
within IAPT services. The IES-R and PCL-5 were also taken at the last possible 
treatment session. 
The procedure of completing measures was continued across PTSD treatment. 
Participants were followed for a maximum number of sessions that study data 
collection allowed. Therefore there is some inconsistency across cases in terms of 
how many data points were obtained in Phase B, however all participants, apart from 
one, had a minimum number of 3 data points in Phase B. Participation ended in the 
study when recruitment ended in May 2017. Study involvement was terminated at this 
point and participants continued with treatment as usual. Due to limited time to collect 
data, no follow up data was collected. Table 4 details the measures taken within each 
session. 
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Table 4. 
 
Summary of measures taken within each session. 
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PCL-5        
IES-R        
IVAS        
EBVAS        
LEC        
PHQ-9, 
GAD-7, 
W&SAS 
       
 
 
 
Coding. All formulation diagrams were rated using the ICF-RS. Similarly to 
the post-diagrams in Phase 1, two researchers (GB & RH) rated diagrams on each of 
the 9 items. This ensured rating accuracy to the scale and increased inter-rater 
reliability. A final score out of 27 was given for each ICF created by clinicians.  
 
Service user perspective.  In order to gain valuable insights from people with 
PTSD to determine the acceptability of study materials, SUs were approached in 
individual sessions by treating clinicians. SUs were given questionnaire measures 
including VASs and the participant information sheet and consent form and asked to 
comment on the ease of understanding the materials and how well the measures 
reflected PTSD symptoms. This was carried out in order to capture any concerns with 
the materials and to highlight potential changes that could be made to the study. 
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SU feedback yielded a number of useful comments and suggestions. Firstly, 
SUs felt that there were a lot of measures to complete that could be burdensome for 
people who are in distress. One SU involved in the study described the measures as 
tiring and taking a long time to complete. However, mostly SUs agreed that the 
routine, weekly measures looked quick and easy to complete so it would not be too 
onerous for participants and it was only the weeks requiring increased measures that 
might be more time-consuming. Furthermore, one SU described that it would be 
useful to track symptoms weekly using the VAS scales and also that the measures 
mapped well onto the symptoms they were experiencing. Another SU in the study 
also described that because the measures were relevant and often discussed in the 
session, completing them did not feel burdensome.  
One therapist involved in the study described that the EBVAS had been a little 
confusing to complete and that they and the SU had found it difficult to fully 
understand what was being asked because of the way the scale was written. This was 
useful feedback to take forward to future research using this scale. 
One SU described that the idea of having difficulties shared with them in a 
formulation, especially in a diagram sounded potentially daunting but also helpful to 
increase understanding of symptoms. Other feedback included that the consent form 
was easy to understand but that the participant information sheet could be shortened. 
Unfortunately, by the time service user feedback had been collected, most 
participants had started in the research with baseline data already collected and thus 
there was insufficient time to make any changes to the measures. However, if the 
research protocol is continued to be utilised within the services it would be important 
to take the SU perspective forward and make necessary amendments for participants 
and therapists involved.  
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Results 
Phase 1 
Coding. Phase 1 analysis involved rating pre-/post- workshop formulations. 
Four pre-workshop formulations were rated dichotomously by two researchers (AG & 
DP), indicating whether an item was present or absent. Inter-rater reliability was 
assessed using Cohen’s Kappa that expresses the level of agreement after chance 
agreement has been taken into account. The inter-rater agreement in Phase 1 was 
kappa=0.68, indicating a good level of agreement between the raters. 
The ICF-RS was used to rate four post-formulations by two researchers (GB & 
RH). Table 5 demonstrates the dichotomous comparisons of scores for the pre-/post- 
formulations. Due to the small sample size, statistical comparison was deemed 
inappropriate and thus tentative qualitative observational differences are discussed. 
As Table 5 indicates, all post-workshop formulations contained an increased 
number of elements compared to pre-workshop formulations, demonstrating that a 
higher number of ICF criteria were met following training. Therapist 2 (T2) showed 
the most changes, with five extra items detailed in their post-workshop diagram and 
four additional items for T1 and T3 compared to pre-workshop diagrams. T4 only 
included one extra item however had already scored 8/9 for the pre-workshop 
diagram. Importantly, no items that were present in the pre-workshop formulations 
were absent in the post-workshop diagrams, suggesting that the only difference 
between the diagrams were additions made and that no skills were “lost” following 
training. 
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Table 5. 
Comparison of scores for pre-/post- workshop formulation diagrams.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Note: A score of 1 means an item was present, 0 means an item was absent. Changes in scores between pre-/post- formulations  
are in bold. 
Therapist Item 1 Item 2 Item 3 Item 4 Item 5 Item 6 Item 7 Item 8 Item 9  
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Change 
pre/post 
1 0 1 1 1 0 1 1 1 0 1 0 1 1 1 1 1 1 1 +4 
2 0 1 1 1 1 1 0 1 0 1 1 1 0 1 0 1 0 1 +5 
3 0 0 0 1 1 1 0 1 0 1 1 1 0 1 0 0 0 0 +4 
4 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 +1 
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As the table illustrates, when an item was not present in pre-workshop diagrams, it 
was either present in post-workshop diagrams or continued to be absent, supporting 
the inference that changes between pre- and post-workshop reflected skills gained. 
Inspection of the differences reveal that there were some patterns across 
therapists with regards to item criteria being increasingly met in post-workshop 
diagrams compared to before the training. Item 4 was an additional item in post-
workshop diagrams for T2, T3 and T4. This means that following workshop training, 
key contextual elements were more likely to be included that were not included in 
pre-workshop diagrams. Therefore, post-workshop diagrams contained increased 
moderators relevant to the exacerbation or improvement of an aspect of a difficulty, 
providing a useful context for understanding triggers and the circumstances under 
which it presents itself. Since the case vignette was the same for pre/post-workshop 
formulations, this suggests that the workshop assisted clinicians in adding contextual 
information that they did not include in their first attempt. Other patterns demonstrate 
that Item 1 was included in post-formulation diagrams compared to pre-workshop 
diagrams by T1 and T2 suggesting that the workshop assisted with representing 
increased nature and sources of observations that were separated successfully from 
explanations. Item 5 was also added in T1 and T3’s diagrams compared to pre-
workshop diagrams, suggesting that the workshop helped with representing functional 
equivalence between elements that demonstrate understanding of the problem. Lastly, 
Item 7 was an addition for T2 and T3, suggesting that increased comprehensive 
accounts of the available information were included post-training, with the diagrams 
structuring information in a way that more comprehensively drew factors together that 
were influencing the problem, portraying patterns of interaction.   
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Closer analysis of the individual differences between therapists also indicates 
that therapists individually met increased criteria for items in post-diagrams. T1 
seemed to enhance skills mostly in defining the problem. T3 demonstrated some 
increases also with these items but also provided a more coherent and comprehensive 
account post-training. Despite an additional four items within their post-workshop 
diagram, T3 did not improve on Item 1, 8 or 9 with these items absent in both pre- and 
post-workshop diagrams suggesting that some skills and knowledge were not gained 
from the workshop for this individual. For T2, some skills appeared to be picked up 
across the scale including defining the problem in more detail but mostly in adding 
explanatory and validity sufficiency. These findings provide further indication that 
knowledge was gained as a result of the workshop. 
 
 
Phase 2  
 
Findings across the whole sample are presented followed by individual 
analysis to provide detailed examination between formulations and outcomes. 
 
Overview. Table 6 and 7 provide a summary of pre-/post- outcome measures 
across participants for PTSD measures and IAPT measures. Since most participants 
were still in treatment, the post score indicates the most recent data point available. 
Further analyses were carried out to determine those who met reliable and clinically 
significant change.  
 
 
 
 
  83 
Table 6. 
Summary of pre-/post- scores for PTSD measures. 
Participant SS pre SS post PCL-5 
Pre 
PCL-5 
Post 
IES-R 
Pre 
IES-R 
Post 
A 65 10 38 14 46 9 
B 61.3 15 57 9 62 13 
C 95 0 36 4 46 7 
D 25 3.5 39 3 35 7 
E 38.3 5 47 2 45 16 
F 42 10 55 7 64 3 
G 52 20 54 32 40 29 
H 85 85 66 - 67 - 
Note. SS - Symptom Severity, PCL-5 - PTSD Checklist for DSM-5, IES-R - Impact 
of Events Scale- Revised.  
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Table 7. 
Summary of pre-/post- scores and interpretations for PHQ-9, GAD-7 and W&SAS. 
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A 11 2 Moderate- 
None 
7 3 Mild- None 19 8 Moderate-
Mild 
B 17 4 Moderately 
severe - None 
14 4 Moderate- 
None 
27 6 Severe- 
Mild 
C 17 3 Moderately 
severe - None 
21 1 Severe-
None 
30 4 Severe-Mild 
D 7 2 Mild- None 9 2 Mild- None 10 0 Mild- None 
E 14 5 Moderate- 
Mild 
15 3 Severe- 
None 
16 10 Moderate-
Mild 
F 12 3 Mild-None 20 3 Severe- 
None 
8 0 Mild-None 
G 11 7 Moderate-
Mild 
14 8 Moderate-
Mild 
21 9 Severe-Mild 
H 24 25 Severe- 
Severe 
20 20 Severe- 
Severe 
26 35 Severe-
Severe 
Note: PHQ-9 - measure of depression, GAD-7 - measure of anxiety and W&SAS – 
Work & Social Adjustment Scale.  
 
 
 
Changes in Symptomology  
 
Symptom severity. The Symptom Severity measure (SS; combination of 
Frequency & Distress on the IVASs) was used to identify those who met statistically 
reliable and clinically significant changes following the shared formulation in Phase 
B. Figure 5 depicts changes on symptom severity scores between baseline Phase A 
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and the last data point available in intervention Phase B and indicates those that met 
reliable and clinically significant change.  
To calculate reliable change, the standard error of the mean (SEm) and the 
standard error of the difference (SEdiff) need to be computed (Morley, 1994). To 
calculate the standard error of mean, SEm = SD x √(1-r) with r = test-retest reliability 
of the measure. Using each participant’s first two baseline data points, test-retest 
reliability was calculated using Kendall’s r and found to be .74. The Standard Error of 
Difference is calculated as SEdiff = (√(2 x SEm2). SEm was calculated as 10.25 and the 
SEdiff calculated as 14.50.  
Reliable change was calculated using Jacobson and Traux (1991) reliable 
change index (RCI), calculated as RCI=M1 – M2 / SEdiff. Each participant’s last 
available data point for SS was subtracted from their average baseline SS score and 
divided by SEdiff. If the RCI is greater than 1.96, this is indicative of statistically 
reliable change (Jacobson & Traux, 1991; Morley, 1994). 
Clinically significant change was also calculated using two standard 
deviations above/below the mean of the pre-formulation scores (Veale, Page, 
Woodward & Salkovskis, 2015). A cut off point of 14 was produced. As displayed in 
Figure 5, three participants (PA, PB, and PC) met criteria for reliable change. Of 
these, two (PA and PC) also met criteria for clinically significant change.  
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Figure 5. Scatter plot of pre- and post- Symptom Severity scores. 
 
Impact of Events Scale-Revised. Reliable and clinically significant change 
was also calculated for the Impact of Events Scale-Revised (IES-R), as this is a 
standardised and routine measure of PTSD symptoms.  Figure 6 depicts changes on 
IES-R between scores from Session 1 and the last data point available in intervention 
Phase B and indicates those that showed reliable and clinically significant change. 
Reliable and clinically significant change were calculated in the same way as the SS 
as guided by Jacobson and Traux (1991), but with use of the IES-R clinical cut-off 
score for PTSD of 33 as recommended across PTSD literature (Creamer et al., 2003; 
Haagsma, van Beeck, Toet, & Polinder, 2013; Morina, Ehring, & Priebe, 2013) and 
using reliability, r=.89-.94 from the literature (Weiss & Marmar, 1997). Participant H 
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(PH) was excluded from the analysis since they did not have an available data point to 
compare to Session 1. As the plot demonstrates, all seven participants included in the 
analysis (PA-PF) met criteria for reliable and clinically significant change, 
demonstrating that symptoms of PTSD improved for all participants over the course 
of the study. 
 
 
 
Figure 6. Scatter plot of pre- and post- IES-R scores. 
 
Coding. The ICF-RS was used to rate ICFs within Phase 2. Eight ICFs were 
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use of intra-class correlation to evaluate reliability more formally. Average ratings 
were calculated between raters where there was a one-point difference. Where there 
was disagreement >1 point between the raters, the middle rating was agreed on. 
Table 8 details the scores given to each item on the ICF including the total 
score for each participant’s diagram. As described, all participants met reliable and 
clinically significant change on the IES-R but not the SS measure. The SS measure 
permitted a detailed analysis of the changes and thus, the results are discussed in 
relation to those deemed as “high responders” indicating participants who met reliable 
change on the SS (PA, PB, PC). Table 8 depicts differences between the eight 
participants ICF’s alongside associated changes in SS across the intervention. 
Generally, scores on the ICF’s were rather low compared to the possible maximum 
score of 27, with many items averaging a score of 1, suggesting low quality of 
formulations across the sample. Due to the small sample size, statistical comparison 
was deemed inappropriate and thus observational differences between high and low 
responders are described instead. Results are discussed tentatively in light of the low 
quality of formulations observed, the small sample size and the reliance on visual 
analysis. 
Overall, changes in SS scores across treatment were moderate-good with all 
participants demonstrating change, except for PH. Higher quality formulation 
diagrams are indicated by a higher total score on the ICF-RS, suggesting that 
diagrams created for PA, PC, PE, PF and PG met more criteria compared with other 
participants. Of those with the highest scores, PA and PC also showed reliable and 
clinically significant change. The diagram with the least criteria met was created for 
PB, however PB still met criteria for reliable change. PE and PF also showed similar 
ICF ratings to high responders but did not demonstrate comparable change. PG had 
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the diagram with the most criteria met and this was therefore rated as the highest 
quality.  However, it is worth noting that for PF and PG, they had only had six 
sessions at this point, compared to PA and PC who had finished treatment (receiving 
10 and 13 sessions respectively). Therefore, it is likely that PF and PG would have 
shown improved scores as treatment progressed. Therefore, with the exception of PB, 
a slight trend could be observed whereby increased ICF ratings and increased SS 
changes are linked. This is backed up by the finding that other than PB, the lowest 
responders (PD and PH) also displayed the lowest scores on the ICF-RS. However, 
overall, ICF scores are quite similar across participants and mostly rated as low in 
quality.  
Some preliminary observations are potentially worth noting. With regards to 
formulation content, an observed difference was found for Items 7, 8 and 9 that rate 
the extent to which the formulation provides a coherent and comprehensive account of 
the available information and has a relationship to intervention, providing detail on 
mechanisms of change for guiding treatment. While the scores are quite low, it does 
appear that scores were slightly higher on these items for individuals who improved 
most, with PA and PC who met clinically significant change scoring mostly the 
highest on these items. This suggests that these participants’ formulations met criteria 
for increased integration and structure of information to convey factors influencing 
the presentation of the problem, compared to other diagrams of lower responders.  
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Table 8. 
Scores on each item of the ICF-RS for Participants A-H. 
Participant SS 
Change 
Item 1 Item 2 Item 3 Item 4 Item 5 Item 6 Item 7 Item 8 Item 9 Total 
 
  
 A* -55 1.5 0.5 0.5 1.5 1 1 1.5 1.5 1 10 
 
 
B -46 0 0.5 0.5 1 0.5 0.5 1 1 0.5 5.5 
 
  
 C* -95 1.5 0.5 1 1.5 1.5 1.5 1.5 1 0.5 10.5 
 
 
D -22 1.5 0.5 0.5 1 0.5 0.5 0.5 1 0.5 6.5 
 
 
E -33 1 0.5 1.5 1.5 2 1 1 1 0.5 10 
 
 
F -32 2 0.5 0.5 2 1.5 0 1 1 1 9.5 
 
 
G -32 1.5 1 1 2 1.5 1.5 1 1 0.5 11 
 
 
H -0 1 0.5 1 1 1.5 1 1 1 0.5 8.5 
Note. High-responders are shown in bold with an asterisk for those meeting clinically significant change. Coding of each item  
Ranges from 0-3. Darker shading represents higher scores. 
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Interestingly, diagrams of lower responders generally scored higher on Item 5 
than diagrams of high responders, suggesting that lower responders’ diagrams 
displayed increased functional equivalence between elements. This suggests that 
observations noted are more functionally equivalent, in that they function to produce 
similar consequences (for example, avoidance) or that comparably more cues are 
present that function equivalently to provoke a similar response. The degree of 
functional equivalence might be an indirect marker of a more chronic difficulty, 
which would suggest that the individual could have developed increased ways of 
coping maladaptively for the same purpose or had an increased number of cues 
triggering a difficulty in a similar way. 
A similar pattern that is likely to be linked to the foregoing observation 
regarding functional analysis can be noted for Item 4, with lower responders generally 
scoring for having a greater number of moderators within the diagrams, such as 
immediate and historical information that could be impacting a problem, than high 
responders who tended to score slightly lower on this item. Moderators and functional 
equivalence are likely to be linked (for example, triggering cues serving as 
moderators that are functionally equivalent), which could account for the observed 
patterns of these items. 
Less clear differences were found for Item 1: the nature and source of 
observations are clear and explicit and not confused with explanations. Most diagrams 
scored moderately for this item, apart from PB’s. For high responders, 2/3 mostly met 
this criteria within formulation diagrams and for low responders, this criteria was met 
in 3/5 diagrams.   
All participants apart from PG scored 0.5 on Item 2, indicating that detailing 
contingencies between observations and how they increase each other’s occurrence 
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could be a skill that was not as developed as some of the others might have been. This 
is one of the key items of the ICF model as it demonstrates that arrows represent 
meaningful contingent relationships as opposed to indicating vague connections. This 
suggests a common default to represent ambiguous links between items in a diagram. 
This finding is the same for Item 9, with only PA and PF scoring above 0.5, 
suggesting that for most cases, managing complexity in the diagrams was often not 
rated as successful. For the remaining items including diagrams containing mediators 
displaying meaningful links between factors (Item 6) and diagrams displaying clear 
distinctions between observations and explanations (Item 3), no discernible patterns 
were observed. 
Overall, use of an ICF to capture elements was applied with low quality across 
the sample. However, there appears to be some suggestion that participants whose 
diagrams reflected some increased synthesis of elements showed signs of 
improvement.  
 
Individual analysis. 
For SCEDs, visual analysis of data is typically employed in order to judge if a 
relation between an independent variable and outcome appears to exist as well as 
inferring the strength of that relation (Kennedy, 2005; Kratochwill et al., 2010). If 
changes in the outcome variable following systematic introduction of an independent 
variable are observed between baseline and intervention phases with at least three 
demonstrations of the effect (Kratochwill et al., 2010) and differ more than would be 
expected (Horner et al., 2005), causal relations can more readily be inferred 
(Kratochwill et al., 2010). 
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Kratochwill et al. (2010) described the necessary steps for completing visual 
analysis. Firstly, baseline stability needs to be established to determine if the baseline 
is stable enough to assess and demonstrate intervention effects. The second step 
involves examining the data and documenting the level, trend and variability within 
each phase (Krathochwill et al., 2010). Gast (2005) describes level as the magnitude/ 
strength of the data, trend as the progress of the data over time and variability as the 
stability of the data. Next steps include comparing the data between phases to 
investigate patterns across phases and to determine if an effect exists. 
Gast and Spriggs (2010) provide guidance on baseline stability. Ideally, 
baseline data would be collected until clear stability is observed (Kennedy, 2005). To 
ensure participants did not wait unduly for treatment, this study required three 
baseline data points. Gast and Spriggs (2010) suggest that for cases like this, baseline 
stability can be assumed when 80% of the baseline data falls within a 20% range of 
the median. For this study, it was decided that baseline stability would be assumed 
when all of the data points fell within 20% range of the median, due to the small 
amount of data. 
When baseline data is not deemed to be stable, it is recommended that 
statistical analysis of data is carried out (Morley, 2015a; Parker, Vannest, David, & 
Sauber, 2011). Tau-U analysis can be used which combines nonoverlap between 
phases with trend from the intervention Phase controlling for trend in the baseline 
Phase (Parker et al., 2011). Therefore, when there were three data points in both 
baseline and intervention phases, Tau-U analyses were carried out. Where there were 
less than three data points in either phase, variability is discussed without the use of 
statistical analysis, as suggested by Krathochwill et al., (2010). In these cases, 
observations are interpreted with caution.  
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Morley and Adams (1991) and Morley (2015a) describe useful tools for 
documenting the level, trend and variability and provide guidance depending on phase 
lengths. Morley and Adams (1991) suggest using central tendency, recommending use 
of the median. Rosenberger and Gasko (1983) suggest that when there are over five 
data points, the broadened median (BMED) is calculated, because the median may not 
fully reflect the magnitude of the sample. For fewer than five data points, the median 
is calculated. For investigating non-linear trends, Morley and Adams (1991) suggest 
use of the running median (RM) that plots central tendency over time, calculated by 
segmenting data into successive sets and calculating the average for each set. For this 
study, a RM of two was used. To demonstrate variability across time, Morley and 
Adams (1991) suggest plotting the trended range (TR) using a split middle technique 
of dividing the data into two halves and identifying the maximum and minimum 
values. For the repeated VASs, central tendency, trend and variability were calculated 
for each participant. Definitions of the terms used and how they are represented 
graphically are displayed in Table 9. 
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Table 9. 
 
Definitions of visual analysis terms. 
 
 
For each participant, increased information regarding trauma details and the 
treatment type each person received is presented. Some information has been changed 
in order to protect participant anonymity. Graphical analysis depicting central 
tendency and trend of repeated outcome measures are displayed for each participant. 
Baseline and intervention phases are separated by solid vertical lines. Graphs showing 
TR are displayed in Appendices 21-28. A summary of the ICF content is also 
presented for each participant. 
 
 
 
Term Definition  Represented 
 graphically 
Raw data Data points. Round Dots  
Median (M)  The middle value when the data is rank 
ordered. Used when there were 1-5 data points 
in the Phase. 
Dashed line 
Broadened 
Median 
(BMED) 
The average of the three middle values when 
the data is rank ordered. Used when there were 
5+ data points in the Phase. 
Dashed line 
Running 
Median 
(RM) 
Average of consecutive sets of 2 data points 
throughout the Phase. 
Dotted line 
Connected with 
Crosses 
Trended 
Range (TR)  
Lines connecting maximum and minimum data 
points in each half of the Phase. 
Solid lines 
connected with 
Diamonds 
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Participant A. Table PA1 details trauma information, specific images and the 
key meaning of the images, treatment type and the formulation shared. PA spoke 
Portuguese as her first language and had experienced a single instance of trauma 2 
months prior to receiving treatment.  In the past she had also witnessed other 
traumatic incidents. She also had some features of low self-esteem. 
Table PA1.  
Trauma type, specific images, encapsulated beliefs, formulation shared, treatment 
type for PA. 
 
PA had three baseline data points followed by seven data points captured 
following sharing of the formulation, reflecting the full course of treatment she 
received. Baseline data across measures with the exception of frequency was either 
increasing or within a 20% range of the median and was therefore deemed to be 
stable. Further statistical analyses were carried out for the VASs, controlling for 
baseline instability for frequency, summarised in table PA2. Image intrusiveness and 
encapsulated belief VASs are graphically displayed in Figures PA1-5 and PA6 
respectively. Summary of the ICF content is shown in Table PA3. 
Trauma type Specific images Encapsulated beliefs Formulation 
shared 
 
Treatment 
type 
Sexual 
Harassment– 
fear of sexual 
assault. 
 
Perpetrator 
becoming angry. 
Perpetrators face. 
Being sexually 
assaulted. 
 
He is going to rape 
me. 
I can’t trust anybody. 
There is no justice in 
the world. 
He is capable of 
killing me. 
Individual 
Case 
Formulation 
Trauma 
Focused 
CBT.  
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                 Figure PA1. Frequency VAS: raw data, central tendency and trend.                         Figure PA2. Interference VAS: raw data, central tendency and trend. 
               Figure PA3.Uncontrollability VAS: raw data, central tendency and trend.               Figure PA4. Distress VAS: raw data, central tendency and trend. 
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                     Figure PA5.Nowness VAS: raw data, central tendency and trend.                         Figure PA6. Key Meaning VAS: raw data, central tendency and trend.  
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Table PA2.  
Tau-U analysis for Frequency, Interference, Uncontrollability, Distress, Nowness and 
Key Meaning for PA. 
 TAUb p value CI 90% 
Frequency -.90 .03 -1<>-.22 
 
Interference -1 .02 -1<>-.31 
 
Uncontrollability  -1 .02 -1<>-.31 
 
Distress -1 .02 -1<>-.31 
 
Nowness -.98 .02          -1<>-.27 
 
Key Meaning  -1 .02 -1<>-.31 
 
Sharing the formulation. For image intrusiveness, there is a general downward 
trend, suggesting improvement across treatment. This trend was also observed on the 
EBVAS for the key meaning of the images. Promisingly, the gains observed were 
maintained over the course of treatment. There are clear, observable differences in 
scores at Session 4 for all of the image intrusiveness items apart from nowness. 
Reductions in scores are observable at Session 4 for frequency, interference, 
uncontrollability and distress. This is also apparent for the EBVAS, suggesting that 
sharing the formulation could have contributed to reducing image intrusiveness and 
belief in the meaning of images. A change in nowness was observed but not until 
Session 5. 
For frequency, baseline was deemed unstable. However, non-overlap analysis 
was carried out for all VASs, to determine if any significant differences between 
phases existed. These revealed that for all IVASs and the EBVAS, scores in baseline 
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Phase A were significantly different from scores in Phase B, indicating a significant 
change in image intrusiveness and key meaning of images between Phases. 
 
Table PA3. 
ICF-RS content code. 
IC
F
-R
S
 
to
ta
l 
It
em
 1
 
It
em
 2
 
It
em
 3
 
It
em
 4
 
It
em
 5
 
It
em
 6
 
It
em
 7
 
It
em
 8
 
It
em
 9
 
 
10 1.5 0.5 0.5 1.5 1 1 1.5 1.5 1 
 
Linking ICF to outcome. The coding summary shows that PA’s diagram 
scored 10/27 in total, scoring within all domains, suggesting it captured an element of 
each item, albeit very little for some items and scoring low for overall quality. Highest 
ratings were given for Items 1, 4, 7 and 8, although still moderate. This included 
meeting criteria for containing the nature and source of observations clearly and 
explicitly, with observations not confused with explanations, containing key 
contextual elements and providing a fairly coherent account of the information 
available which allows some basis for identifying where and how to intervene.  Items 
5, 6 and 9 were deemed to be partially present in the diagram suggesting functional 
equivalence between elements, mediators between factors and complexity are all 
partially present but mainly did not display main links or add explanatory value. Items 
2 and 3 were less apparent in the ICF, demonstrating that there was a high degree of 
ambiguity in the diagram with regards to observations and explanations and how they 
linked to each other.  
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In terms of outcome, PA’s scores showed a general downward trend across all 
items including the IVASs and EBVAS over the course of treatment with a significant 
difference between phases obtained. For all items apart from nowness, this occurred at 
the start of Phase B. These scores continued to decrease in a stable manner as 
treatment progressed. This finding occurred for all pre-/post- measures including on 
the PHQ-9, GAD-7 and W&SAS and standardised PTSD measures with PA no longer 
meeting caseness for PTSD by the end of treatment. Thus, observed gains from 
baseline to end of treatment across all measures were large.  
 
Participant B. Table PB1 details trauma information, specific images, the key 
meaning of the images, formulation shared and treatment information. PB spoke 
English as her first language and had experienced a single instance of trauma 5 years 
prior to receiving current treatment. She also had low mood. 
Table PB1.  
Trauma type, specific images, encapsulated Beliefs, formulation shared, treatment 
type for PB. 
Trauma type Specific images Encapsulated 
beliefs 
Formulation 
Shared 
Treatment 
type 
Attempted sexual 
assault at 
knifepoint. 
Being pushed 
onto the floor. 
Her and 
perpetrator trying 
to grasp the 
knife. 
Hooded heads. 
I am guilty. 
I should 
have fought 
him off. 
 
Ehlers & 
Clark. 
Trauma 
Focused 
CBT. 
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PB had three baseline data points followed by seven data points captured 
following sharing of the formulation. This captured all of her treatment sessions. 
VASs are graphically displayed in Figures PB1-5 and PB6. Baseline data did not meet 
stability criteria for uncontrollability or nowness. See table PB2 for Tau-U analyses. 
Summary of the ICF content is shown in Table PB3. 
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        Figure PB1. Frequency VAS: raw data, central tendency and trend.                        Figure PB2. Interference VAS: raw data, central tendency and trend.  
    Figure PB3.Uncontrollability VAS: raw data, central tendency and trend.                   Figure PB4. Distress VAS: raw data, central tendency and trend.  
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           Figure PB5.Nowness VAS: raw data, central tendency and trend.                                Figure PB6. Key Meaning VAS: raw data, central tendency and trend. 
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Table PB2.  
Tau-U analysis for Frequency, Interference, Uncontrollability, Distress, Nowness and 
Key Meaning for PB. 
 TAUb p value CI 90% 
Frequency -1 .02 -1<>-.31 
 
Interference -1 .02 -1<>-.31 
 
Uncontrollability  -.86 .04 -1<>-.17 
 
Distress -.81 .05 -1<>-.12 
 
Nowness -.76 .07          -1<>-.08 
 
Key Meaning  -1 .02 -1<>-.31 
 
Sharing the formulation. In general, there is a downward trend from Phase A 
to Phase B, suggesting improvement in image intrusiveness and encapsulated belief 
scores across treatment. At session 4, scores reduce for frequency, interference and 
key meaning with a downward trend generally continued for these items across 
treatment. With baseline data meeting stability criteria including increasing for 
interference, this suggests that sharing the formulation could potentially have 
contributed to reducing image intrusiveness in these domains and for reducing 
believability of images. Furthermore, nonoverlap analyses revealed that there was a 
significant difference in these VASs between Phase A and Phase B.   
For uncontrollability and nowness, significant baseline trend also resulted in 
further statistical analyses being carried out. Nonoverlap analyses revealed that for 
uncontrollability, there was a significant difference between scores in Phase A and B. 
For distress and nowness, scores increased at Session 4, suggesting that sharing the 
formulation was not helpful for assisting with these domains. However, at Session 5, 
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scores had reduced again followed by a downward trend mostly continuing for the 
remainder of treatment. Nonoverlap analysis indicated that for nowness and distress, 
scores were not significantly different between phases.  
Despite general downward trends, raw data points reveal variability of the data 
whereby scores increased at Sessions 7 and 8 in almost all image intrusiveness 
measures. The EBVAS did not show this trend and scores continued to reduce across 
treatment from Session 4.  
Information from the treating therapist revealed that PB had been experiencing 
stressors in other areas of her life including work and home issues that had also 
affected her sleep. One of these stressors had involved another potentially traumatic 
incident. The therapist felt that an increase in PTSD symptoms towards the end of 
therapy was due to these factors and that scores were relatively low considering this.  
Finally, despite not being required to provide qualitative feedback, PB 
described having a “180 degree turn around” after sharing of the formulation diagram 
with regards to beliefs about coping with reliving or elaborating on memories. She 
described thinking that it would be “overwhelming and frightening”, but that the 
formulation made “absolute sense” and that she found the diagram “extremely 
valuable” and kept a copy of the diagram to reference.  
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Table PB3. 
ICF-RS content code. 
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5.5 0 0.5 0.5 1 0.5 0.5 1 1 0.5 
 
Linking ICF to outcome. The coding summary reveals that PB’s diagram scored low 
for overall quality with a total score of 5.5/27. The formulation was rated as not 
meeting criteria for Item 1 suggesting that observations were not sufficiently 
described with regards to their origin, which could have created ambiguity in terms of 
what was reported by the participant or actually observed.  The diagram also only 
very marginally met criteria for Items 2, 3, 5, 6 and 9. This means that the diagram 
was mostly ambiguous with regards to how observations were thought to be linked 
and follow on from each other, required explanations were lacking, very little 
functional equivalence between items existed that did not add explanatory value and 
mediators that were included failed to demonstrate their linking function. Complexity 
was also not often successfully captured within the diagrams. 
The diagram scored 1 for Item 4, 7 and 8 indicating that it met criteria for 
containing some moderators that contributed to a difficulty although they provided 
limited information about how they operate. The formulation also partially accounted 
for information gained about the problem however some important observations were 
deemed to not have been included. Next, the formulation did not satisfactorily provide 
an account for how the difficulty arose or how it was maintained and thus it would be 
difficult to fully determine where and how to intervene. Therefore, overall the ICF 
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produced for PB lacked many factors deemed to increase quality to a formulation 
diagram. 
In terms of overall outcome, PTSD and IAPT measures showed symptom reduction 
across therapy with PB not meeting caseness for PTSD by the end of treatment. 
Qualitative feedback gained from PB suggested helpfulness of the shared formulation. 
Further discussion with the therapist revealed that the ICF diagram was drawn out and 
rated prior to Session 3, as per the instructions of the research design. However, over 
the course of treatment, the diagram was added to and revised. Therefore, the diagram 
that was completed by the end of therapy, which was subject to changes and revisions, 
would have looked quite different and possibly more complex to the formulation 
diagram that was rated at Session 3. This suggests that the diagram could have been 
higher in quality and better represented the complexity of the case by the end of 
treatment and that the rated diagram does not account for all the factors that could 
have been included by the end. 
 
Participant C. Table PC1 details trauma information, specific images, the key 
meaning of the images, treatment received and the formulation shared. PC was 
Ukrainian and therefore English was not his first language. He had experienced 
multiple traumas in his life but was receiving treatment for a single incident that 
occurred 6 months prior to treatment. He also suffered with low mood. 
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Table PC1.  
Trauma type, specific images, encapsulated Beliefs, formulation shared, treatment 
type for PC. 
 
  For PC, only two baseline data points were available followed by ten data 
points in Phase B. Baseline data therefore falls short of what is necessary to make 
clear inferences in SCED and thus no statistical analyses were carried out on the data.  
PC continued to receive treatment following data collection. VASs are graphically 
displayed in Figures PC1-5 and PC6. Summary of ICF content is shown in Table 
PC2. 
 
 
Trauma type Specific images Encapsulated 
beliefs 
Formulation 
shared 
Treatment 
type 
Machinery 
accident at 
work. 
Being put in jail. 
Images of the 
accident. 
  
The world is a 
bad place. 
I am powerless. 
I am vulnerable. 
The government 
has created all 
these problems. 
 
Ehlers & 
Clark. 
Trauma 
Focused 
 CBT.  
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        Figure PC1. Frequency VAS: raw data, central tendency and trend.                Figure PC2. Interference VAS: raw data, central tendency and trend.                  
 
                   Figure PC3.Uncontrollability VAS: raw data, central tendency and trend.          Figure PC4. Distress VAS: raw data, central tendency and trend.  
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                 Figure PC5.Nowness VAS: raw data, central tendency and trend.                          Figure PC6. Key Meaning VAS: raw data, central tendency and trend.                    
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Sharing the formulation. Despite lack of complete baseline data, visual 
analysis demonstrates a downward trend following the shared formulation for all 
items on the IVAS. Although the scores had begun to reduce in the baseline phase 
between Session 2 and 3, the reduction from Session 3 to 4 across all items on the 
IVAS is the largest across all sessions. This suggests that sharing the formulation with 
PC impacted on these scores. Although there are some patterns of variability in the 
data, especially for interference and across other items with scores increasing at 
Session 7 and 8, this is mostly followed by a continued and stable decrease across 
treatment with scores of 0 by Session 12 and 13. Conversely, the EBVAS displays 
high levels of variability, with scores declining at Session 4, followed by a large 
increase at Session 5, reduction in Session 6 and gradually increasing again until 
scores begin to reduce from Session 11. Thus, the gains made at Session 4 for the 
belief in the meaning of the images were not maintained. However, by the end of data 
collection, the score on the EBVAS had reduced considerably in comparison to 
baseline data. 
Table PC2. 
ICF-RS content code. 
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Linking ICF to outcome. PC’s diagram scored 10.5/27, the second highest 
score of all participants, scoring within each item, albeit still low for overall quality. 
Highest ratings were given for Items 1, 4, 5, 6 and 7. This suggests that the diagram 
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moderately met criteria for observations being described with some precision with 
regards to their nature and source, although some ambiguity remained regarding 
whether they were based on inference or supposition. Next, some moderators were 
included that helped to build a picture of the problem, as well inclusion of some 
mediators linking observations together. Detail regarding how they operate is 
somewhat lacking although there is some functional equivalence between items 
represented. Scores demonstrated that the formulation accounts for the information 
gained to a degree but that some information is not completely integrated to reflect a 
comprehensive account. 
Items 3 and 8 were deemed to be partially present in the diagram suggesting 
that some explanations were present in the diagram, although they did not always 
relate to or distinguish from specific observations. The formulation fails to provide a 
readily apparent account of how the problem has arisen and how it is being sustained. 
Therefore, it is less useful for anticipating how the problem could change under 
different circumstances and for choosing where and how to intervene and what to 
prioritise. Furthermore, Items 2 and 9 were less apparent in the ICF, suggesting that 
the formulation contained ambiguity about how processes link to each other and that 
it did not fully capture the complexity of the person’s presentation. 
In terms of outcome, PC’s scores showed a reduced trend across all items 
including the IVASs and EBVAS despite patterns of variability over the course of 
treatment. The scores mostly continued to decrease in a stable manner as treatment 
progressed, suggesting that although baseline data was not complete and thus stability 
was not fulfilled, it seems that the graphs are suggestive of a reduction in symptoms 
across treatment. This finding occurred for all pre-/post- measures with PC no longer 
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meeting caseness for PTSD, depression or anxiety by the end of data collection. Thus, 
observed gains from baseline to end of treatment across items were large.  
 
Participant D. Table PD1 details trauma information, specific images, key 
meaning of images as well as the formulation shared and the treatment received. PD 
spoke English as her first language. She had experienced a single incident of trauma 
around 4 years prior to receiving treatment. She also had a long-term health difficulty.  
Table PD1.  
Trauma type, specific images, encapsulated beliefs, formulation shared, treatment 
type for PD. 
Trauma type Specific images Encapsulated 
beliefs 
Formulation 
shared 
Treatment 
type 
Medical 
procedure 
involving going 
into hospital 
theatre for an 
operation. 
Lying in hospital 
bed in hospital 
room with 
medical 
procedures about 
to happen. 
I am going to 
die. 
I will not wake 
up. 
I am not in 
control. 
Vicious 
flower 
Trauma 
focused 
CBT. 
 
PD had three baseline data points followed by five data points following 
sharing of the formulation. PD continued to receive treatment following involvement 
in the study. Baseline data did not meet stability criteria for any items of the IVAS 
and thus further statistical analyses were carried out for frequency, interference, 
uncontrollability distress and nowness and key meaning. See table PD2 for Tau-U 
analyses. Image intrusiveness and encapsulated belief VASs are graphically displayed 
in Figures PD1-5 and PD6. Summary of the formulation content is shown in Table 
PD3. 
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Figure PD1. Frequency VAS: raw data, central tendency and trend.                          Figure PD2. Interference VAS: raw data, central tendency and trend. 
Figure PD3. Uncontrollability VAS: raw data, central tendency and trend.                     Figure PD4. Distress VAS: raw data, central tendency and trend. 
0
10
20
30
40
50
60
70
80
90
100
0 1 2 3 4 5 6 7 8
F
re
q
u
en
cy
Measurement
0
10
20
30
40
50
60
70
80
90
100
0 1 2 3 4 5 6 7 8
In
te
rf
er
en
ce
Measurement
0
10
20
30
40
50
60
70
80
90
100
0 1 2 3 4 5 6 7 8
U
n
co
n
tr
o
ll
ab
il
it
y
Measurement
0
10
20
30
40
50
60
70
80
90
100
0 1 2 3 4 5 6 7 8
D
is
tr
es
s
Measurement
  116 
  
 
              Figure PD5.Nowness VAS: raw data, central tendency and trend.                             Figure PD6. Key Meaning VAS: raw data, central tendency and trend.            
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Table PD2.  
Tau-U analysis for Frequency, Interference, Uncontrollability, Distress, Nowness and 
Key Meaning for PD. 
 TAUb p value CI 90% 
Frequency -.07 .88 .80<>0.67 
 
Interference .15 .77 -.87<>.60 
 
Uncontrollability  -.07 .88 .80<>0.67 
 
Distress -.70 .18 -1<>.14 
 
Nowness .23 .65 -.54<>.94 
 
Meaning  -.62 .18 -1<>.14 
 
Sharing the formulation. As the graphs display, PD’s scores generally show 
lower levels of image intrusiveness symptoms in the baseline Phase compared to 
some other participants. The data shows a pattern of variability whereby scores 
decreased at Baseline point 2.  This was followed by a further decrease in scores 
(frequency and nowness), a slight increase (interference and uncontrollability) or the 
same score (distress) at Session 3.  The variability of the data and unstable baseline of 
all items could have been due to a positive life event that happened to PD between 
Sessions 2 and 3 and therefore results need to be interpreted with caution. The data 
also continues to show a pattern of variability over the course of therapy. For 
frequency, scores increase at Session 4 and begin to reduce at Session 6. Nowness 
also slightly increases at Session 4 also, with other image intrusiveness scores 
remaining the same. Belief in the key meaning of images reduces slightly at Session 
4. The EBVAS demonstrates a pattern of variability whereby scores decrease in 
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Session 3 and 4, increase at Session 5, decrease at Session 6 and rise again in Session 
7 and 8.  
Tau-U analyses revealed no significant differences between scores in Phase A 
and Phase B for any of the Items. Towards the end of data collection, scores across all 
IVAS items reduced. However, with the patterns of variability in the data, it is 
difficult to be confident that this finding would remain stable. 
 
Table PD3. 
ICF-RS content code. 
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Liking ICF to outcome. Overall, PD’s diagram scored low for quality with a 
total score of 6.5/27 scoring 0.5 on most items. The diagram scored highest on Item 1. 
This suggests that the diagram moderately met criteria for demonstrating the nature 
and source of observations and these were moderately separated from explanations. 
Items 4 and 8 were marginally represented suggesting that there was some evidence 
of contextual elements included in the diagram and also some ability to provide a 
basis of understanding of how to intervene, although this was deemed as too basic to 
enable precise guiding of treatment.  
Other item criteria very slightly met in the diagram included some linking of 
observations and explanations, some functional equivalence highlighted between 
factors and some identification of mediators, although the score suggests that mostly 
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these were not coherently organised as complex pieces of information into a 
comprehensive understanding.  
With regards to outcome, PD showed a reduction in PTSD symptoms on 
pre/post measures including the IES-R and PCL-5 whereby she no longer met 
caseness for PTSD. She also improved on IAPT measures of depression and anxiety. 
However, due to the weekly variability of scores observable it is not clear if these 
findings would remain stable over the course of therapy. Furthermore, the gains made 
from the beginning of treatment to when the last data point was collected are 
moderate. However, as PTSD scores were fairly low at the start of treatment and she 
had not yet completed treatment, this is more likely to be expected.  
 
Participant E. Table PE1 details trauma information, specific images, key 
meaning of the images, the formulation shared as well as treatment received. PE 
spoke English as her first language. She had experienced a number of traumatic 
events over her lifetime but was receiving treatment for a specific trauma that 
occurred 15 years ago that had recently been triggered. PE was also experiencing 
symptoms of depression, health anxiety and panic disorder. 
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Table PE1.  
Trauma type, specific images, encapsulated beliefs, formulation shared, treatment 
type for PE. 
Trauma type Specific images Encapsulated 
beliefs 
Formulation 
shared 
Treatment 
type 
Armed robbery 
in which family 
members were 
shot and 
assaulted. 
Being attacked. 
Family being 
hurt and she not 
being able to 
help. 
Dying of an 
unknown illness. 
My family is going 
to die. 
I will be attacked. 
I am vulnerable. 
The world is 
dangerous. 
Individual 
Case 
Formulation 
Trauma 
focused 
CBT. 
 
PE had three baseline data points followed by five data points captured 
following sharing of the formulation. She continued to receive trauma focused CBT 
following the study involvement. Baseline data for measures of frequency, nowness 
and key meaning failed to meet stability criteria. VASs are graphically displayed in 
Figures PE1-5 and PE6. See Table PE2 for Tau-U analyses. Summary of the ICF 
content is shown in Table PE3. 
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                Figure PE1. Frequency VAS: raw data, central tendency and trend.                               Figure PE2. Interference VAS: raw data, central tendency and trend. 
            Figure PE3.Uncontrollability VAS: raw data, central tendency and trend.                       Figure PE4. Distress VAS: raw data, central tendency and trend. 
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      Figure PE5.Nowness VAS: raw data, central tendency and trend.                         Figure PE6. Key Meaning VAS: raw data, central tendency and trend.
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Table PE2.  
Tau-U analysis for Frequency, Interference, Uncontrollability, Distress, Nowness and 
Key Meaning for PE. 
 TAUb p value CI 90% 
Frequency -.31 .55 -1<>-.47 
 
Interference 0 1 -.73<>.73 
 
Uncontrollability  -.28 .55 -1<>.47 
 
Distress -.60 .17 -1<>.17 
 
Nowness -.87 .05 -1<>.13 
 
Key Meaning  -.80 .07 -1<>-.06 
 
Sharing the formulation. PE’s scores are generally low for image intrusiveness 
compared to other participants in the baseline phase, but high for key meaning of the 
image. Scores have mostly reduced by Session 8 on image intrusiveness and 
encapsulated belief. However, visual analysis reveals considerable variability of the 
scores. The baseline is stable for interference, uncontrollability and distress. 
Interference and uncontrollability show a similar pattern of variability whereby scores 
increase at Session 4 and 5 followed by a decrease in scores from Session 6. Distress 
shows a pattern whereby scores decrease at Session 4 but increase considerably at 
Session 5, followed by a decrease from Session 6. Scores for belief in the meaning of 
the images also increase at Session 4. Therefore Session 4 appears to be a point of 
change for PE, with scores either increasing considerably or decreasing. Tau-U 
analyses reveal that there was no significant differences between Phase A and B for 
any of the IVASs. Overall there is a reduction of symptoms across treatment, with 
  124 
greatest gains on the EBVAS. However, Tau-U analyses revealed that differences on 
the key meaning of images between Phase A and B were not significant. 
Table PE3. 
 ICF content code. 
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Linking ICF to outcome. Overall, PE’s diagram scored 10/27 on the ICF-RS 
scoring low for over quality. Scores reveal that PE’s diagram showed a high level of 
functional equivalence (Item 5) between elements that allows some understanding for 
how elements contributed to the delineation of the patterns of circumstances. Linked 
to this, there is also presence of explanations used to make sense of the information 
included as well as contextual elements (moderators) that give some understanding 
about the conditions under which the problem presents and is maintained. The 
diagram also somewhat met criteria for containing mediators, although their linking 
function to other observations is not convincingly established and the nature and 
source of the observations are not completely clear. These scores demonstrate that the 
diagram met some criteria for level of detail available in the diagram that allows for 
some information regarding how factors relate to each other. However, the diagram 
does not provide a readily apparent account of how the problem has arisen and how it 
is being sustained. Therefore, it is of limited use for anticipating how the problem 
could change under different circumstances and for choosing where and how to 
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intervene. Therefore, although some level of detail is present, especially with regards 
to the functional equivalence of items, the diagram does not manage complexity as 
successfully as required to adequately guide intervention.  
Overall outcome revealed that by the end of data collection, PE no longer met 
criteria for PTSD, displaying asymptomatic scores on the PCL-5 and IES-R. Scores 
on IAPT measures also reduced including depression. Gains from Session 1 to 
Session 8 appear moderate.  
 
 
Participant F. Table PF1 details trauma information, specific images, key 
meaning of images, the formulation shared and the treatment received. PF spoke 
English as his first language. He had experienced a number of traumatic events over 
his lifetime but was receiving treatment for a specific trauma that occurred within the 
last year. As well as symptoms of PTSD, PF had symptoms of complicated grief 
disorder and was finding the death of a family member very difficult to cope with. 
Table PF1.  
Trauma type, specific images, encapsulated beliefs, formulation shared, treatment 
type for PF. 
Trauma type Specific 
images 
Encapsulated 
beliefs 
Formulation 
shared 
Treatment 
type 
Physically 
assaulted whilst 
caring for dying 
relative.  
Perpetrator 
attacking 
him. 
Hands of 
perpetrator 
around neck. 
He is going to kill 
me. 
People are 
unpredictable. 
The world can be 
horrible. 
Individual 
Case 
Formulation. 
Trauma 
focused 
CBT. 
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PF had three baseline data points followed by three data points following 
sharing of the formulation. PF continued to receive therapy following involvement in 
the study. Image intrusiveness and encapsulated belief VASs are graphically 
displayed in Figures PF1-5 and PF6. PF showed significant baseline trend on all Items 
of the IVAS requiring further statistical analyses that are summarised in Table PF2. 
Summary of formulation content is shown in Table PF3. 
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               Figure PF1. Frequency VAS: raw data, central tendency and trend.                            Figure PF2. Interference VAS: raw data, central tendency and trend. 
 Figure PF3.Uncontrollability VAS: raw data, central tendency and trend.                Figure PF4. Distress VAS: raw data, central tendency and trend. 
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        Figure PF5. Nowness VAS: raw data, central tendency and trend.                    Figure PF6. Key Meaning VAS: raw data, central tendency and trend. 
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Table PF2.  
Tau-U analysis for Frequency, Interference, Uncontrollability, Distress, Nowness and 
Key Meaning for PF. 
 TAUb p value CI 90% 
Frequency -.78 .13 -1<>.06 
 
Interference -.78 .13 -1<>.06 
 
Uncontrollability  -.78 .13 -1<>.06 
 
Distress -.78 .13 -1<>.06 
 
Nowness -.78 .13 -1<>.06 
 
Key Meaning  -1 .05 -1<>-.16 
 
Sharing the formulation. Visual analysis reveals that there is a pattern of 
variability in the data whereby scores reduce at Baseline point 2, followed by the 
same score at Session 3. Scores reduce again at Session 4 and remain reduced until 
Session 6 where there was a slight increase in scores. This occurred across all image 
intrusiveness items.  There is a clear reduction in scores at Session 4 for PF, 
suggesting that sharing the formulation diagram may have contributed to reduction of 
image intrusiveness scores. However, as described there was also a reduction at 
Session 2 suggesting that these findings need to be interpreted with caution. 
Furthermore, Tau-U analyses revealed no significant differences between Phase A 
and Phase B in any of the items, suggesting that any observed differences were not 
significant. For key meaning of images, visual analysis shows that following the 
stable baseline, there was a reduction at Session 4, followed by an increase in Session 
5 and a reduction at Session 6. Tau-U analyses revealed that the differences just failed 
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to meet significance. Although scores generally appear to reduce over treatment, the 
differences between phases are not significant and with the patterns of variability in 
the data, it is difficult to be confident that scores would remain stable. 
Table PF3. 
ICF content code. 
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Linking ICF to outcome. The coding summary shows that PF’s diagram scored 
9.5/27 in total, scoring within all domains except Item 6. Highest ratings were given 
for Items 1 and 4. This suggests that items regarding the nature and source of 
observations were clear and explicit, and not confused with explanations. 
Furthermore, the diagram contained key contextual elements that provided a useful 
context for understanding triggers of the problem and where it presents itself. 
Functional equivalence between items, contributing to the difficulty, was also 
moderately captured. 
Item 7, 8 and 9 were scored as partially meeting criteria suggesting that the 
diagram moderately accounts for information gained about the client’s problem, but 
that some important observations were not satisfactorily integrated, suggesting that it 
is difficult to adequately direct treatment from this information. Regarding 
complexity, the formulation included some higher-level detail but the overall 
organisation appeared somewhat problematic. The formulation also fails to identify or 
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include mediators that maintain difficulties leaving ambiguity with regards to 
explanations and observations and the links between them. 
With regards to overall outcome, PF demonstrated a good level of symptom 
reduction across all measures, no longer meeting caseness on PTSD measures. IAPT 
measure scores also reduced considerably for depression and anxiety. Considering 
that PF was only half way through treatment at this stage, gains made this far were 
promising.  
 
Participant G. Table PG1 details trauma information, specific images, key 
meaning of images, the formulation shared as well as the treatment received. PG 
spoke English as her first language and had experienced a single instance of trauma 
one year prior to receiving treatment.  
Table PG1. 
Trauma type, specific images, encapsulated beliefs, formulation shared, treatment 
type for PG. 
Trauma type Specific 
images 
Encapsulated 
beliefs 
Formulation 
shared 
Treatment 
type 
Road Traffic 
Accident. 
Person’s leg 
being hit 
People 
kicking the 
car. 
I am a bad person. 
I can’t deal with 
responsibility. 
I can’t be trusted. 
I am not good 
enough. 
Ehlers & 
Clark. 
Trauma 
Focused 
CBT. 
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PG had three baseline data points followed by three data points following 
sharing of the formulation. PG continued to receive therapy following involvement in 
the study. Image intrusiveness and encapsulated belief VASs are graphically 
displayed in Figures PG1-5 and PG6. Baseline data was stable, either within a 20% 
range of the median or increasing. However, further Tau-U analyses were carried out 
to statistically investigate the differences between phases, detailed in Table PG2. 
Summary of formulation content is shown in Table PG3. 
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Figure PG1. Frequency VAS: raw data, central tendency and trend.                         Figure PG2. Interference VAS: raw data, central tendency and trend. 
Figure PG3.Uncontrollability VAS: raw data, central tendency and trend.                    Figure PG4. Distress VAS: raw data, central tendency and trend.  
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Figure PG5.Nowness VAS: raw data, central tendency and trend.                        Figure PG6. Key Meaning VAS: raw data, central tendency and trend. 
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Table PG2.  
Tau-U analysis for Frequency, Interference, Uncontrollability, Distress, Nowness and 
Key Meaning for PG. 
 TAUb p value CI 90% 
Frequency .13 .82 -95<>.73 
 
Interference -.71 .28 -1<>.28 
 
Uncontrollability  -1 .04 -1<>-.16 
 
Distress -1 .04 -1<>-.16 
 
Nowness -.11 .83 -.95<>.73 
 
Key Meaning  .94 .08 -1<>.05 
 
There is variability in the data for image intrusiveness across treatment. At 
Session 4, for frequency, there is a pattern of variability whereby scores increase 
followed by a decrease in Session 5 and 6. Scores had already begun to increase at 
Session 3. For the other items, variability is generally lower with a stable and 
continued decrease for scores for interference, uncontrollability and distress from 
Session 4, an important observation because baseline data for these was either stable 
or increasing. Further visual analysis through investigation of the central tendency for 
frequency and interference reveal no changes across Phase A and B. For nowness, 
central tendency increased in Phase B. For distress and uncontrollability central 
tendency is lower in Phase B. Tau-U analyses reveal that there was a significant 
difference for scores for uncontrollability and distress between Phases. None of the 
other analyses revealed a significant difference between Phase A and B. For the key 
meaning of the image, baseline is stable with a reduction in scores at Session 4 
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followed by a decrease in scores.  
 
 Table PG3. 
 ICF content code. 
IC
F
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11 1.5 1 1 2 1.5 1.5 1 1 0.5 
 
Linking ICF to outcome. The coding summary demonstrates that PG’s 
diagram scored 11/27 in total, making it the highest scoring formulation across all 
participants and scoring within all domains, capturing an element of each item. 
Despite this, it still scores low for overall quality. The highest rating was given to 
Item 4 indicating that the diagram successfully met criteria for inclusion of key 
contextual moderators that provided a useful context of the circumstances in which 
the problem could be expected to occur and the form it takes. The diagram also 
partially met criteria for Items 1, 5 and 6, suggesting that some descriptions of 
observations were present as well as functional equivalence between elements and 
that mediators between factors were partially present.  
Items 2 and 3 scored moderately illustrating that although explanations and 
observations were mostly present, there was some ambiguity in terms of how these 
differed and were related to each other. Scores on Items 7 and 8 suggest that the 
diagram partially met criteria for including relevant information about the 
presentation of the problem but that this was not sufficiently detailed to adequately 
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direct intervention and was also limited with regards to anticipating how the problem 
could change under different circumstances. Overall, the diagram appears to not 
capture complexity as successfully as it could have.  
In terms of overall outcome, at Session 6, PG showed reductions in scores on 
PTSD measures of IES-R and PCL-5 and was just under caseness on these measures. 
However, scores were still relatively high for PTSD, although this is expected since 
PG was only half way through treatment. Reductions were observed across IAPT 
measures also. Thus, observed gains from baseline to Session 6 appear to be moderate 
with further improvements hoped for as treatment progressed. 
 
Participant H. Table PH1 details trauma information, specific images, key 
meaning of the images, formulation shared and treatment received. PH spoke English 
as her first language. She had experienced two traumatic incidents over her lifetime of 
a similar nature with similar themes and beliefs attached to them. PH had other 
systemic difficulties at the time of treatment.  
Table PH1. 
Trauma type, specific images, encapsulated beliefs, formulation shared, treatment 
type for PH. 
Trauma type Specific 
images 
Encapsulated 
beliefs 
Formulation 
shared 
Treatment 
type 
Sexual and 
physical assault. 
Images 
relating to 
sexual and 
physical 
assault.  
People cannot be 
trusted. 
The world is unfair. 
I will not survive 
this.  
 
Ehlers & 
Clark. 
Trauma 
Focused 
CBT. 
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Due to data collection time restrictions, PH had three baseline data points 
followed by one data point in Phase B. PH continued to receive therapy following 
involvement in the study however since dropped out of therapy. Due to the limited 
data in Phase B, results are interpreted with caution. Image intrusiveness and 
encapsulated belief VASs are graphically displayed in Figures PH1-5 and PH6. 
Baseline trend was significant for interference and uncontrollability, but was 
increasing or met stability criteria for remaining items. Tau-U analyses were deemed 
inappropriate due to the limited data available. Summary of formulation content is 
shown in Table PH2. 
 
  139 
  
Figure PH1. Frequency VAS: raw data, central tendency and trend.                        Figure PH2. Interference VAS: raw data, central tendency and trend.  
 
Figure PH3. Uncontrollability VAS: raw data, central tendency and trend.  Figure PH4. Distress VAS: raw data, central tendency and trend. 
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 Figure PH5. Nowness VAS: raw data, central tendency and trend.                          Figure PH6. Key Meaning VAS: raw data, central tendency and trend 
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Sharing the formulation. Visual analysis reveals that following sharing of the 
formulation, there was no change in scores. For frequency, interference, 
uncontrollability and nowness, there was a pattern whereby scores decreased at 
Session 2, with this reduction maintained across the following two sessions. Distress 
increased at Session 2 and remained at this score in the following sessions.  There was 
no difference for key meaning of images over the course of the sessions. Discussion 
with the therapist revealed that this individual since dropped out of treatment, 
suggesting that they found the treatment difficult or that there were other difficulties 
that made committing to therapy hard. With this information and due to the lack of 
treatment phase data, caution is required when interpreting the data. 
Table PH2. 
ICF content code. 
 
Linking ICF to outcome. Overall, PH’s diagram scored 8.5/27. All item 
criteria were met to an extent, but scores were generally low. Item 5 was rated 
highest, suggesting that the formulation diagram contained elements with functional 
equivalence that moderately explained how elements contributed to the pattern of 
circumstances observed.  
Items 1, 3, 4 and 6 were also partially present, suggesting that some 
explanations and observations were included, although explanations were not 
completely related to a particular observation. Furthermore, observations were not 
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described with sufficient precision. Some moderators and mediators were included in 
the diagram to demonstrate elements that contribute to the difficulty, however they 
provided somewhat limited information about how the problem operates under certain 
circumstances.  
Scores for Items 7 and 8 indicate that the formulation partially accounted for 
information gained about the problem, but that it does not allow a complete 
understanding for how the problem arose or is maintained. Therefore it is of less use 
for anticipating how the problem could change under different circumstances, for 
guiding intervention or choosing what to prioritise than perhaps if it was increased in 
quality. Indeed, overall quality for this diagram was low.  
Due to limited data in Phase 2, little information is obtained regarding 
outcome. However, scores on the SS measure reveal no change in symptoms between 
Phase A and Phase B and IAPT measures on depression, anxiety and W&SAS 
demonstrate that PH’s symptoms worsened over the captured treatment.  
 
Summary across participants. Patterns across participants are discussed 
tentatively in light of baseline instability, high levels of variability and small sample 
size. Findings reveal differential responses of eight participants undergoing similar 
treatment.  Most participants showed improvement over the course of treatment with 
PH as the only non-responder according to measures. All other participants met 
reliable and clinically significant change on a standardised measure of PTSD, despite 
some participants only being half way through treatment. Again it is worth noting that 
for PH, there were systemic issues and other difficulties that likely contributed to 
symptoms and could have resulted in her dropping out of treatment.  
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Overall, formulation diagrams were rated as low for quality and the change in 
scores across participants was quite similar. However, there seems to be some 
evidence that participants whose diagrams yielded higher ratings tended to experience 
greatest decreases across most image intrusiveness items and encapsulated belief 
scores. Those with increased quality of formulations mostly displayed a downward 
trend across image intrusiveness scores and key meaning. However, one participant 
(PB), whose formulation diagram was rated the lowest met reliable change and 
showed significant reductions on scores across treatment.  
Whilst the scores were quite low, image intrusiveness and key meaning of 
images was reduced most in those with a higher score on Items 7 and 8. This suggests 
that those who displayed downward trends in scores had formulations that mostly 
provided slightly more coherent and comprehensive accounts of the available 
information, integrating some of the information necessary to draw together the 
factors influencing the problem. This then potentially displayed some of the patterns 
of interaction between factors, which may have assisted with some understanding of 
how to intervene. Those who responded lower tended to have a lower score on these 
items, suggesting a less coherent account of information displayed in the diagram that 
did not assist with as clear and precise targets for treatment. 
Those who displayed increased variability in scores over therapy and 
responded less to treatment appeared to have increased scores for Items 4 and 5. This 
suggests that those whose scores reduced less had increased moderators included in 
diagrams that demonstrated exacerbation or improvement of symptoms as well as 
demonstration of functional equivalence between elements (either triggers or 
responses) that described the overall pattern of circumstances that made aspects of the 
problem more likely to occur.  
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Session 4 appeared to be a marker of change for most participants, either 
displaying decreases (PA, PB, PC, PF, PG) or increases (PE, PD, PG) in scores in 
some image intrusiveness measures. In most cases, frequency, interference, 
uncontrollability, distress and key meaning reduced at Session 4, although for some 
participants, frequency (PD, PG) and nowness (PD) increased. Nowness was also 
slower to change in some participants (PA, PB), compared to other image 
intrusiveness items. Most changes that occurred during treatment tended to appear 
stable, however with high variability across participants (PC, PD, PE, PF), it is 
difficult to assert that these changes would be sustained.  
Those with increased variability tended to score more highly for Item 1 but 
less highly for Item 9. This suggests that although the nature and source of 
observations could have been made fairly clear and explicit in some cases, overall, the 
formulations did not address issues of complexity, and there were some questionable 
decisions about what was included, the level of detail or organisation of elements.  
With regards to image intrusiveness, decreases ranged from small-large and 
stable-variable. Mostly, participants displayed a downward trend in image 
intrusiveness even when they had not completed treatment.  Significant differences 
between phases tended to mostly be observed in treatment completers, although PG 
showed a significant difference between phases in two IVASs after only six sessions. 
In general, key meaning was more variable than image intrusiveness. Some 
participants showed a stable and decreased decline (PA, PB, PE, PG), whereas others 
showed variable data that changed considerably, in some participants, across weeks 
(PC, PG, PF).  
A pattern did not appear to exist between the types of formulation diagram 
shared with participants, with gains found for all participants with varying diagrams 
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shared. Sharing of the Individual Case Formulation and Ehlers and Clark (2000) 
model was associated with similar results in terms of responsiveness to treatment. 
Interestingly, the less complex diagram, the vicious flower, was shared with the 
lowest responder to treatment between Phase A and B (PD).  
Idiographic and group analysis revealed that participants experienced 
differential changes in symptoms in differing phases of treatment. Overall, the use of 
an ICF was applied with low quality across the sample. Promisingly, all participants 
except one demonstrated a reduction in PTSD symptoms during study involvement. 
However, it is important to note that scores might reflect changes from therapy in 
general and the natural course of treatment for PTSD, as opposed to being linked to 
formulation processes. 
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Discussion 
This study employed a SCED design with a newly proposed individual approach to 
formulation with use of a rating scale to investigate factors potentially contributing to 
change in PTSD symptoms. The study also sought to evaluate whether sharing a 
formulation diagram could relate to treatment outcome especially in relation to 
reducing frequency, distress and the meaning of intrusive images. This study hoped 
that therapists would use the ICF to inform their treatment and that they might use the 
ICF in other ways that Hallam (2013) suggests in order to supplement the means they 
chose for communicating a formulation diagram. In this way, the hope was to predict 
outcome using the rating scale and demonstrate a relationship that would support the 
interpretation that the ICF approach impacted treatment. Bieling and Kuyken (2003) 
set out a research agenda for CF: (i) more in depth analysis with regards to how 
practicing clinicians formulate in reality, (ii) investigation of the link of formulation 
and treatment outcome (iii) investigation of reliability and validity of CFs and (iv) 
begin the process of moving towards an evidence base for individual CFs. Therefore, 
the current research provided a starting point in investigating these factors using an 
exploratory design with a small sample of people with PTSD.  
       Inherent difficulties that arise during formulation research due to the nature of 
formulations including variation across therapists with regard to formulation style and 
form, the naturalistic approach with which CF is carried out in therapy and the often 
idiographic nature of CFs, mean that investigation and measurement of this core 
process of CBT is methodologically challenging. As in this study, introducing a new 
and untested CF to clinicians can be difficult during formulation research and might 
suggest that the efficacy of ICF might not have been measured or used in the way it 
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was originally hoped and proposed by Hallam. In this study, the extent to which the 
newly proposed system of an ICF was drawn upon in order to guide treatment is 
unknown, although a rating scale was used to attempt to demonstrate a relationship 
between ICF and outcome. However, as little differences between ICFs were 
observed, it is difficult to attribute changes in symptomatology to ICF specifically as 
opposed to formulation in general (or in fact to normal PTSD treatment). The fact that 
treatment commenced in the baseline phase is also problematic for making strong 
inferences about the specific implications of the ICF, as again, treatment gains may 
have occurred even before ICF construction. These are the main limitations and 
difficulties encountered in this study and mean that making strong, confident 
inferences regarding the usefulness of ICF to PTSD outcome is challenging.  
      Phase 1 of the study aimed to evaluate if training on a new approach to 
formulation, Hallam’s (2013) ICF, can contribute to higher quality formulations, to 
provide insight into how expertise and skill are developed in formulation. This phase 
also used a new rating scale to measure components within the formulations. Phase 2 
prospectively investigated changes in symptoms of PTSD after a formulation was 
shared with participants. Close attention was paid to quality and ability to capture 
complexity within formulations and also whether components within diagrams 
appeared to contribute to treatment outcome. In general, diagrams were found to be 
lower in quality than expected including scoring very low for managing overall 
complexity. Furthermore, a central confound to the study is that the observations 
could be a result of on-going PTSD treatment. Given these factors, findings are 
discussed with caution. Overall effectiveness of the treatment will be discussed 
followed by Phase 1 and 2 findings in relation to the hypotheses and existing theory 
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and literature. Following this, strengths and limitations of the current study will be 
discussed as well as future research and clinical implications.  
Effectiveness of the Treatment: Interpretation of results  
Case series analysis provided detailed data for eight participants from 
assessment, baseline and intervention using measures of PTSD symptoms. All 
participants presented with PTSD at the start of the study, all above proposed clinical 
ranges on standardised measures of PTSD. By the end of data collection, only one 
was still within clinical range, despite the fact that most participants were still 
receiving therapy. The participant still within clinical range since dropped out of 
treatment. Of those below clinical range, all met criteria for reliable and clinically 
significant change on the IES-R.  
This suggests that treatment was effective in reducing PTSD symptoms in 
seven of eight participants. For many cases, the latest data point available was used 
for pre-/post- analyses suggesting that if analysis had occurred with data collected 
further into treatment, further symptom reduction would have been observed. Despite 
promising results, graphical analysis revealed heterogeneity between participants in 
the patterns of changes observed, as well as between measures. Therefore, results are 
discussed tentatively.  
Training on ICF. The first hypothesis was that therapist formulation skill 
would increase following workshop training on ICFs, potentially demonstrating 
increased quality of formulations, as shown by comparing pre-/post- workshop 
formulation diagrams. Comparison of diagrams was conducted via visual inspection 
only and therefore preliminary findings are discussed with caution. Visual inspection 
suggested that there was a difference between pre and post diagrams, with post-
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diagrams meeting a higher number of ICF criteria than pre-workshop diagrams. All 
therapists’ post-formulation diagrams contained more elements than pre-diagrams and 
thus were rated as being higher in quality than pre-diagrams. This is consistent with 
the expectation that workshop training assisted with enhancing knowledge and skills 
of formulation in therapists.  
A recent study conducted by Pettman (2017) also found that following ICF 
workshop training of 47 trainee psychological well-being practitioners, ICF diagrams 
were rated as significantly higher in quality following training, as measured through 
differences in pre-/post- diagrams using the same rating scale used within this study. 
Since the same pattern was found in the small current sample, this provides a basis for 
greater confidence in the interpretation of the present results as showing a gain in 
skills following training. 
In the current study, additional elements were enhanced most in post-
formulation diagrams including, (i) additional key contextual elements (moderators), 
(ii) increased representation of the nature and sources of observations, (iii) increased 
representation of functional equivalence between elements and, (iv) increased 
comprehensive accounts of the available information that more comprehensively draw 
factors together that influence a problem and display patterns of interaction.  This 
suggests that the workshop could have assisted with increasing formulation skills 
within these areas and therapists could potentially enhance skills in these areas with 
formulation training. Therapists also demonstrated individual differences in post-
diagrams also, suggesting training could improve therapist formulation skills in 
varying ways. 
 These observations are consistent with the findings of Kendjelic and Eells 
(2007) who found that a short amount of training can increase formulation skill and 
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assist clinicians in producing higher quality and more comprehensive formulations. In 
accordance with their recommendations, it might not be that clinicians are now at an 
“expert” status, but certainly results are promising and suggest that even a short 
workshop could be helpful in improving formulation skill. Findings suggest that 
formulation is indeed a skill that clinicians need extra training in to fully understand, 
use and develop (Dudley et al., 2010). This research has highlighted that formulation 
skills can be taught and potentially enhanced through formulation training.   
 
Quality and complexity of ICFs.  Results offer tentative and initial support to 
the idea that quality of formulations could be related, in part, to outcome and rate of 
improvement for people with PTSD. Overall, diagrams displayed a low level of 
quality across participants. However, findings appear to suggest that participants 
whose diagrams reflected increased synthesis of elements, indicated by a higher 
overall score showed signs of improvement. At a group level, higher responsiveness 
to treatment appeared to show some links to having some increased quality of 
formulation diagrams.  At an individual level, some higher formulation scores 
observed were also linked to larger and more stable reductions in image intrusiveness 
measures and key meaning of images. This finding suggests that when clinicians 
created higher quality formulations that reflected and included comprehensive and 
coherent linking of elements, this was linked to improvement. This idea is supported 
by the finding that lower responders in the study were clients of therapists who 
produced diagrams that scored some of the lowest overall ratings. Perhaps higher 
quality formulations display organisation and structure of materials that better 
provides guidance for where and what to prioritise during intervention. This supports 
some psychodynamic literature from Silberschatz et al. (1986) and Crits-Christoph et 
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al. (1988) who found that increased accuracy and quality of interpretations were 
associated with enhanced therapy gains.  
It cannot be ignored that formulations were mostly rated as low in quality 
across the sample, a finding replicated within Kuyken et al. (2005) who found that 
overall quality of formulations produced by mental health practitioners were low, with 
over a third of therapists rated as producing “very poor” CFs. Furthermore, most 
participants in the current study demonstrated a moderate amount of change, with all 
participants apart from one demonstrating reliable and clinically significant change on 
a standardised measure of PTSD. The study conducted by Gladwin and Evangeli 
(2013) also found that quality of CF was not associated with change. Therefore, these 
findings do not support the claim made by Tarrier (2006) that high quality CF is 
essential for effective treatment as most participants in the current study demonstrated 
symptomatic reduction with low quality formulation diagrams. Indeed, a central 
confound to the study is that the observations of reductions in symptoms could be a 
result of normal PTSD treatment and reflect typical symptom trajectory of the 
disorder whilst undergoing treatment in primary care.  
Furthermore, one could propose that increased scores on items actually 
suggest that a case is increasingly more difficult to treat rather than that the diagram is 
of higher quality. Increased scores on items could suggest that an element was 
increasingly captured or that there are increased factors that trigger a similar response. 
Therefore, a higher score overall could potentially indicate that treatment might be 
less likely to be successful if there are increased elements to target. This idea is 
reflected in the findings from one participant who scored highest on the ICF-RS but 
did not meet clinical or reliable change on the SS measure.  
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Therapists had limited success in representing complexity in their diagrams and no 
clear patterns of differences were observed between diagrams. Therefore, at a group 
level, it was not possible to satisfactorily address the idea that well formulated 
complexity within CFs might be linked to treatment outcome within this study. One 
participant who met reliable and clinically significant change scored highest for 
representing complexity in the diagram produced. However this finding alone is 
clearly not adequate to make inferences about the link of CF ability to capture 
complexity to outcome and more research is needed to investigate this.   
           In summary, the findings offer tentative and preliminary support to the idea 
that quality of formulations might potentially be linked to outcome. It is worth noting 
that participants did demonstrate enhanced recovery compared to typical recovery 
rates observed across IAPT services for PTSD treatment. If there is a link between 
case formulation and outcome, the direction of the outcome might be variable. For 
some therapists, development of higher quality and detailed formulations might 
enhance understanding of the presentation, providing helpful targets for treatment. For 
other therapists, a higher “quality” formulation that actually demonstrates increased 
processes, links and maintaining factors might suggest that treatment will be more 
difficult.  With very little complexity successfully captured within formulation 
diagrams, it was difficult to adequately address the hypothesis regarding complexity 
and make inferences about the link of complexity to treatment outcome. There are 
potential reasons for why case complexity may have been more difficult to capture 
within the diagrams. Firstly, the ICF was a new formulation system for therapists and 
therefore, linking all the information together, using a new system to represent the full 
extent of a client’s problem may have been challenging for therapists. Increased 
practice using an ICF might help to enhance this skill. It might also be that therapists 
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did not gather as much information about the client as is necessary to understand and 
represent clear links and that the organisation of the information might not have been 
represented as successfully as hoped. Therapists might also have preferred to rely on 
other, more frequently used formulation models. This also means that the ICF may 
have only been completed as part of study involvement, rather than something to draw 
upon and fully utilise. A formulation capturing increased case complexity might have 
been less appealing to some clinicians who prefer to use simpler looking diagrams, 
rather than capture the full complexity of a case. It is worth noting that this was a 
tentative hypothesis and more research appears to be required to determine if there is 
any link between ability to formulate case complexity and outcome. It might be that 
complexity in formulations is in no way linked to outcome. This information is likely 
to be useful for any training on formulation skill. 
 
Predictors of outcome. The third hypothesis was that components found 
within ICFs could potentially help to predict outcome at a group and individual level. 
As described, at a group and individual level, patterns across results tentatively 
indicated that there appeared to be some suggestion that overall higher scores on the 
ICF-RS, suggesting higher quality CFs with regards to ICF principles, was associated 
with participants showing most signs of improvement. However, there was variability 
within the findings, with some participants demonstrating similar ratings in ICFs to 
high responders but showing less probable change indicators.  
Results suggest that there might be some preliminary evidence to indicate that 
there could be a link between other specific items within the ICF and outcome.  
Despite scores being quite low, participants generally showing increased symptom 
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improvements had diagrams that increasingly met criteria for including increased 
coherence and comprehensiveness of available information that in turn, suggested 
links to intervention. Increased structuring of information could have contributed to 
increased understanding of where and how to intervene and what to prioritise in 
intervention. Hallam (2013) suggests that a feature of the ICF is that it assists with 
choosing an intervention guided by the mechanisms assumed to be maintaining the 
problem. Findings from Silberschatz et al. (1986) and Crits-Christoph et al. (1988) 
support this; they found that when more accurate interpretations were made and used 
to direct and guide treatment, enhanced therapy gains were produced. Therefore, this 
suggests that increased information in formulations that then guides intervention can 
assist with outcomes. Accordingly, CF has been described as a “therapist’s compass”, 
(Persons, 1989, p.37), used to steer treatment in the correct direction. 
Item scores for lower responders were relatively higher on items measuring 
the extent to which the diagram captured functional equivalence between elements 
and contained moderators that could impact a problem, compared to other items in the 
diagram. Firstly, it is unsurprising that these items might show similar scores and be 
linked, for example if there are triggering cues serving as moderators that are 
functionally equivalent and set a difficulty in motion. Hallam (2013) describes the 
importance of identifying contextual moderators to demonstrate when the problem is 
more or less likely to occur and what is maintaining it, especially when there is a 
common theme underlying difficulties during different time periods from a person’s 
history. Hayes and O’Brien (2000) discuss the role of causal mechanisms at length, 
noting that a number of functional relationships could be equivalent that maintain a 
difficulty. For lower responders, increased observations of these items suggest that 
there might be increased triggers to a difficulty that function equivalently to produce a 
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response or that particular observations lead to similar consequences occurring (for 
example, avoidance). The degree of functional equivalence might be an indirect 
marker of a more chronic difficulty which would suggest that the individual could 
have developed increased ways of coping maladaptively for the same purpose or have 
an increased number of cues triggering a difficulty in a similar way. This might 
suggest why these individuals scored higher on these items but demonstrated less 
change in symptoms. Indeed, Hallam (2013) suggests that functional relationships can 
be interpreted as representing key arrangements that provide conditions for learning 
and intervention and could be a central hypothesis within a formulation for 
understanding a presentation. 
 
Sharing formulations. Results offer tentative, initial support to the hypothesis 
that sharing formulations may, in part, contribute in some way to change in 
symptoms. Change was observed to occur at the session subsequent to sharing the 
formulation, supporting the inference that this process was associated, to an extent, 
with the resulting change. Therefore unlike previous studies that found no link 
between outcome and sharing formulations (Chadwick et al., 2003; Evans & Parry, 
1996), this study suggested that change in symptoms might be associated with the 
shared formulation. 
CAT (Ryle, Leighton & Pollock, 1997) involves diagrammatic formulation 
development and modification between clients and therapists (Denman, 2001). 
Formulation sharing in CAT is carried out on the premise that it can serve a number 
of functions. For individuals experiencing the world in a threatening and fragmentary 
way as in PTSD, diagrammatically formulating these processes could help an 
individual make sense of their internal world in the context of life experiences and 
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highlight patterns of entrenched maladaptive behaviours to both the client and 
therapists (Mitzman, 2010). However, despite serving as an active part of the 
intervention (Gladwin & Evangeli, 2012), research has found no support that joint 
formulation letter writing improves treatment outcome (Evans & Perry, 1996). 
Bieling and Kuyken (2003) argued that there was no evidence to link CF to 
treatment outcome and that the only benefit that they had identified in sharing CFs is 
in Chadwick et al. (2003) study, where therapists reported increased therapeutic 
alliance. Bieling and Kuyken (2003) suggest that it may have been wrongly assumed 
that CF can directly impact outcome and instead, it might be that CF can indirectly 
assist with treatment, for example through aiding selection of an appropriate 
intervention (Jacobson et al., 1989). Findings from one of the only studies linking CF 
to outcome (Crits-Christoph et al., 1988) also support this finding. 
Within the current study, graphical analysis revealed heterogeneity between 
participants in the patterns of change observed, suggesting that clients might be 
influenced differently by a shared formulation perhaps due to individual differences. 
This is supported by the Gladwin and Evangeli (2013) study, which found that seven 
participants had improved outcomes following sharing CF but six did not. However, 
the current study revealed that at Session 4, a change in scores was often observed 
within most participants. Typically, there was a downward trend in scores following 
sharing of the formulation with five participants demonstrating reductions in scores at 
Session 4 for some image intrusiveness measures. Image intrusiveness increased at 
Session 4 for three participants, suggesting that sharing the formulation was 
associated with change in symptoms in some way. It is important to consider what it 
is about sharing formulations that might have directly or indirectly contributed to 
therapist or participant behaviour that was associated with a change in symptoms.  
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Therapists.  Gladwin and Evangeli (2012) suggested that it has been assumed 
that sharing a CF is therapeutic in itself and that the mechanism between CF and 
outcome might be direct. However, this relationship might instead be mediated by 
separate variables that are reflective of the therapeutic relationship during sharing a 
CF including enhancing therapeutic alliance and therapist motivation, increasing 
engagement or self-esteem of the client (Gladwin & Evangeli, 2012). Further research 
has also suggested that developing shared CFs could have indirect effects on outcome 
through increasing clinician understanding (Kinderman & Lobban, 2000) and 
confidence (Chadwick et al., 2003), selecting of intervention by therapists (Johnstone 
& Dallos, 2013), predicting difficulties in treatment (Butler, 1998), increasing 
empathy (Horowitz et al., 1989) assisting with supervision guidance (Bieling & 
Kuyken, 2003) or as Kuyken (2006) suggests, it might be a combination of these 
factors that influence therapist behaviour. Therefore, reduction in symptoms at 
Session 4 observed in the current study could be due to effects on therapists that 
sharing the formulation had, that in some way enhanced treatment. This idea however 
does not account for some increases displayed in symptoms at Session 4. 
 
Service-Users.  It is possible that CF could provide insight to service users that 
contributes to behavioural change. One study examined the experiences of completing 
CF in young people with PTSD and first episode psychosis (Halpin, Kugathasan, 
Hulbert, Alvarez-Jimenez, & Bendall, 2016). Clients reported increased insight into 
predisposing, precipitating and perpetuating factors, benefits also highlighted by other 
CF manuals (Smith et al., 2007). Halpin et al. (2016) found that increased insight 
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facilitated awareness to past experiences and their relationship to current symptoms, 
encouraging relevant behavioural changes to reduce the maintenance of symptoms. 
This suggests that by using CF and highlighting to clients unhelpful coping strategies 
such as avoidance that are linked to past experiences, insight is gained that leads to 
actions to change these behaviours. This suggests indirect assistance of CF to support 
behaviour change.  
Similarly, Stiles (1999) suggests an assimilation process that occurs in therapy 
whereby a problem (for example a trauma memory) is assimilated into a schema (a 
way of living or narrative of a problem). According to Stiles and Morrison (1991), 
stages occur during assimilation including “understanding/insight” whereby the 
problem is formulated and understood. Stiles (1999) warns that there might be 
unpleasant recognition during this process, but that it offers strong insight. The next 
stage involves “application/working through” whereby the gained understanding from 
formulation is used to address the difficulty, leading to optimism in the client. This 
suggests that sharing a formulation may start this assimilation process, whereby 
clients gain insight and understanding that in turn encourages a person to begin to 
address problems and update their behaviour. 
Smith et al. (2007) also detail case studies whereby developmental CFs 
enabled clients with PTSD and psychosis to reappraise traumatic events without use 
of reliving. This suggests further indirect assistance of a shared CF, through 
facilitating a different way of perceiving an event. This research also suggests the 
usefulness of CF for those where there is not an evidence-based protocol, for example 
in co-morbid cases. In the current study, it might be that the formulation sharing 
provided new insights that helped to begin to challenge appraisals. Increased 
compassion could be gained whereby clients understand that their response is normal 
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and expected given the circumstances. Indeed, in Compassion-Focused Therapy, the 
role of the formulation is to validate fears, make sense of safety strategies and 
highlight the role of compassion for assisting with PTSD symptoms and remove 
blame (Gilbert, 2010). Therefore, Halpin et al. (2016) and Smith et al. (2007) studies 
suggest that for clients, developing insight could be a helpful, indirect route to 
assisting with alleviating symptoms through affecting behaviour change or updating 
appraisals. This could potentially assist in explaining the reduction of symptoms at 
Session 4. 
Another factor that could explain the reduction in image intrusiveness is that, 
whilst CF is not specifically intended to figure into exposure treatment, it could serve 
to function as part of exposure to trauma memory processing. In support of this, Van 
Dan Berg et al. (2015) found that extensive trauma interview and assessment can lead 
to covert exposure in people with PTSD. Halpin et al. (2016) also found that one 
client reprocessed memories whilst undertaking the CF. PTSD theories (Brewin et al., 
1996, 2010; Ehlers & Clark, 2000, Foa et al., 1989) also suggest this idea to an extent, 
describing that exposure to original trauma imagery might facilitate processing of 
material and reduce intrusive symptoms. This could tentatively suggest that the 
formulation process could potentially serve a function to expose people to trauma 
memories. Indeed, when trauma experiences are put into words, as they typically are 
during CF sharing, this acts as a part of reliving (Foa & Rothbaum, 1998). Therefore, 
CF sharing could possibly start the elaboration and contextualisation of memories into 
autobiographical memory store, helping the memory to become a more normal 
recollection, increasing coherence of the narrative and reducing reliving symptoms 
(Ehlers & Clark, 2000). Indeed, one would expect lower scores on image 
intrusiveness and belief in appraisals once trauma memories begin to be processed as 
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endorsed by the theories of PTSD treatment (Brewin et al., 1996; 2010; Ehlers & 
Clark, 2000; Foa & Rothbaum, 1998). This idea was not specifically tested and is 
therefore offered as a preliminary explanation to account for some of the findings. 
However, this idea is consistent with the observation of initial symptom increases in 
some participants, as research indicates that when trauma memories are triggered and 
begin to be processed, exacerbation of symptoms can occur in the short term (Van 
Minnen, Harned, Zoellner, & Mills, 2012). Halpin et al. (2016) suggest that the 
idiosyncratic nature of CFs increases distress because individualised information 
collected resonates with the individual. This could also suggest why participants in 
other studies have found sharing of the formulation difficult (Chadwick et al., 2003; 
Deman, 2001; Halpin et al., 2016) if past memories are being triggered and relived.  
This study provides a potential basis for the interpretation of the current 
findings and might offer preliminary and tentative explanations as to reasons for 
improvements being observed following sharing of the formulation: (i) via an indirect 
route whereby therapist factors are influenced, which in turn leads to better 
understanding and thus more suitable therapy, (ii) via an indirect route that highlights 
to the client dysfunctional behaviours, negative appraisals or patterns of avoidance or 
(iii) directly contributing to assisting with processing memories, beginning to bring 
parts of the memory “online”.  
 
Study Strengths  
Firstly, this study is believed to be the first to investigate the use of an 
individual case formulation for assisting with predicting treatment outcome of PTSD. 
This included investigating the association between sharing a formulation and 
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symptoms of PTSD as well as examining the components of an ICF that could predict 
treatment outcome. Some research suggested that CF might have found a place in 
practice ahead of any evidence for its proposed advantages (Tarrier, 2006). Thus, this 
research was important for a number of reasons: (i) to generally determine the clinical 
usefulness of CF to outcome, (ii) to determine the impact that CF can have on 
outcome for PTSD (iii) to offer insight and recommendations to assist with poor 
recovery rates for PTSD. 
 
Design.  The use of SCED was a strength of this study. A SCED design meant 
that detailed case-by-case analysis examining change processes within individuals 
(Elliott, 2002) was possible. Each participant demonstrated different patterns of 
change and these differences would not have been identifiable without use of 
idiographic analysis. Findings suggest that participant characteristics are important in 
predicting change (Kazdin, 1981).  Using an idiographic approach to analysis through 
SCED enabled enhanced clinical depth and understanding that would not be gained if 
experimental approaches had been employed (Grey & Holmes, 2008). With a large 
sample, this level of detailed analysis would also not be feasible. 
The use of repeated continuous measurement is a further strength of this study. 
Firstly, research has indicated that regular symptom monitoring and eliciting feedback 
from SUs is likely to reduce dropout rates in PTSD treatment  (Zandberg et al., 2016). 
Standardised measures also enabled pre-/post- clinical and reliable changes over time 
to be detected. However the strength of the measures lie in the VASs that enabled a 
high level of specificity relating to specific images. The EBVAS also provided a 
specific idiographic measure in relation to the key meaning of the images. Other 
formulation studies have not used idiographic outcome measures (Chadwick et al., 
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2003; Emmelkamp et al., 1994; Schulte et al., 1992) meaning that important, small 
changes might have been missed. Idiographic measures are recommended within 
SCED (Morley, 2015b) as they capture small changes over short time periods that 
standardised measures may not. Repeated measurement occurred across Phase A and 
B, allowing for clear, in-depth examination into the change to PTSD symptoms 
following sharing a formulation. Often, more than three data points were collected 
during Phase B, over the course of full treatment in two cases, allowing change in 
participant variables to be measured for longer, providing more detailed information 
than would be the case if fewer data points had been collected.  
Furthermore, isolating the treatment component was also relatively 
straightforward within this study without significantly interrupting routine treatment. 
This increased the ability to make inferences about how sharing the formulation 
impacted on treatment outcome. Use of a baseline phase and investigating and 
controlling for baseline instability using statistical analysis also assisted in 
interpreting the data.  
 
Coding formulations. Coding of formulations using the ICF-RS was another 
strength of this study. It is widely agreed within CF literature that there is a need to 
develop ways of measuring CFs (Bucci et al., 2016; Eels, 2010). This study utilised a 
new measurement of CFs in an attempt to begin to address the lack of reliability that 
is a central weakness of the existing literature on formulation (Kuyken et al., 2005). 
Furthermore, using the ICF-RS allowed for in-depth analysis of the components that 
made up formulations. Coding on the ICF-RS highlighted components within a 
formulation that might not have been so easily observable or understood in the first 
instance, assisting with detailed analysis into the processes within ICFs, allowing a 
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wider range of potentially important factors that may have contributed to treatment 
outcome to be identified. Furthermore, reliability was also established by two 
researchers coding the formulations. 
External validity. Due to the naturalistic design, this study did not 
substantially impact routine treatment for PTSD. Kazdin (2007) highlights the 
importance of understanding the mechanisms that occur within therapy that might 
affect outcome. Therefore, this study focused on the process of formulation and no 
specific treatment was imposed on participants with therapists using their own clinical 
judgment to decide the most appropriate treatment to use, unrelated to study 
involvement. Although therapists were required to share formulations within Session 
3, the style and form with which formulations were shared was based on therapist 
judgment. Therefore, as far as possible, this study reflects routine treatment for PTSD.  
Differences in formulations used enabled comparison between these methods and 
allows consideration of refinement to future studies. Anonymity of therapists also 
means that hopefully formulation procedures and routine therapy was not impacted by 
the possibility of being recognised and was reflective of routine practice. 
An additional strength of the study was the heterogeneous sample used, a 
recommendation for SCEDs (Kazdin, 1981). Participants were from a range of 
different cultures, of different ages, including both male and female participants with 
varying trauma histories in terms of trauma type and length of time since the trauma. 
Also, although not a requirement, no participants had received prior treatment before 
involvement in the study. Therefore, this reduces the chance that previous knowledge 
of CBT or other psychological therapy techniques or prior processing may have 
impacted on symptom changes.  
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PTSD clients with co-morbidities are also often excluded from research 
studies (Zandberg et al., 2016), whereas the inclusion criteria of this study enabled 
participants with co-morbidity to be included and thus, the sample gained is likely to 
reflect people who routinely seek help for PTSD. The heterogeneous sample 
combined with the specificity of measures and the routine nature of the PTSD 
treatment enhances external validity of this study. 
 
Study Limitations 
Sample. Despite some strengths, the sample was limited by a number of 
factors. Firstly, the final sample did not reach the intended recruitment target. The aim 
of the study was to recruit ten participants. The final recruitment fell short of this by 
two participants. Therefore, the study may lack sufficient power to make strong 
inferences. Recruitment was made difficult for a number of reasons. Firstly, the site 
that was meant to recruit the majority of participants pulled out of study involvement 
in Summer 2016. This meant that amendments to the study had to be made that 
required further ethical approval as well as identifying new recruitment sites. This had 
a significant impact on the time available to recruit participants. Given that it can be 
challenging to engage clients in treatment for PTSD (Courtois, 2004) and with limited 
recruitment time for the study, a sample of eight is satisfactory. In addition, 
participants with mental health difficulties can be difficult to recruit into studies 
(Hughes-Morley, Young, Waheed, Small, & Bower, 2015). Woodall, Morgan, Sloan, 
and Howard (2010) found that barriers to study recruitment included distrust and 
suspicion of researchers as well as stigma of mental health. PTSD is associated with 
strong emotions including guilt, shame and mistrust (Lee, Scragg, & Turner, 2001). 
These difficult emotions may prevent clients from taking part in a research study if 
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they feel ashamed or are concerned about not being able to trust a research team with 
sensitive and difficult information. This suggests that there is a possibility that 
sampling is selective. Perhaps those who agreed to take part were more trusting of 
therapists, meaning that changes in symptom scores could have been influenced by 
individual or therapist factors. 
Furthermore, this study did not use a control group and therefore there was no 
comparison to clients who did not have a formulation shared with them during their 
treatment. Although formulation sharing is not always a necessary part of CBT, it 
would have been unethical to explicitly withdraw case conceptualisation from a 
person’s therapy or curtail it in some way to permit an empirical comparison. 
However, lack of a control group makes it difficult to infer if scores relate to sharing 
the formulation or whether they reflect the natural course of the disorder or treatment.  
Lastly, one participant required the use of an interpreter. Although this therapy 
was carried out in the individuals own language, hopefully increasing accurate 
descriptions of experiences and enabling the participant to communicate more fluently 
(Costa, 2010), some of the measures may have been invalid for use. Adapting 
measures for use in different languages is a complex task requiring careful 
consideration of factors for validity for the intended population (Cassepp-Borges, 
Balbinotti, & Teodoro, 2010). Another participant in the current study also had an 
alternative first language to English, meaning they may have struggled with accurate 
communication and fully understanding the measures. Therefore, this may have 
impacted the data with regards to how much they could understand and accurately 
complete measures.  
Finally, because there was no standardised inclusion / exclusion criteria for the 
study, it might be that this study is more difficult to replicate especially as individual 
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factors appear to affect the formulation process.  
 
Training. Although changes were observed in post-formulation diagrams in 
this study and Pettman’s (2017) study, it is unclear how useful the training on 
formulation was from therapists’ perspectives. This study did not collect or evaluate 
therapist feedback on the training. This would be important for future implementation 
of ICF training. Furthermore, diagrams were mostly rated as low in quality in Phase 2, 
suggesting that the training might not have improved skills as much as it was first 
hoped. However, it might be that this study had too high expectation of therapists to 
produce higher quality diagrams following workshop training. With all diagrams 
demonstrating some elements of the ICF approach, credit should be given to 
therapists for capturing some of the elements. 
However, despite this, it is difficult to completely attribute changes in post-
formulations to the training. Increased quality in formulations observed in the post-
formulations could have been due to a variety of factors including increased time to 
complete post-formulations, discussion with other therapists about the vignette that 
highlighted items missed out in the pre-formulations or perhaps motivation to score 
more highly on post-formulations, knowing that these would be rated and compared 
to pre-formulations. Furthermore, no information was collected on how much training 
therapists had previously received on formulation prior to the workshop.  
 
Design. SCED strictly adheres to repeated measurements over time and a 
stable baseline. This ensures that change can be attributed to a specific intervention 
(Turpin, 2001). In this study, one participant did not have all the baseline data points 
and only one participant displayed a completely stable baseline. Turpin (2001) 
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suggested that data should be collected until a stable baseline is produced, although 
acknowledges that in therapeutic research, this can be difficult. Indeed, it would have 
been unethical to ask participants to wait for treatment for this extended period. 
However, without a stable baseline, there is increased risk that interpretations are 
wrongly attributed to sharing the formulation, rather than natural variation of PTSD or 
maturation effects.  
Next, it is problematic that treatment commenced during the baseline period. 
This means that obtaining a stable baseline was more difficult because treatment 
effects might have already commenced. This also means that something other than 
sharing the formulation might have impacted changes in symptom scores, as it would 
be expected to observe change as the therapy progresses. Research carried out by 
Ilardi and Craighead (1994) indicated that 60-70% of symptom improvement for 
people with depression occurred in the first four weeks of treatment, suggesting that 
most improvement is seen in the first four sessions. This is problematic for the current 
research because changes observed in Session 4 might wrongly be inferred to being 
linked to sharing the formulation, whereas these changes may have occurred 
nonetheless. However Tang and DeRubeis (1999) criticised Ilardi and Craighead’s 
(1994) study as their account suggests that only four therapy sessions occurred in the 
first four weeks in the study. However, they found that, in fact, two sessions were 
typically carried out per week, suggesting that changes observed were not actually 
observed until session eight. Therefore, this in turn strengthens the inferences 
observed in the current study because changes were observed in some participants by 
Session 4, following sharing of the formulation, further strengthening the conclusion 
that sharing a formulation can impact treatment outcome.   
Another limitation of the design is the lack of follow-up data for participants. 
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Due to time constraints, it was not possible to collect follow-up data, meaning it is 
unknown whether effects were maintained and extended past treatment. This is an 
important consideration for future research investigating formulation and outcome.  
Furthermore, the number of sessions could explain the results. Higher 
responders typically had an increased number of sessions or had completed treatment 
compared to low responders. Therefore, duration of treatment is likely to have been a 
contributing factor to outcome.  
Lastly, as in the study conducted by Chadwick et al. (2003), this study did not 
include a second rating of formulation diagrams in Phase 2. Any additional elements 
incorporated into the formulation following the initial creation of the diagram would 
have been lost if the diagrams were rated too early, missing potentially important 
information. Furthermore, formulation diagrams created by therapists might have 
contained other specific items not measured by the ICF-RS, suggesting that other 
factors contributing to PTSD might not have been captured. If this is the case then the 
ICF-RS might lack content validity.  
Lastly, the extent to which ICFs were used and referred to by therapists to 
assist treatment was not measured and therefore it is unclear how much ICFs might 
have been used to support treatment or completed simply as part of study 
involvement. 
 
Therapist factors. Silberschatz and Curtis (1986) suggest that many other 
factors are likely to contribute to therapy outcome including therapist skill (Schaffer, 
1983), a good therapeutic relationship (Luborsky, 1984) and even fostering hope in 
treatment (Frank, 1982), suggesting the importance of therapist factors in outcome. 
Factors including warmth and empathy have been found to be related to treatment 
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outcome, rather than the therapeutic approach used (Lambert & Barley, 2001). This 
suggests that observed effects could be dependent on therapist variables or factors 
within the therapeutic alliance rather than sharing the formulation or items within the 
ICF.  However, Hallam (2013) would argue that some of these additional factors 
could be aspects that arise during the formulation process or that these factors might 
even rely on the formulation, suggesting that the shared understanding of the 
intervention could provide a basis for the therapeutic alliance.  
In addition, this study may have been exposing for therapists. Despite 
anonymity procedures, therapists may still have felt that their work was being 
assessed as the study linked formulation diagrams to treatment outcome. Fear of 
judgement may have prevented some therapists from taking part. This may explain 
why, despite some SUs expressing interest in taking part, some therapists declined to 
be involved in the study. This is a factor to consider in future research investigating 
treatment outcome. 
 
Other. For some participants, extra formulations were completed as part of 
homework. Completion of an extra formulation as part of homework was not 
measured or controlled for as part of this study. Cully and Teten (2008) found that 
homework can facilitate skill and acquisition in CBT and even reduce symptoms by 
integrating concepts from sessions into daily routines. Therefore, homework can be a 
mechanism for facilitating progress. Completing formulation homework and drawing 
on the concepts of the formulation between sessions may have impacted symptom 
scores. An additional measure of homework would have been useful.  
Lastly, the extent to which ICFs were used and referred to by therapists to 
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assist treatment was not measured and therefore it is unclear how much ICFs might 
have been used to support treatment or completed simply as part of study 
involvement. Therefore, the nature or complexity of ICFs that were produced might 
not fully measure the efficacy of ICFs. 
Future Research 
Given that the findings provide some evidence that components of formulations could 
link to treatment outcome, there is a strong case to continue research in this area and 
to replicate findings. A first step would be to continue to measure and follow-up with 
participants to investigate if gains observed remained.  
It is necessary to further determine if sharing a formulation can impact on 
outcome. To broaden this investigation, the next step would be to vary when 
therapists share formulations with participants and therefore vary the length of the 
baseline phase. This could be done naturally in therapy as in Pain et al. (2008) and 
increase external validity, maintaining clinically valid conditions or manipulated in an 
experimental design. Either way, varying when the formulation was shared would 
increase the ability to make inferences about how this process can impact outcome 
and relate to change in symptoms.  
The mechanisms of formulation also need to be investigated in detail. It would 
be important to further determine why sharing a formulation might predict symptom 
change. This could be collected by qualitative feedback from clinicians or participants 
to gain information on how they were influenced by the CF, if at all.  The present 
study did not collect qualitative feedback from clinicians or participants; however, 
this would have been useful to help to shed light on whether CF can directly or 
indirectly contribute to outcome, by collecting participant verbal responses to sharing 
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the CF.  
This study was one of the first to investigate the predictive validity of CFs. 
Some links were identified that might predict outcome in treatment. Further research 
into this is necessary to investigate if CF can predict expected outcomes and 
difficulties in therapy. If it can, it could be an extremely powerful tool (Bieling & 
Kuyken, 2003). Further research could also help to identify whether formulation 
factors can independently impact on outcome or whether they rely on each other to 
contribute to outcome. Studies also comparing outcomes between clinicians using 
CBT, based on a working CF, compared to those not drawing on a formulation, with 
related investigation of adherence to high-quality CF, would provide further insight 
into the role of CF to outcome. 
Lastly, this study used a new scale to measure formulations. More frequent 
ratings of formulation diagrams as a process over the course of treatment would be 
important for future research, in case added complexities have been included later in 
therapy, which would be lost if rated too early. This would also give an indication into 
how formulations evolve as treatment progresses. Furthermore, increased research is 
required to develop and test the rating scale to work towards creating a standardised 
measure of CFs with strong validity and reliability, which is lacking in the CF 
literature (Bucci et al., 2016). Systematic measurement of CFs using a valid measure 
would improve the quality of formulation research allowing clearer inferences to be 
made about the usefulness of CF. Bieling and Kuken (2003) argue that CFs could be 
valid and reliable and have no impact on outcome, or be unreliable and invalid and 
enhance outcomes through alternative mechanisms. Further research will shed light 
onto this and determine the most useful criteria for “good” formulation practice. By 
doing so, training programs can incorporate teaching on evidence-based CF.   
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Larger scale studies, with increased recruitment time, are required to 
demonstrate effects across more participants and to assist with sample limitations and 
reduce selection bias, allowing more detailed analysis of how CF components 
contribute to treatment outcome. 
 
Clinical implications 
Clinical implications are provided tentatively in light of limitations. However, 
the findings offer some suggestions for clinical practice. Although this study 
specifically investigated PTSD, some findings could extend across other disorders 
treated with CBT. Firstly, teaching on formulation appeared to enable increased 
elements to be captured in formulation diagrams, suggesting that formulation skill 
may have been improved following training. Therefore, this research highlights the 
importance of further training in CF for clinicians, in order to develop formulation 
skills. Indeed, increased literature is highlighting the importance of identifying 
existing gaps in expertise by commissioning services advocating a roll out of CBT 
and suggests that these gaps should be filled with specific skills training (Zivor et al., 
2013).   
Secondly, results from this study and from other studies indicate that sharing 
formulations impacts people differently. Therefore, it appears necessary that 
clinicians use clinical judgement in deciding when and how and which parts of a CF 
to share with clients, based on understanding of the individual in order to reduce 
disengagement from treatment. Linked to this, as Stewart (2014) argues, this finding 
also suggests that CF is not a ‘one size fits all’ approach and emphasises the 
importance of considering individual processes when formulating in order to develop 
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idiosyncratic links. Dallos, Wright, Stedmon, and Johnstone (2006) also suggest that 
CFs are interpersonal processes. This study found features within ICF diagrams that 
would not have been included in the standardised model of PTSD. This study 
therefore promotes use of an idiographic approach to CF, formulating in a bottom-up 
way using theory to enhance individual understanding (Bieling & Kuyken, 2006) and 
assist in identifying any off model elements that might be contributing and 
maintaining factors. Despite this, this research also suggests that clinicians should not 
become so focused on idiosyncrasies that factors important for assisting with effective 
treatment are ignored (Zivor et al., 2013). Overall, even though sharing formulations 
is not a routine part of CBT treatment, this study has provided preliminary evidence 
that it could contribute to change in symptoms.  
Another finding related to use of ICF suggests that if the produced formulation 
can provide a coherent account of the available information, portraying patterns 
defining mechanisms of change, it might be important for assisting with treatment 
outcomes by providing a basis for understanding where and how to intervene. 
Furthermore, identification of increased contextual elements contributing to the 
problem that demonstrate functional equivalence (triggers or responses) could be an 
indication that a person demonstrates increased chronicity or enduring symptoms that 
may require longer or more extensive treatment. Therefore, gathering increased 
information to add to a diagram followed by scrutiny of formulation diagrams might 
provide better guidance to assist with treatment or predict when a person might 
respond less to therapy. Furthermore, when an intervention is unsuccessful, therapists 
are encouraged to re-formulate and reflect on the reasons that a person’s symptoms 
may not be improving (Hallam, 2013). There is currently little guidance on this 
process. An ICF could be helpful during these conditions, when empirically supported 
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treatment protocols are not sufficient in treating a difficulty (Halpin et al., 2016) or 
when no evidence-based treatments are available (Persons, 2012) or difficulties are 
more complex (Van Dan Berg, 2015) than for use of single-disorder models. 
Furthermore, this study found that for one participant, reliving enabled 
activation and elaboration of another memory, which was then added to the 
formulation. This highlights the importance of viewing formulations as an ongoing, 
collaborative and dynamic process (Dallos et al., 2006), rather than a one-off event. 
Indeed, Kindermann and Lobban (2000) argue that formulations should be an 
evolving process that enables development of complex, idiographic understanding. If 
appropriate, the evolving nature of formulations should be reflected in clinical 
practice and thus be regularly reviewed, reshaped and re-shared in supervision and in 
therapy.  
For PTSD specifically, in light of the tentative idea suggesting that processing 
may potentially occur during CF it is important to ensure that clients have adequate 
coping skills and feel in a safe environment to complete the CF to prevent re-
traumatisation from elaborating on the memory. Teaching grounding techniques is 
usually an important first part of PTSD treatment (Coleman, 2015), but it might be 
that these skills need to be taught earlier in therapy if memories are triggered through 
formulation. It also suggests that if CF can act as a facilitator or mechanism of 
change, through beginning to activate past trauma memories, a clear rationale for 
completion should be discussed, to potentially reduce therapy drop out in clients. 
Psycho-education of finding the CF process difficult could be carried out in order to 
normalise and validate this reaction. This also suggests that CFs need to be completed 
tentatively and sensitively.  
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Lastly, this research provides some evidence that PTSD treatment that does 
not exclude people due to co-morbidities can decrease other symptoms, including 
symptoms of depression and anxiety. This supports other trans-diagnostic treatment 
approaches that are emerging that detail similar cognitive and behavioural processes 
across disorders (Barlow, Allen, & Choate, 2004; Mansell, Harvey, Watkins, & 
Shafran, 2008, 2009). Some changes to current protocols might be required in order to 
account for co-morbidity in psychological treatment to improve therapist confidence 
to treat people presenting with co-morbidities. 
 
Conclusions 
This preliminary and exploratory study aimed to assist with answering some 
of the questions that remain regarding usefulness of CF in clinical practice, including 
the efficacy of training to increase formulation skill and specifically the link of CF to 
treatment outcome. 
The first phase of this study found some evidence that training can improve 
skills in formulating, increasing the overall number of elements captured following 
training and increasing the overall quality of formulation diagrams. This suggests that 
formulation is a skill that can be taught and further developed and specific training on 
formulation can increase formulation skills and quality of formulation diagrams. 
The second phase of this study offers initial support that overall quality of 
diagrams might be linked to improving treatment outcome, with increased elements 
synthesised within diagrams demonstrating a potential link to increased symptom 
reduction. No compelling evidence was found suggesting that better diagrams made 
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for more complex cases is linked to overall outcome, although future research is 
required to investigate this further.  
Some evidence was found suggesting specific items within formulation 
diagrams might predict symptom trajectory. Formulations containing increased 
organisation and structure of coherent information that provides a basis for directing 
treatment might be associated with increased change in symptoms if the information 
is used to guide treatment. Formulations that suggest long-term chronicity of 
difficulties through increased moderators and functional equivalence between items 
might suggest lower responsiveness to treatment.  
Sharing formulations with clients appeared to act as a marker of change across 
many participants mostly followed by a reduction in symptoms. This suggests that 
sharing a formulation might be useful for contributing to change in PTSD symptoms. 
Significant differences between phases observed within some participants strengthen 
this inference. Hypothetical reasons for why formulations might influence change 
have been suggested, but further research is required to investigate these in more 
detail. Furthermore, it cannot be ruled out that these findings simply reflect typical 
symptom trajectory during treatment for PTSD. 
Results offer some useful insights into case formulation factors that may 
contribute to clinical change in symptoms of PTSD. Interpretation of the results 
remains tentative due to the small sample size, the observational nature of analysis 
and the variability across some of the data. Future research will be necessary in order 
to support some of the findings within this study and to further investigate the 
mechanisms of case formulation in clinical practice.  
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Appendices 
Appendix 1. Individual case formulation rating scale 
Individual case formulation rating scale 
A. The problem is clearly defined in terms of how observations inter-relate. 
1. The nature and source of observations are made clear and explicit, and 
observations are not confused with explanations.  
0 – The diagram mainly consists of observations that are not described with 
sufficient precision.  Sources of information are not made clear, which may 
create ambiguity about whether information provided is based on supposition 
or speculation rather than reflecting what has been reported or directly 
observed.   
1 – A substantial proportion of observations in the diagram are not described 
with sufficient precision, or sources of information are unclear. There may be 
some instances of observations appearing to be based at least in part on 
inference or supposition.  
2 - Descriptions of observations are sometimes ambiguous or insufficiently 
precise, or sources of information are sometimes not clear, or there is minor or 
infrequent ambiguity regarding whether observations are based on inference or 
supposition. 
3 - Sufficiently detailed and precise descriptions of observations are provided 
and sources of information are made clear if they are not self-evident. These 
are based on what is directly observable and/or what can be determined with 
minimal inference or speculation. 
2. The nature and basis for how observations relate to each other is made clear  
0 – For the most part, it is not possible to readily discern how observations are 
thought to be linked and to follow from each other. The positioning of 
observations in relation to each other and the links portrayed between them 
seem arbitrary or loosely based on a common theme rather than representing 
sensible contingent relationships. What is provided bears little resemblance to 
how events inter-relate in real-life, and the diagram does not appear to depict a 
plausible configuration of circumstances.  
1 – There is considerable ambiguity in the diagram regarding the positioning of 
observations in relation to each other and the use of linking symbols to convey 
the nature of their contingent relationships, leaving the intention of what is 
being depicted difficult to fully understand and to infer the set of real-life 
circumstances to which the diagram corresponds. 
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2 – There is minor ambiguity in the diagram regarding the positioning of 
observations in relation to each other and the use of linking symbols to convey 
the nature of contingent relationships. However, where this occurs, what is 
intended can be readily inferred, and it is possible to imagine a set of real-life 
circumstances to which the diagram corresponds. 
3 – For the most part, the basis for how observations are linked to each other is 
made clear through their relative positioning within the diagram and through 
clear use of linking symbols (e.g., specifying if causally related or correlated 
and direction of causality). The nature of contingencies between observations 
and how they are thought to increase the likelihood of each other’s occurrence 
is readily understood and corresponds sensibly to a potential real-life situation.   
3. Explanations (hypotheses, theories, membership in a diagnostic group or other 
typology, inferred aetiology, inferred historical processes or developmental 
events) are included that are distinct from observations. These are used to help 
synthesise and make sense of the information included in the diagram.  
0 – Needed explanations are lacking and little is provided by way of conceptual 
synthesis. 
1 – Insufficient explanations are provided to complement what can be 
portrayed by the observations alone. Provided explanations are unclear or it is 
not immediately apparent what the basis is for relating the explanation to the 
particular observations. 
2 – Sufficient explanations are provided that are clearly linked to relevant 
observations, but there is some lack of clarity about the conceptual basis for 
explanations or their relevance to the observations. 
3 – Provided explanations are clearly and sensibly linked to observations, and 
they complement what can be addressed by observations alone. The 
explanations contribute to an integrated conceptual basis for what is 
represented in the formulation.   
4. Key contextual elements are included. The formulation incorporates contextual 
elements (moderators) such as time, place, others present or absent, emotional 
state, and other factors relevant to exacerbation or amelioration of an aspect of 
the problem in terms of its form and frequency of occurrence. Taken together, 
they provide a useful context for understanding the antecedents (both 
immediate and historical) of the problem and the circumstances under which it 
presents itself.  
0 – Moderators are not included or their presence does not add explanatory 
value 
1 – Some moderators are included but these are isolated or otherwise provide 
limited information about how they operate and the circumstances in which 
the problem can be expected to occur. 
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2 – Moderators are included that help build a contextual picture of the 
circumstances in which the problem can be expected to occur and 
the form it takes, but how they operate is incomplete or unclear in 
some way. 
3 – Moderators are included that play a clear role in the formulation and 
together help build a comprehensive contextual picture of the 
circumstances in which the significant aspects of the problem can 
be expected to occur and what form this takes. 
5. Functional equivalence between superficially dissimilar elements (either 
triggers or responses) is denoted where this has implications for understanding 
the problem.  The common function underlying the elements contributes to the 
delineation of the overall pattern of circumstances that make aspects of the 
problem more likely to occur.   
NA- Not applicable 
0 - Functional equivalence is overlooked or not represented when appropriate 
1 – Functional equivalence is represented but equivalence is not convincing or 
doesn’t add explanatory value.  
2 – Functional equivalence is represented but equivalence is not fully 
convincing or adds little explanatory value 
3 - Functional equivalence is represented convincingly and in a way that 
contributes to understanding of the patterns of circumstances within which the 
problem is likely to occur. 
 
6. Significant mediators are identified and their roles are made clear. Potential 
psychological (e.g., client self-talk and content of beliefs) or other mediators 
(e.g., mood) are identified through the client’s report or, where clearly justified 
by the evidence, through inference. These are meaningfully situated within the 
diagram in a manner that makes their role clear. 
0 – Mediators are not included where they would be expected to play a role or 
their presence or how they are described is confusing or otherwise does not add 
explanatory value 
1 – Mediators are included but their linking function between the other 
observations to which they are related is not convincingly established or made 
clear. 
2 – Mediators are included that meaningfully link indirectly related 
observations but there is some lack of clarity about the nature of its mediation 
role or its necessity in the causal sequence in which it plays a part.  
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3 – Mediators are included that meaningfully link indirectly related 
observations in a way that sheds light on their necessity in the causal sequence 
in which they play a part.  
 
B. Validity and Explanatory sufficiency 
 
7. The formulation is a coherent and comprehensive account of the available 
information. The diagram integrates and structures the information to draw 
together all the factors comprising and influencing the problem and portrays 
their patterns of interaction.   
0 – The formulation lacks coherence and does not satisfactorily account for 
information that has been gained.   
1 – The formulation partially accounts for the information gained about the 
client’s problem, but there are important observations that are not satisfactorily 
integrated or accounted for and an overall lack of explanatory coherence.  
2 – The formulation accounts for most of the information gained about the 
client’s problem, but there are some observations that are not satisfactorily 
integrated or accounted for or comparable minor issues related to explanatory 
coherence.   
3 – Overall, the formulation provides a coherent account of the client’s 
problem that incorporates the relevant information and leaves comparatively 
little unexplained, integrating and structuring the factors contributing to the 
problem and delineating their patterns of interaction. 
 
8. The formulation delineates mechanisms of change in terms of the elements 
(observations and explanations) depicted in the diagram and their connections, 
and provides a basis for understanding where and how to intervene and what to 
prioritise.  
0 – The formulation does not appear to be suitable for establishing how the 
problem has arisen and how it is being sustained and so does not provide any 
apparent basis for choosing where and how to intervene and what to prioritise.  
1 – The formulation does not provide a readily apparent account of how the 
problem has arisen and how it is being sustained and so is of limited use for 
anticipating how the problem could change under different circumstances and 
for choosing where and how to intervene and what to prioritise. 
2 – The formulation accounts for how the problem has arisen and how it is 
being sustained, which provides a basis for identifying where and how to 
intervene. However, this basis may be not be immediately apparent or it may 
be incomplete or unclear in some respect. There may also be uncertainty about 
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how the problem could change under different circumstances or what to 
prioritise.  
3 – The formulation incorporates key causal patterns that account for how the 
problem has arisen and how it is being sustained. It supports inferences about 
how the problem could change under different circumstances that provide a 
sufficient basis for choosing where and how to intervene, including what to 
prioritise.  
 
9. The formulation manages complexity successfully.  
NA- Not applicable 
0 – The formulation fails to address the issue of complexity in terms of the 
overall organisation of information into separate or non-separate sets of 
problems.  
1 – Regarding complexity, the formulation reflects questionable decisions 
about what to include or the level of detail. There may be problems with the 
overall organisation of the information into separate or non-separate sets of 
problems or arbitrary lumping together of observations with minimal 
conceptual basis.  
2 –Complexity is adequately addressed, but minor shortcomings are evident 
with regard to level of detail, what is included, how information is combined or 
kept separate, or ambiguity regarding how separate problems are defined.     
3 – The formulation achieves a successful balance between choice of what 
information to include, the level of detail, and whether multiple problems 
should be combined or addressed separately. Where multiple problems exist, 
these are clearly defined and are discernible from each other.   
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Appendix 2. Pre and post formulation instructions 
Pre- Formulation training diagram form 
INSTRUCTIONS:  
Thank you for helping our research by completing a formulation diagram—we are 
very grateful for your assistance.  Please follow these steps: 
1. Please look at the next page for an idea of the sort of diagram we are interested 
in. We are asking you to provide an ad hoc, non-structured diagram, rather 
than a structured diagram such as a hot-cross bun, vicious flower, etc.  
2. Please read the vignette, identifying the information that appears to be relevant 
to addressing the person’s concerns. 
3. On Page 4, please provide a formulation diagram of the client’s situation that 
conveys how you have drawn on the information provided in the vignette to 
formulate their problem in order to guide a potential intervention. 
4. Please explain the symbols you used in your diagram, below. 
Example:  Boxes = behaviours; Single headed arrows = shows one thing 
causing another 
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Therapist number: 
Your formulation diagram: 
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Post- Formulation training diagram form 
INSTRUCTIONS: 
Thank you for helping our research by completing a post workshop formulation 
diagram—we are very grateful for your assistance.  Please follow these steps: 
1. Based on the workshop you attended, please complete an individual case 
formulation in line with the system presented in the workshop, etc.  
 
2. Please re-read the vignette (the same vignette as for the pre-workshop 
diagram), identifying the information that appears to be relevant to addressing 
the person’s concerns. 
3. On Page 3, please provide a formulation diagram of the client’s situation that 
conveys how you have drawn on the information provided in the vignette to 
formulate their problem in order to guide a potential intervention. 
 
Suggested strategy for creating an ICF diagram  
 
1.Run through the text, identifying potential elements that need to go into the 
diagram. Elements requiring little or no inference are represented in circles or ovals.  
2.Identify elements that are functionally equivalent—e.g., elements that are either (a) 
all capable of evoking the main problem or (b) how the person responds/tries to cope 
when the problem arises. Group functionally equivalent elements together, linked by 
double non-headed lines.  
3.Consider what the antecedents are of observed elements (behaviours, unpleasant 
emotions, thoughts, etc.) or groups of elements (where these are functionally 
equivalent). Link antecedents to corresponding behaviours with a single headed arrow 
where the direction of causality is one-way or with a two-headed arrow where the 
causality is reciprocal.  
4.For reciprocal relationships, indicate whether it is a positive loop or a negative one, 
if clarity is needed.  
5.Consider what the consequences are of observed elements or groups of elements 
(where functionally equivalent). Link triggering elements to their consequences.  
6.Consider what could possibly explain the relationships among the observed 
elements. Place possible explanations in squares/rectangles and link these to the 
relevant observed elements with dashed un-headed lines.  
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Therapist number: 
Your formulation diagram post workshop: 
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Appendix 3. Ethical Approval: South East Scotland Research Ethics Committee 
02
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Appendix 4: Health Research Authority (HRA) approval 
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Appendix 5. A substantial amendment Approval by the HRA 
 
Dear Alicia Griffiths, 
Further to the below, I am pleased to confirm that HRA Approval has been 
issued for the referenced amendment, following assessment against the HRA 
criteria and standards. 
 The sponsor should now work collaboratively with participating NHS 
organisations in England to implement the amendment as per the below 
categorisation information.  This email may be provided by the sponsor to 
participating organisations in England to evidence that the amendment has 
HRA Approval. 
 Please contact hra.amendments@nhs.net  for any queries relating to the 
assessment of this amendment. 
Yours sincerely, 
Rekha 
 
Rekha Keshvara |  Assessor 
Health Research Authority 
Nottingham HRA Centre, The Old Chapel, 
Royal Standard Court, Nottingham NG1 6FS 
E: Rekha.Keshvara@nhs.net | T: 0207 104 8191 
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Appendix 6: A substantial amendment Approval by South East Scotland 
Research Ethics Committee 02 
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Appendix 7. Local Research and Development (R&D) department ethical 
approval: Homerton University 
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Appendix 8. Local Research and Development (R&D) department ethical 
approval: Barnet, Enfield & Haringey 
 
Dear Alicia, 
RE: IRAS 201009. Confirmation of Capacity and Capability at Barnet Enfield & 
Haringey NHS Mental Health Trust 
 Full Study Title: A single case study exploring the use of an individual case 
formulation for assisting treatment of PTSD. 
 Latest HRA Approval Date: HRA Approval – Dated  25.05.2016 
  
This email confirms that Barnet Enfield & Haringey NHS Mental Health Trust has the 
capacity and capability to deliver the above referenced study. Please find attached the 
signed agreement  as confirmation. 
Barnet Enfield & Haringey NHS Mental Health Trust agrees to start this study on a 
date to be agreed when you as sponsor give the green light to begin. Please ensure 
the R&D office and local CRN contacts are provided with this date. 
  
If you wish to discuss further, please do not hesitate to contact us. 
  
As specified in the HRA Approval, Letters of Access for members of the external 
research team maybe required and should be arranged prior to the relevant team 
members conducting any study interventions. 
 Please note, in line with national HRA approvals process, you will no longer receive 
an NHS R&D Approval/Permission letter. 
 Kind regards, 
 Atote On behalf of Barnet Enfield & Haringey NHS Mental Health Trust 
 Noclor Research Support Service 
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Appendix 9. Local Research and Development (R&D) department ethical 
approval: The Whittington Hospital 
 
Dear Alicia, 
RE: IRAS 201009. Confirmation of Capacity and Capability at The Whittington 
Hospital NHS Trust 
 Full Study Title: A single case study exploring the use of an individual case 
formulation for assisting treatment of PTSD. 
 Latest HRA Approval Date: HRA Approval – Dated  25.05.2016 
  
This email confirms that The Whittington Hospital NHS Trust has the capacity and 
capability to deliver the above referenced study. Please find attached the signed 
agreement  as confirmation. 
The Whittington Hospital NHS Trust agrees to start this study on a date to be 
agreed when you as sponsor give the green light to begin. Please ensure the R&D 
office and local CRN contacts are provided with this date. 
  
If you wish to discuss further, please do not hesitate to contact us. 
  
As specified in the HRA Approval, Letters of Access for members of the external 
research team maybe required and should be arranged prior to the relevant team 
members conducting any study interventions. 
 Please note, in line with national HRA approvals process, you will no longer receive 
an NHS R&D Approval/Permission letter. 
 Kind regards, 
 Atote On behalf of The Whittington Hospital NHS Trust 
 Research Support Service 
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Appendix 10: Image Intrusiveness Visual Analogue Scales (IVAS) 
When people experience traumatic events they often have distressing intrusive images or 
memories from the past.  
Please circle a number from the scales below which best describes your experience 
of distressing intrusive images or memories you have had over the past week. 
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Appendix 11: Encapsulated Belief Visual Analogue Scale (EBVAS) 
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Appendix 12: Impact of Events Scale-Revised 
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Appendix 13: PTSD checklist for DSM- 5 
PCL-5 
Instructions: This questionnaire asks about problems you may have had 
after a very stressful experience involving actual or threatened death, 
serious injury, or sexual violence. It could be something that happened 
to you directly, something you witnessed, or something you learned 
happened to a close family member or close friend. Some examples are 
a serious accident; fire; disaster such as a hurricane, tornado, or 
earthquake; physical or sexual attack or abuse; war; homicide; or 
suicide.  
First, please answer a few questions about your worst event, which for 
this questionnaire means the event that currently bothers you the most. 
This could be one of the examples above or some other very stressful 
experience. Also, it could be a single event (for example, a car crash) or 
multiple similar events (for example, multiple stressful events in a war-
zone or repeated sexual abuse).  
Briefly identify the worst event (if you feel comfortable doing so): 
_________________________  
How long ago did it happen? ____________________ (please estimate if 
you are not sure)  
Did it involve actual or threatened death, serious injury, or sexual 
violence?  
_____Yes  
_____No  
How did you experience it?  
_____ It happened to me directly  
_____ I witnessed it  
_____ I learned about it happening to a close family member or close friend  
_____ I was repeatedly exposed to details about it as part of my job (for example, paramedic, 
police, military, or other first responder)  
_____ Other, please describe ____________________________  
If the event involved the death of a close family member or close friend, 
was it due to some kind of accident or violence, or was it due to natural 
causes?  
_____Accident or violence  
_____Natural causes  
_____Not applicable (the event did not involve the death of a close family member or close 
friend)  
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Appendix 14. Life Events Checklist 
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Appendix 15. The Patient Health Questionnaire-9 (PHQ-9) 
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Appendix 16: The Generalised Anxiety Disorder Scale (GAD-7) 
 
 
 
 
 
 
 
 
  241 
Appendix 17. The Work and Social Adjustment Scale (W&SAS) 
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Appendix 18. Participant Information sheet 
Participant Information Sheet (version 3, 26/09/2016) 
(Headed paper of NHS foundation Trust) 
 
 
 
Study title: A single case study exploring the use of an individual case 
formulation in assisting treatment of PTSD. 
 
Invitation  
We would like to invite you to take part in our research study. Joining the 
study is entirely up to you and before you decide we would like you to 
understand why the research is being conducted and what it would involve for 
you. One of our team will go through this information sheet with you to help 
you to decide whether or not you would like to take part and answer any 
questions you may have. Please take time to read the following information 
carefully and feel free to ask any questions as you go through the information 
sheet.  
 
Summary 
This study is part of a Clinical Psychology Doctoral research project 
investigating how clinicians make sense of individual cases in treating 
Post-Traumatic Stress Disorder (PTSD), a process called “formulation”. 
We are interested in finding out more about treating PTSD that co-
occurs with other disorders and this study will examine which aspects of a 
formulation relate to treating PTSD, particularly in the context of co-existing 
problems.  
This research will potentially have implications for psychology services and 
treatment of psychological disorders that co-occur with other disorders.  
 
Why have I been invited?  
You have been invited to take part because you have symptoms of PTSD and 
are awaiting treatment for PTSD at xxxxxxxxx, where this research is being 
carried out.  
 
What would taking part involve? 
By taking part, the treatment that you receive for PTSD will not differ from 
treatment as usual. You will be asked to complete questionnaire measures at 
3 time points before you start treatment and also at the end of each treatment 
session. The questionnaires should take around 10 minutes to complete after 
each session. For PTSD treatment, people usually attend sessions weekly, 
but this will be decided between you and your treating Clinician. The study will 
last around 10 months in total. You will be involved in the study for as long as 
your treatment lasts. Data collection for this study will end in spring 2017 and 
therefore if your treatment has not finished at this point, we will use the data 
that we have collected already and your treatment will continue as normal.  
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If you would like to know the results of this study, please inform your Clinician 
as a report will be generated at the end of the study for all research 
participants to learn about the results. By taking part, you will be adding to 
existing knowledge about formulations and also about treatment of PTSD 
alongside co-morbidities.   
 
Are there any risks of taking part in the study? 
There are no additional risks of taking part in the study than there are for 
routine treatment for PTSD.  
 
Confidentiality 
Confidentiality will be maintained during the study. All data that is collected 
will remain confidential to the researchers. You will be given a unique 
identification number and no one other than the research team will be able to 
identify you from this number. Data collected will be anonymised, stored 
securely and evaluated only at xxxxxxxxx. Your data will be kept for the 
purposes of this research only and will be destroyed once the study has 
finished. We would like to let your GP know that you are involved in the study. 
The findings of this study will hopefully be published. Your anonymity will be 
maintained during publication. 
 
Risk to confidentiality  
Consistent with treatment as usual, if you disclose risk of harm to yourself or 
another individual, we might need to inform your GP. Any risk issues that are 
disclosed will be managed and monitored by your Clinician and the team at 
xxxxxxxxx. 
 
Onward referral 
As with normal treatment, onward referral to another service may be required 
part way through the study (or at the end of the study). Onward referral to a 
crisis team might be required if you disclose risk of harm to yourself during 
treatment sessions.  
 
What happens if I decide not to take part? 
There is no obligation to take part in this study. If after reading this information 
sheet you decide that you do not wish to participate in the study, your 
treatment will not be affected in any way.  
 
Can I leave the study part way through? 
If you decide to take part in the study, you have the right to withdraw at any 
time during the study without giving a reason. Your access to treatment will 
not be affected.  
 
What happens next if I decide to take part? 
If after reading this information sheet you are happy to be involved in the 
study, please sign the consent form. You will be asked to complete some 
questionnaires prior to your treatment sessions.  
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Thank you for reading this participant information sheet. If you have any 
questions now or at any time, please do not hesitate to contact a Clinician at 
xxxxxxx or contact xxxxxxx, Consultant Psychologist and Clinical Lead 
who is the field supervisor for this project.   
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Appendix 19. Consent form 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	
 
 
(Headed	paper	of	NHS	foundation	Trust)  
	
	
	
	
Participant Identification Number: 
Consent form (version 3, 26/09/2016) 
Title of Project:	A single case study exploring the use of an individual case formulation in 
assisting treatment of PTSD. 
Name of Researcher: Alicia Griffiths 
Please initial box  
1. I confirm that I have read the information sheet dated.................... (version............) for the 
above study. I have had the opportunity to consider the information, ask questions and have 
had these answered satisfactorily. 
 
2. I understand that my participation is voluntary and that I am free to withdraw at any time 
without giving any reason, without my medical care or legal rights being affected. 
 
3. I understand that relevant sections of my medical notes and data collected during 
the study may be looked at by individuals from the research team, or from the NHS Trust,                              
where it is relevant to my taking part in this research. I give permission for 
these individuals to have access to my records.  
 
4. I agree to my General Practitioner being informed of my participation in the study. 
 
5. I agree to take part in the above study. 
 
            
Name of Participant  Date    Signature 
 
            
Name of Person taking consent   Date                         Signature              
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Appendix 20: Example pages from the therapist research pack 
 
THESIS PROJECT: A single case study exploring the use of an individual case 
formulation in assisting treatment of PTSD. 
Dear therapist,  
Thank you for supporting this research project. This folder was created in order to clarify 
and simplify administration of measures and to increase consistency across participants.  
 
 
Project information  
This study is using a single case experimental design (SCED). This means that the study 
requires 3 baseline data points per participant before implementation of the intervention. 
Data will then be collected after the intervention for a minimum of 3 weeks. 
 
This folder contains an index detailing where you can find the materials including all the 
measures necessary on a week-by-week basis.  
 
 
Procedure  
• Measures are to be collected at each Session. 
• This pack will provide a step-by-step guide as to which measures to collect at 
each Session (they are all in plastic wallets provided labeled by Session 
number). 
 
 
 
Index page 
 
Demographic information              Page 3 
Session 1 + 2                                    Page 4 
After Session 2                               Page 5 
Session 3                                           Page 7 
Session 4 onwards                        Page 8 
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Demographic information  
 
 
Participant ID ____________________________________ 
 
 
Age _____________ 
  
 
Gender ___________ 
 
 
Ethnicity ______________________________ 
 
 
Current employment ____________________________________________________ 
 
 
Trauma Type _________________________________________________________ 
 
 
Trauma Duration ______________________________________________________ 
 
 
Time since Trauma _____________________________________________________ 
 
 
 
Previous trauma treatment _______________________________________________ 
 
 
Co-morbid disorders____________________________________________________ 
 
 
Current medication _____________________________________________________ 
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Sessions 1 + 2 - measures only 
 
Measures are provided in the plastic wallets labeled Session 1 and Session 2. Please 
ask Clients to complete all of these before the start of each session and put them back 
in the wallets afterwards. I will collect these and remove them afterwards. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
After session 2 - Creating the formulation 
After Session 2, we will ask you to complete an Individual Case Formulation for your 
client based on the training you had. There is a step-by-step guide on the next page to 
help you to do this. Please use this check box to help you to remember the stages. 
 
 
Measure (Session 1) 
PLEASE 
TICK WHEN 
COMPLETE 
(Session 2) 
PLEASE 
TICK WHEN 
COMPLETE 
 
Intrusive images visual analogue scales 
(VASs) 
  
Encapsulated belief scale (EVAS)   
Impact of Events Scale Revised (IES-R)   
PTSD checklist for DSM-5 (PCL-5)   
Life Events Checklist (LEC) – only at 
Session 1  
  
 YES/NO 
Have you drawn out an ICF for this participant prior 
to session 3?  
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Appendix 21. PA: Variability Analysis (Trended Range) IVAS and EBVAS  
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Appendix 22. PB: Variability Analysis (Trended Range) IVAS and EBVAS 
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Appendix 23. PC: Variability Analysis (Trended Range) IVAS and EBVAS 
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Appendix 24. PD: Variability Analysis (Trended Range) IVAS and EBVAS  
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Appendix 25. PE: Variability Analysis (Trended Range) IVAS and EBVAS 
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Appendix 26. PF: Variability Analysis (Trended Range) IVAS and EBVAS  
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Appendix 27. PG: Variability Analysis (Trended Range) IVAS and EBVAS  
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Appendix 28. PH: Variability Analysis (Trended Range) IVAS and EBVAS 
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